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Abstract
Understanding the mechanisms that control the body’s response to inflammation is
of key importance, due to its involvement in myriad medical conditions, including
cancer, arthritis, Alzheimer’s disease and asthma. While resolving inflammation has
historically been considered a passive process, since the turn of the century the hunt
for novel therapeutic interventions has begun to focus upon active manipulation of
constituent mechanisms, particularly involving interactions between immune cells and
pro- and anti-inflammatory mediators. We here address the specific question of how
inflammatory damage can spread spatially due to the motility of these cells and
mediators using mathematical and agent-based modelling.
We firstly extend the existing homogeneous models of Dunster et al. (2014) to
incorporate spatial behaviours. Through bifurcation analysis and numerical sim-
ulation of the resulting partial differential equation (PDE) models, we show that
spatially-inhomogeneous outcomes can present close to the switch from bistability to
guaranteed resolution in the corresponding homogeneous models, but that this be-
haviour is tightly controlled by the dynamics of anti-inflammatory mediators. We
then move to a hybrid PDE-Agent Based Model (ABM) approach, capable of sim-
ulating individual cells and a more diverse range of cell behaviours. In particular,
we address the questions of whether initially localised damage can invade neighbour-
ing healthy tissue, and the extent to which sub-optimal directed cell motility (such
as that associated inflammatory conditions such as chronic obstructive pulmonary
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disease) can impact upon the long-term outcome. We illustrate that changes to the
values of physiologically-relevant parameters can act as a switch between healthy and
pathological scenarios; with careful parameterisation, our approach exhibits scope for
elucidating how these key mechanisms could be actively manipulated to potentially
identify new therapeutic interventions.
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Chapter 1
Introduction
Inflammation (and its resolution) is central to the progression of many diseases and
health conditions. Therefore, a thorough understanding of the process involved in
the inflammatory response is central to the ongoing hunt for new treatments and
therapies. The over-arching aim of this thesis is to investigate, through mathemati-
cal models, the implications of the spatial spread of inflammation on the long-term
global outcome, examining whether spatially-dependent aspects of the inflammatory
response, such as cell motility, can allow localised damage to invade neighbouring
healthy tissue or can present a switch between restoration of health and chronic
outcomes. This is motivated by current gaps in the existing literature, in which theo-
retical models of inflammation overwhelmingly focus on its temporal dynamics, often
neglecting the spatial domain in which biological variables of interest operate.
In this study, we aim at addressing these gaps by developing spatial models of in-
flammation, focusing on interactions between groups of cells prompted by the immune
response upon tissue injury. We first extend an existing homogeneous model that cap-
tures interactions between inflammatory mediators, neutrophils and macrophages to
incorporate spatial behaviour. Through bifurcation analysis and numerical simula-
tion, we show that spatially inhomogeneous outcomes can present close to the switch
10
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from bistability to guaranteed resolution in the corresponding homogeneous model.
Finally, we show how aberrant spatial mechanisms can play a role in the failure of
inflammation to resolve and discuss our results within the broader context of seek-
ing novel inflammatory treatments. We then proceed to describe the assembly of a
hybrid mathematical model in which the spatial spread of inflammatory mediators is
described through partial differential equations, and immune cells (neutrophils and
macrophages) are described individually via an agent-based modelling approach. We
pay close attention to how immune cells chemotax toward pro-inflammatory media-
tors, presenting a model for cell chemotaxis that is calibrated against experimentally
observed cell trajectories in healthy and Chronic Obstructive Pulmonary Disease
(COPD)-affected scenarios. We illustrate how variations in key model parameters
can drive the switch from resolution of inflammation to chronic outcomes, and show
that aberrant neutrophil chemotaxis can move an otherwise healthy outcome to one
of chronicity. Finally, we reflect on our results in the context of the on-going hunt for
new therapeutic interventions.
This chapter presents an overview of the main topics of interest for this work,
by providing a theoretical introduction to a number of subjects that will be further
developed in the following chapters. Firstly, a brief summary of the conditions that
involve inflammation is provided in Section 1.1; a detailed biological description of
the inflammatory process follows in Section 1.2; a review of the relevant literature
in the modelling of inflammation is also presented in Section 1.3, followed by the
definition and significance of patterns in biology and mathematics in Section 1.4;
finally an overview of the whole thesis is provided, by outlining each chapter’s content
in Section 1.5.
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1.1 The prominence of inflammation in health and
disease
Inflammation has a central role in a large variety of pathophysiological processes
and has long been recognised as a crucial step in the development of many diseases
and chronic conditions. Although the range of pathologies that feature or arise from
inflammation varies greatly (from cancer, to diabetes, to arthritis just to name a
few), the cellular and chemical pathways that characterise the acute inflammatory
response remain the same, making it important to specify and clarify these generic
underlying mechanisms that control and lead these processes. As the common denom-
inator in response to both tissue injuries and infectious agents, inflammation has long
been associated to many diseases, thus suggesting a new approach in investigating
complex pathologies such as cancer or Alzheimer, amongst others, by tackling those
inflammatory mechanisms that have been shown to play a role in the development
of such serious conditions. In this sense, inflammation can be regarded as key to a
variety of diseases, many of which are still poorly understood; studying inflammation
thus provides scope for new perspectives in the development of drugs and treatments
(Hunter, 2012). While acute inflammation in itself is a physiological process aimed
at promoting the release and action of specific cells and chemicals in order to re-
store a healthy state that has been disrupted by either injury or external pathogens,
impairments and disorders affecting the delicate network of interactions that tightly
regulate the inflammatory response can lead to chronic damage. Most diseases asso-
ciated with inflammation arise from its degeneration into chronic state (Libby, 2007),
with perpetual or recurring inflammations recognised as symptoms and features of
such conditions.
Diabetes, a metabolic disease affecting an ever increasing number of people world-
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wide, has long been associated with inflammation, with researchers identifying the
role of the immune system in its pathogenesis (Pollack et al., 2016). While this con-
nection has already been characterised in type 1 diabetes, the links suggesting the
exact mechanisms of inflammation’s action on pancreatic cells and insulin resistance
are still poorly understood, but nevertheless remain key in type 2 diabetes as well,
as illustrated by Donath & Shoelson (2011). While traditional treatment for type 2
diabetes focuses on reducing hyperglycemia, completely neglecting the role of inflam-
mation in this disease, in recent years a great interest has been posed in targeting
this debilitating and costly long term condition with anti-inflammatory therapies.
However, it still remains challenging to fully appreciate the inflammatory pathways
that feature in diabetes and how best to address them in terms of development of
new drugs and treatments (Deans & Sattar, 2006). Furthermore, the link between
inflammation and diabetes has much wider implications, by directly involving or trig-
gering other pathologies such as obesity, which has also been associated to low levels
of chronic inflammation, as exposed by Wellen & Hotamisligil (2005).
A number of heart conditions have also been shown to arise in response to inflam-
matory mechanisms. Given the impact of these diseases and their strong correlation
to type 2 diabetes and obesity, the centrality of inflammation and in particular of
pro-inflammatory cytokines as markers of cardiac disorders motivate the interest of
researchers in further investigating the links between these often complementary and
overlapping conditions (Yudkin et al., 2000). Following this pattern, Koenig (2001)
and Yudkin et al. (2000) have individuated specific inflammatory mediators that are
key in the development of coronary heart disease. More generally, as illustrated by
Hansson (2005), atherosclerosis, which eventually leads to coronary heart disease, is
in itself an inflammatory disease that still remains challenging to tackle in spite of
its high incidence in mortality rates worldwide (Barquera et al., 2015; Roquer & Ois,
2010). As explained by Libby (2006), the focus of researchers in this area is to better
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clarify the inflammatory mechanisms that underlie cardiovascular diseases, in order
to help targeting and prevent their development at much earlier stages.
Among the pathologies directly arising as a result of systemic chronic inflamma-
tion, rheumatoid arthritis is of particular importance. This disease is characterised by
recurring inflammation of joints, eventually leading to their irreversible deterioration
and triggering in turn the activation of additional inflammatory pathways (Sweeney
& Firestein, 2004; Chimenti et al., 2015). The systemic spread of inflammatory pro-
cesses initiated by articular inflammation further worsens the risks of cardiovascular
morbidity and constitutes a precursor of ventricular arrhythmias (Lazzerini et al.,
2017).
Pulmonary diseases also figure amongst the many chronic conditions associated
with inflammatory mechanisms. As highlighted by Gan et al. (2004), inflammatory
markers are expressed in correspondence to impaired lung functionality, typical of
chronic obstructive pulmonary disease. This disease is itself a leading factor towards
a number of conditions like cardiovascular disorders and osteoporosis. Again, a funda-
mental link between these diseases is systemic inflammation, as exposed by Sevenoaks
& Stockley (2006), with early detection of the pro-inflammatory activity and targeted
therapeutics currently being crucial points of focus within the research community.
As it is well established that many cancers arise from chronic states of inflamma-
tion (Moss & Blaser, 2005; Itzkowitz & Xianyang, 2004), much of the research related
to tumourigenesis as well as its proliferation and metastatisation involves the study
and analysis of the inflammatory pathways from which neoplasias may arise. While it
is clear that inflammation does not necessarily degenerate into cancer development,
the understanding of the mechanisms that regulate its chronicisation remains one of
the key issues researchers are interested in. Inflammation is known to be a risk factor
for many cancers (Shanthini & Balkwill, 2015), while also playing a critical role in fur-
ther stages of tumour progression (Grivennikov et al., 2010; Coussens & Werb, 2002).
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As such, the new approaches in both the diagnosis of early tumour formation and the
development of anti-tumoural drugs point towards the benefits of targeting inflam-
mation as a promising alternative to more traditional and aggressive treatments. In
particular, the expression of inflammatory cytokines within the neoplastic microenvi-
ronment suggests to further investigate the impact of anti-inflammatory therapies in
the treatment of cancer. While tumour related therapies already include a number of
anti-inflammatory drugs and treatments, the clarification of the role of inflammation
in tumour growth and spread remains a promising leading aspect of cancer research
(Rayburn et al., 2009; Balkwill et al., 2005).
Inflammation has been shown to be critical and possibly decisive also in the
broader spectrum of Central Nervous System (CNS) injuries and diseases as well as
modulating the progression of neurodegenerative disorders. The implications of such
a link are multiple and fundamental in suggesting new investigative and therapeutic
approaches to a variety of serious conditions (strokes, Alzheimer’s and Parkinson’s
diseases, . . . ) that are still incurable and affect a growing number of people worldwide.
In particular, inflammatory activity within the CNS is now recognised as a leading
factor in the development of neurodegenerative diseases (Perry, 2004). On the other
hand, the expression of different cytokines and their varied effects at different stages
of the inflammatory response highlights the difficulties in determining the exact mech-
anisms that regulate the progression of CNS diseases. The highly dynamical nature
of inflammation as a tightly balanced and controlled response of both beneficial and
disruptive cascades of interactions explains the more recent interest of researchers
in investigating the impact of the promotion of specific inflammatory pathways as
a therapeutic tool, rather than suppressing inflammation altogether (Wyss-Coray &
Mucke, 2002). Lucas et al. (2006) expose the promising but still partial results that
this approach has provided for various CNS diseases, by targeting specific inflamma-
tory mediators in the development of new therapies. While the potential benefits of
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this approach for acute CNS injuries (traumatic brain injuries, stroke, cerebral is-
chaemia, epilepsy, . . . ) are already clear, this paper also highlights the criticality and
challenges in the characterisation of chronic CNS diseases, where the exact role and
effect of inflammatory mediators on the progression of neurodegenerative disorders
are still poorly understood, with experimental trials and animal models providing
mixed results. In particular, as shown by Gao & Hong (2008), is the degeneration
of neuroinflammation into an uncontrolled process that characterises the progression
of irreversible neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Hunt-
ington’s diseases and multiple and amyotrophic lateral scleroses. The understanding
and regulation of inflammation is thus seen as key in the progression of neurodegen-
erative disorders, whose development and outcome can be modulated by the same
inflammatory mechanisms that trigger them. This principle has since shifted the fo-
cus of researchers in treating and analysing Alzeheimer’s as an inflammatory disease
(Strohmeyer & Rogers, 2001; Heppner et al., 2015; Holmes & Butchart, 2011), with
Wyss-Coray & Rogers (2012) identifying inflammation as a possible tuning tool in the
prevention and treatment of Alzheimer’s. Similarly, the research of other prominent
neurodegenerative disorders has also seen significant progress in this direction (Hald
& Lotharius, 2005; Perez-Cerda et al., 2016; Rocha et al., 2016).
Below, we examine in greater detail the key cellular and molecular events that
contribute to the inflammatory response in the myriad conditions described above.
1.2 A biological introduction to inflammation
Inflammation is a physiological process that involves a complex and intricate chain
of reactions, at both cellular and molecular levels, as well as on a macroscopic scale,
that has long been investigated and studied. The understanding of acute inflam-
mation can be easily traced back to antiquity, with the four cardinal signs of the
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inflammatory event being identified, more than two millennia ago, by the Roman
physician Cornelius Celsus as rubor et tumor cum calore et dolore, that is redness
and swelling with heat and pain (Woolf, 1986; Plytycz & Seljelid, 2003). By taking
into account also a fifth key feature, that is functio laesa or loss of function, a minimal
but accurate description of what inflammation is already emerges. In the following
centuries and up to now, many more in-depth mechanisms have been identified and
clarified, outlining how inflammation consists of a number of many complex, different
and overlapping events, with the main aim of restoring the perturbed equilibrium of
a previous healthy state. This perturbation can come in a variety of forms, most
commonly by either injury or pathogenic infection, with any of such disruptive events
eventually damaging the tissue and thus immediately triggering acute inflammation,
expressly a series of localised and cellular changes that typically resolve within hours
to days.
In this context, upon damage, the inflammatory response is set up by specific
immune cells which are locally recruited and serve as sentinels of the insulted tissue
(Diegelmann & Chalfant, 2016). Sentinel cells are a group of various cells that are
involved, with different roles, in the first line of defence to develop an appropriate line
of action against the occurring injury. More specifically, this consists in identifying
the damage (either traumatic or pathogenic) through special surface receptors that
recognise molecular patterns typical of wounded tissue or infectious agents. The swift
sensing of sentinel cells is the main trigger to a larger scale of cellular interactions and
prompts the further release of pro-inflammatory mediators which in turn contribute
to and actively promote the inflammatory response. The chain of cellular interactions
that spur from the prolonged pro-inflammatory activity eventually leads to a quick
and efficient clearance of the damaged site, paving the way for tissue repair and full
recovery, by a strong decrease in concentration of both pro-inflammatory mediators
and acute inflammatory cells while enhancing the production of anti-inflammatory
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mediators which actively counteract inflammation’s spread and development, thus
ensuring that a healthy condition is restored (Serhan et al., 2010).
1.2.1 Cellular events in acute inflammation
The tight network of events that regulate acute inflammation, upon tissue damage,
provide the injured site with a quick and continuous release of inflammatory mediators
that differentiate in nature, specific function and timespan effectiveness but overall
help to coordinate, promote and eventually resolve inflammation. In particular, two
large groups of chemicals serving as pro- and anti-inflammatory mediators are active
and high in concentration, the former at early and progressing stages of inflammation
and the latter in its final stages. Pro-inflammatory mediators comprise a wide range of
molecules, with a subset already present and stored as preformed in the healthy tissue
and immediately released by specific cells (mast cells, Diegelmann & Chalfant, 2016).
From the variety of chemicals released by these cellular granular stores, (namely serine
proteases, vasoactive amines, cytokines and growth factors), the vasoactive amine
histamine is responsible for vasodilation and increase in capillary permeability. This
is a key feature to allow circulating immune cells and proteins to enter the injured area
that results in local edema. Activated mast cells are also responsible for synthesising
a variety of inflammatory cytokines and lipid molecules, while more mediators are
the resulting product of plasma protein pathways (regulated by complement and
coagulation systems, Phillips et al., 2006).
Similarly to the onset of acute inflammation, as most recent research studies
have underlined, resolution of inflammation is also an active process, with anti-
inflammatory mediators modulating cellular interactions and prompting restoration
of the healthy pre-inflammatory condition (Lawrence et al., 2002). A high number of
anti-inflammatory mediators have been identified in the form of endogenous molecules
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that either restore vascular permeability (such as adrenaline and noradrenaline) or in-
hibit leukocytes activation (through the second messenger signalling molecule cAMP).
Another group of hormones, glucocorticoids, provide the main feedback responsible
for the reduction of inflammation by antagonising the production of pro-inflammatory
mediators on one hand and enhancing the synthesis of more anti-inflammatory medi-
ators on the other (Lawrence et al., 2002). Similarly, lipid mediators also contribute
to the anti-inflammatory activity by actively promoting resolution of inflammation
and tightly regulating cellular concentration levels at the injury site (Lawrence et al.,
2002).
Much of the inflammatory activity initiated by chemical mediators is carried out
by leucocytes or white blood cells, characteristic of the immune system and compris-
ing a varied group of cells with different features and functions. In general, upon tissue
damage, the initial release of pro-inflammatory mediators causes enhanced vasodila-
tion and reduces capillary blood flow, thus resulting in locally increased recruitment
of leucocytes directly interacting with vascular endothelium and finally entering the
injured site through molecule-bound adhesion mechanisms. Different types of leu-
cocytes are recruited at different times and with varied functions. Neutrophils, the
most numerous white blood cells in humans, making up to 75% of the total circu-
lating, are the first cell population to rapidly intervene in the earlier stages of acute
inflammation with varied tasks in tackling the local tissue disruption. Neutrophils are
produced in the bone marrow and released into the blood stream in an already active
form (Kolaczkowska & Kubes, 2013). The main feature of neutrophilic activity is the
ability to rapidly and efficiently migrate to the injury site to engulf or neutralise the
sources causing tissue damage. While most neutrophils are recruited to the injured
site, a smaller number of other leukocytes can already be present in the area of inter-
est (Woolf, 1986). The efficient recruitment of neutrophils is crucial to inflammation
development and its eventual resolution, with these white blood cells typically en-
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tering the insulted site within minutes of the occurred injury. The emigration from
the blood stream to the local damaged tissue is prompted by specific signalling inter-
actions between neutrophils and endothelial cells that, upon activation, attract the
flowing neutrophils to the endothelium through adhesion mechanisms. The conse-
quent cell-to-cell recognition and interaction between the endothelial structure and
adhering neutrophils allows the latter to pass the cellular endothelium gaps and fi-
nally enter the extravascular space (Woolf, 1986; Diegelmann & Chalfant, 2016). This
whole process, while being particularly complicated and presenting some interactive
mechanisms that are not completely clarified yet, is quite rapid and usually requires
from two to fifteen minutes to complete (Kolaczkowska & Kubes, 2013).
The articulate signalling activity that attracts neutrophils to the injury site and
coordinates their phagocytic and neutralising action is known as chemotaxis. This
consists of a chain of signal transmission and transduction events that results in a
highly organised and ordered vectorial motion of neutrophils to the inflammation site,
together with a selective action on those pathogens or harming particles responsible
for the ongoing inflammation (Woolf, 1986). Once at the injury site, the specificity
of neutrophil activity is ensured by a precise recognition of the insulting object that
is thus phagocytosed through engulfment of the intrusive particles to the membrane
and their inclusion in internal vesicles in which they are finally digested and neu-
tralised. Alternatively, neutrophils can also externally trap pathogens or damaging
debris through a network of extracellular fibres, known as Neutrophil Extracellular
Traps (NET), primarily composed of neutrophilic DNA and granular proteins that
effectively clear the selected targets (Kaplan & Radic, 2012; Zawrotniak & Rapala-
Kozik, 2013). Furthermore, essential to the inflammation progress and eventual reso-
lution, neutrophils release internal granular contents to the extracellular environment
in the form of mediators, mainly comprising Reactive Oxygen Species (ROS) and pro-
teases, that further promote inflammation and recruitment of new neutrophils. On
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the other hand, upon phagocytosis, the internal disposal of the phagocytic activity
heavily relies on enzymatic and oxygen-dependant mechanisms also involving ROS.
The typical toxicity of both these enzymatic particles and highly reactive molecules
already suggests a further critical feature of the inflammatory process, that is the
adequate removal and clearance of neutrophils that have completed their activity and
phagocytosis. These neutrophils thus undergo apoptosis, a physiological process of
programmed cellular death that prepares for their clearance and removal, biologically
designed to prevent neutrophilic release of toxic contents (Fox et al., 2010). It is im-
portant to highlight that apoptosis is fundamentally different from necrosis, in which
the cellular death is triggered by irreversible cell damage involving the pouring out of
intracellular particles, that are potentially disruptive and provide a further source of
inflammation (Quinn et al., 2007). On the other hand, neutrophils become apoptotic
upon a regulated change in both their receptivity to specific signalling and mem-
brane proteins, as well as an impairment in adhesion mechanisms (Greenlee-Wacker,
2016). The morphological and chemical alterations that appear to characterise the
transition from active to apoptotic neutrophils are fundamental in initiating a further
cascade of cellular events crucially leading to the resolution of inflammation. In fact,
apoptotic neutrophils induce an increase in anti-inflammatory mediators, while their
presence in apoptotic form is actually limited as a result of a highly effective clear-
ance mechanism. This typically happens through the intervention of another group
of phagocytic white blood cells, called macrophages whose manifold activity includes,
but is not limited to, phagocytising apoptotic neutrophils.
Similarly to neutrophils, macrophages are also produced in the bone marrow but
are released in the blood stream in the immature form of monocytes. Instead, mature
cells are typically within the tissue and prompted into action by a variety of stimuli
characteristic of the earlier stages of inflammation. Depending on the residing tis-
sue, mature macrophages present different morphologies and functionalities and have
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distinct nomenclature to reflect their localisation. However, overall they share the
same distinctive feature of countering intruding agents and further coordinating the
inflammatory response. While classic literature (as suggested by Mosser & Edwards,
2008 and Diegelmann & Chalfant, 2016) considered a well established distinction
between two types of macrophages, namely M1 and M2 phenotypes, differentiating
in specific functions, with M1 macrophages traditionally designated to promote pro-
inflammatory activity and M2 macrophages later releasing anti-inflammatory me-
diators, it has more recently emerged that such subsets are quite limited in their
biological description of the inflammatory events (Lawrence et al., 2002). Rather,
macrophages are believed to express a wide range of phenotypes in between the M1
and M2 ones, with particular specificities but also overlapping functions. More im-
portantly, it is now well established that macrophages play a key role in the resolution
of inflammation, highlighting how the positive outcome of the inflammatory event is
an active process (Serhan et al., 2007; Ortega-Gomez et al., 2013; Freire & Van Dyke,
2013). In this regard, when exposed to the early inflammatory response led by neu-
trophils’ rapid recruitment and release of pro-inflammatory mediators, macrophages
are induced to further reinforce the phagocytic activity, with similar mechanisms to
that of neutrophils. Furthermore, at this stage the interaction of macrophages with
endothelial cells results in chemotactic recruitment of additional pro-inflammatory
mediators that in turn enhance neutrophil activity. With the sequential and coordi-
nated efforts of leukocytes to phagocytose and neutralise the damaging particles and
pathogens, macrophages gradually expose more anti-inflammatory phenotypes that
lead to the eventual resolution of inflammation. The wound healing process lead by
macrophages inhibits the pro-inflammatory response by releasing a variety of chem-
icals as anti-inflammatory mediators and growth factors that induce and promote
tissue repair. Furthermore, an important step towards resolution of inflammation
relies on an efficient clearance by macrophages of the apoptotic neutrophils at the in-
1.2. A BIOLOGICAL INTRODUCTION TO INFLAMMATION 23
flammation site. This process involves multiple interactions between the two groups of
cells, with macrophages firstly attracted by apoptotic neutrophils (Hochreiter-Hufford
& Ravichandran, 2013) and consequently ingesting them through a process named
efferocytosis. Efferocytosis ensures a rapid clearance of apoptotic neutrophils, whose
otherwise prolonged presence and spilling of toxic contents would result in damage
of the local tissue, thus ensuring a correct healing process. This also further clari-
fies how in healthy development and resolution of inflammation, levels of apoptotic
neutrophils are relatively low, since their clearance is physiologically rapid and effec-
tive. On the other hand, impaired macrophagic activity would prolong inflammation,
possibly preventing correct tissue restoration and eventual resolution.
1.2.2 Unresolved outcomes: chronic inflammation
While the physiological response to any tissue damage is immediate and tightly reg-
ulated by specific cellular signalling, acute inflammation is not always naturally or
fully resolved and can degenerate into a pathological state, giving way to inflamma-
tory diseases and chronic inflammations (Phillips et al., 2006). In this regard, it is
still challenging to understand fully the mechanisms that prevent a healthy and phys-
iological recovery and lead instead to a critical and potentially disruptive condition.
At the same time, a variety of faulty events have been recognised and described that
are known to impair or prevent a correct resolution of inflammation, while further
research into this topic is key to suggesting new therapeutic targets to address the
current shortcomings of the understanding of chronic inflammation. Chronic inflam-
mation can result from a wide range of disfunctions of the inflammatory reactions,
as well as repetitive tissue injuries, that interfere with the physiological course of in-
flammation and cause its proliferation by prolonging it and further damaging neigh-
bouring tissues. Preventing the pathological spread of inflammation or appropriately
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and efficiently treating its chronic condition would ensure fundamental advance in
possible therapies of many numerous diseases that invariably present typical chronic
inflammatory patterns in their development and manifestation, such as cancer, dia-
betes, cardiovascular and autoimmune diseases, neurodegenerative disorders (Hunter,
2012). At the cellular level, chronic inflammation is characterised by high concen-
trations of macrophages that in turn provoke an overproduction of pro-inflammatory
mediators, eventually resulting in inflammation spread. In this context, endothelial
cells also undergo pathological changes that lead to an overexpression of adhesive
molecules, thus attracting even more leukocytes to enter the site. Endothelial repair
is also affected with common formation of fibrous scar tissue, possibly preventing
function recovery (Phillips et al., 2006). The mechanisms here described characteris-
ing the disfunctions leading to chronic inflammation will be discussed in greater detail
throughout the thesis.
1.3 Previous mathematical models of inflamma-
tion
With inflammation being such a prominent and complex event that, if uncontrolled,
might eventually lead to a variety of pathologies and unhealthy outcomes (chronic
inflammation, atherosclerosis, diabetes, cancer, etc.), it has long been a primary inter-
est of biologists and physicians to better understand inflammatory mechanisms and
exactly characterise the different pathways that are featured. The lack of knowledge
of specific interactions at both cellular and molecular levels regulating the cascades of
reactions that determine the inflammation spread and outcome has so far prevented
the development of effective and appropriate therapeutic strategies, considerably in-
creasing health costs and resources while also dramatically affecting patients (Pfizer,
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2017). As such, mathematical models are a particularly advantageous tool to fur-
ther deal with and investigate in this field. In general, mathematically modelling
biological processes is of great utility for multiple reasons, especially by enabling us
to predict outcomes of interest, with state of the art models practically providing
reliable simulations that considerably cut both economic and time costs. The study
and development of mathematical models for a wide range of biological applications
has thus been of great interest among the scientific community, involving researchers
from different backgrounds and relying on both a deep knowledge of the relevant
biology and its realistic mathematical representation, with the ultimate aim of bio-
logically analysing and interpreting the mathematical results with regard to insights
and predictions (Murray, 2001).
Many researchers have already developed and investigated valuable mathematical
models of inflammation, with particular focus on its dynamics and progression lead
by infective sources. While, in parallel, animal models are widely investigated (Webb,
2014), the important disadvantages given by this approach, being considerably more
expensive and time-consuming than in silico alternatives, coupled with the ethical
limitations of both animal experimentation and human trials, have further encour-
aged computational modelling research and development (Seoka et al., 2013). The
surge in mathematical models of inflammation comes in response to the inadequacy
of inflammation suppression as a valid and effective therapeutic tool. Meanwhile,
the variety of mathematical approaches that can be applied to the modelling task
(Vodovotz & An, 2013), such as equation-based models, hybrid models (combining
computational model comprising multiple scales), and in silico trials (computational
simulations of clinical trials), provide the opportunity to investigate and clarify those
inflammatory mechanisms that are still poorly understood, possibly suggesting how
to target and regulate therapeutic strategies (Dunster & Dransfield, 2016).
Earlier studies of inflammatory mechanisms at the tissue level, particularly focus-
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ing on the effectiveness of the immune response arising from bacterial infection, are
presented in a series of papers developing mathematical models that investigate the
interactions between inoculated bacteria and resident phagocytosing cells (Lauffen-
burger & Keller, 1979; Lauffenburger & Kennedy, 1981, 1983). In their papers, these
researchers highlight the crucial role of localised accumulation of leukocytes at sites of
infection. Overall, the analysis posed in Lauffenburger & Keller (1979); Lauffenburger
& Kennedy (1983) is however more focused on the mathematical parametrisation of
these features rather than studying the impact different spatial distributions might
have in terms of infection spread and eventual outcome. In particular, Lauffenburger
& Keller (1979) develop a one dimensional model comprising of a group of bacte-
ria acting as a chemoattractant source to leukocytes that in turn neutralise infectious
agents in order analyse how immune cells’ chemotaxis is affected upon bacterial infec-
tion. A detailed bifurcation analysis determines two possible spatially homogeneous
outcomes of a uniformly healthy or damaged tissue, with chemotaxis proving to be
crucial in effectively overcoming bacterial infection. Furthermore, conditions for the
potential existence of spatially heterogeneous steady states are also individuated, sug-
gesting the need to extend the model for further confirmation. This is achieved in
Lauffenburger & Kennedy (1983) in which a more refined model of the interactions
between bacteria and phagocytosing cells exhibits spatially inhomogeneous results
in response to threshold values of the parametrised chemotaxis. In particular, the
non-homogeneous states are shown to arise from the rapidity of cells’ motility with
respect to bacterial motility, with chemotaxis becoming less effective in driving spa-
tially inhomogeneous steady states upon an increased random motility of bacteria.
The related bifurcation analysis provides parametric conditions to predict the homo-
geneity of steady states, with spatial heterogeneity viewed as undesirable in terms of
tissue health. This is further confirmed by numerical results that successfully predict
the spatial nature of the steady states, upon varying values of chemotaxis, by also
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providing a biological interpretation of the severity of infection with respect to bac-
terial concentrations. On the other hand, the authors point to a lack of experimental
data on cells chemotaxis preventing a more accurate analysis of results in terms of
phagocytes spatial behaviour. Values for motility parameters are also adjusted in
order to overcome the limitations introduced by the oversimplification of the model
as well as to try to adapt the available in vitro experimental data to in vivo scenarios.
An interesting inflammatory model was developed by Kumar et al. (2004) by in-
vestigating the mass-action kinetics of two groups of early and late pro-inflammatory
mediators triggered by pathogenic action. The late pro-inflammatory mediator effec-
tiveness is bound to a saturating kinetics. The model’s analysis shows a set of results
consistent with typical acute inflammatory outcomes. In particular, through care-
ful manipulation of parameters, the model determines the links between pathogen’s
virulence and inflammatory response to inform on possible treatment approaches for
sever sepsis. Conversely, a major limitation of this model comes from overlooking
possible varied outcomes that may result from the same setting of clinical symp-
toms. To tackle this, a more structured model that includes more biologically sig-
nificant variables and handles overlapping symptoms is required. In this regard, it
is of particular importance to take into account the active role of anti-inflammatory
mediators in the resolution of inflammation (Serhan et al., 2008) and appropriately
model it. Brady et al. (2016) propose a mathematical model investigating the pro-
and anti-inflammatory interactions spurting from bacterial infection. The model is
calibrated to experimental measurements, with the mediators’ dynamics providing
patient-customised prediction of levels of specific groups of chemicals acting as both
pro- and anti-inflammatory mediators. Since cytokines of interest are modelled and
accounted for separately, the model lacks the analysis of inflammatory pathways aris-
ing from other mediators that have not been included.
A detailed model of inflammation studying the dynamics of anti-inflammatory
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processes has been proposed by Reynolds et al. (2006). This model studies the in-
flammatory components at cellular level, analysing measures of pathogens, active
phagocytes, tissue damage and anti-inflammatory mediators in time. The many pa-
rameters featuring in the resulting system of ordinary differential equations (ODEs)
are partly inferred from previous literature and partly assessed through bifurcation
analysis of the system’s steady states. As expected and widely supported by previous
research, anti-inflammatory mechanisms are shown to be key to a healthy outcome.
On the other hand, in this work, the acute inflammation is modelled as a response
to pathogenic action, thus excluding those instances of inflammation arising from
tissue damage and without any pathogens involved. Furthermore, as is intrinsic to
any model representation of complex processes, the simplifications introduced fail to
capture some biological mechanisms that may be determinant to the overall outcome,
while not all the quantities analysed have a straightforward biological correspondent.
Nonetheless, this model has been further expanded and analysed also by other re-
searchers, with interesting applications. One such application is the work of Day
et al. (2010) that proposes a predictive model to suggest therapeutic indications for
severe sepsis emerging from pathogenic infection, highlighting the potential benefits
introduced by feedback control methods. In response to the crucial need of recog-
nising early the different inflammatory stages and delivering effective therapeutic
strategies accordingly, Radosavljevic et al. (2013) develop a prediction model that
assesses past states and past drugs’ doses in order to predict new levels of pathogen,
pro-inflammatory mediators, markers of tissue damage, and anti-inflammatory me-
diators. This approach showed higher accuracy in the results, while also confirming
that a patient’s response to acute inflammation and specific therapies is complex and
varied. A further study focusing on the inflammatory response triggered by infec-
tion proposes a mathematical model that captures the interactive dynamics between
inflammatory mediators and pathogens (Roy et al., 2007). The prominence of inflam-
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mation in a variety of medical conditions has prompted more researchers to investigate
the potential benefits of computational models to wider and more specific scenarios
that inevitably involve inflammatory events (Russo et al., 2010; Day et al., 2015).
In more recent works, Torres et al. (2019) develop a mathematical model investi-
gating the dynamics of the influx of immune cells upon inflammation driven by peri-
tonitis. A system of ODEs representing the interactions between different groups of
leukocytes is studied with respect to the polarised behaviour of macrophages between
the inflammatory and anti-inflammatory phenotypes. The model is further fitted to
in vivo experimental data providing an extended framework to test intervention hy-
potheses to best assess targets and outcomes of therapeutic actions on macrophage
phenotypes. A further investigation in the role of macrophages is presented by Jansen
et al. (2019) with a particular focus on human inflammatory bowel disease. This work
illustrates the scope for effectively combining in silico modelling and analysis of data
extrapolated from laboratory experimentations. In particular the authors examine
the impact of including rich datasets inferred from relevant biopsies into mechanistic
models, suggesting improved parametrisation and higher spatio-temporal resolution,
which in turn broaden the applicability of such models. An in-depth study of varia-
tions in neutrophil recruitment and death pathway in the inflammatory response is
presented by Presbitero et al. (2019). In their work, Presbitero et al. (2019) inves-
tigate the effects of neutrophil apoptosis and necrosis in terms of evolutionary game
theory. Within this framework, apoptosis and necrosis are presented as diverging
strategies and driving mechanisms regulating the inflammatory outcome. The inte-
gration of this model with data inferred from inflammatory markers further provides
analyses of benefits and costs of each pathway and the prediction of percentages of
occurrence of both apoptotic and necrotic events with respect to the original insult
triggering the inflammatory response.
While the mathematical models reviewed so far consider inflammation at a mi-
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croscopic level, with system variables accounting for group of cells and chemicals,
other researchers have also proposed different approaches by modelling inflammatory
mechanisms at body level. Sullivan & Yotov (2006) develop a spatial model of in-
flammation (later also included in the paper of Upperman et al. (2007)) investigating
organs’ walls and structures, with leukocyte and cytokine interactions being framed
within lumen, epithelium, tissue and blood vessels, with a larger focus on pathogenic
action (with the bacteria’s anatomy affecting the cells migration). In their work, the
main interest is to investigate the response of organ walls to the specific pathological
events that commonly arise within premature infants (necrotizing enterocolitis). The
key results show that, when in presence of damaged epithelial membranes, otherwise
harmless bacteria can penetrate the tissue and cause infection. This, in turn, affects
the final outcome of the body’s inflammatory response, with full healthy recovery in
simulations with membranes damaged only partially, while on the other hand, upon
a complete lack of membrane walls, the results highlight persisting inflammation and
spread of damage. While it provides valuable evidence in terms of spatial modelling,
the specificity of the pathological implications investigated in this work, render this
model quite different from the main objective of our project, thus further motivating
our interest in clarifying the spatial characterisation of the non-pathogenic inflam-
matory response and individuation of possible therapeutic targets, with this latter
aspect missing in the work of Sullivan & Yotov (2006).
An effort in addressing part of these open issues is offered by Penner et al.
(2012), with a mathematical model of skin inflammation to study spatial patterns
typical of rash formations. In this model, the biological relation and interactions of
macrophages, chemoattractant chemicals and anti-inflammatory cytokines are simpli-
fied such that phagocytosing cells appear as a fixed quantity, and anti-inflammatory
mediators inhibiting both themselves and chemoattractants and acting on slower
timescales. This inhibitory and delayed action is proven to further push the model’s
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spatial behaviour, as highlighted by the study of the system’s stability and numeri-
cal simulations, with particular emphasis on the classification of patterns at varying
values of key parameters. While valuable for including spatial considerations in the
study of acute inflammation, this model still lacks fundamental biological features
(namely, the characterisation of macrophage dynamics in terms of phagocytosis and
turnover, the pro-inflammatory activity of both leukocytes and chemicals), as well as
not providing any link up with experimental data in terms of both parameter values
and simulations assessment.
Of particular significance to this work is the work of Dunster et al. (2014), since
this work will form the basis of the novel models presented throughout this thesis.
Analogously to the model of Day et al. (2010), Dunster et al. (2014) also propose
a mathematical representation of inflammation at cellular level in the form of an
ODE system, monitoring the dynamics of cellular components (active and apoptotic
neutrophils, macrophages) and chemicals (pro- and anti-inflammatory mediators).
The acute inflammation is considered to be in response to generic tissue damage,
and is thus in the absence of pathogens. In particular, three different models are
constructed and analysed in which individual populations of white blood cells are ac-
counted for separately, namely comprising active neutrophils, apoptotic neutrophils
and macrophages. Such differentiation allows for an accurate description of the im-
mune cells behaviour, with neutrophils promoting inflammation and macrophages
actively initiating its resolution. The first of the three models presented is deliber-
ately simple in its functions, omitting any anti-inflammatory mediators and charac-
terising cellular interactions in response to pro-inflammatory mediators only, which
trigger the acute inflammation. The numerical analysis of this initial ODE model
provides two sets of results, corresponding to either a healthy (zero) steady state or
unhealthy (chronic, non-zero) steady state. Manipulation of key parameters, namely
the number of cycles of damage and rate at which macrophages phagocytose apoptotic
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neutrophils, are also shown to affect the systems results. Increases in the former pro-
mote unresolved outcomes while enhancing the rate of phagocytosis enables previously
chronic outcomes to fully resolve. The bistability of the model is further investigated
through bifurcation diagrams, exposing the role of other key parameters acting as
a switch between chronic and resolved inflammation. In particular, manipulation of
the parameters controlling the rate at which macrophages leave the tissue and the
concentration of neutrophils required for half-maximal release of pro-inflammatory
mediators can result in a change of the systems stability. In particular, the increase
of the level at which neutrophils saturate in the presence of pro-inflammatory medi-
ators prompts the gradual weakening of the inflammatory response. Such behaviour
ceases for larger values of this saturation parameter when surpassing a bifurcation
point, after which only the healthy steady state is viable. Conversely, the system is
bistable for large values of the rate at which macrophages leave the tissue, while only
healthy outcomes are permissible for smaller values.
In order to model neutrophils behaviour more accurately, to account for them ac-
tively promoting inflammation by releasing toxic granules meant to counter infection,
regardless of the actual presence of pathological agents, the authors then present a
revised model that accounts for this added feature in the form of a positive feedback
for active neutrophils. Numerical and bifurcation analyses of this second model con-
firm the results inferred from the first model while also additionally exposing the key
role of the parameter controlling the rate of neutrophils apoptosis. In particular, an
increased rate of apoptosis favours healthy outcomes.
Finally, in order to include the anti-inflammatory role of macrophages, the au-
thors further extend the model by adding a separate variable accounting for anti-
inflammatory mediators, whose behaviour contrasts that of pro-inflammatory chem-
icals. Crucially, this extended model exhibits, in addition to the healthy and un-
healthy steady states, a sustained oscillatory regime, which is more closely associ-
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ated with chronic inflammation. This third model retrieves the results highlighted
by the previous models and additionally suggests, through bifurcation analysis, the
key role of the parameter controlling the production of anti-inflammatory mediators
by macrophages. In particular, an increase in the production of anti-inflammatory
mediators, reduces the rate of phagocytosis needed to prompt the resolution of in-
flammation.
While the results of Dunster et al. (2014) further confirm the critical and active
role of anti-inflammatory mechanisms in the resolution of inflammation, a key limita-
tion of this work is that spatial behaviours are omitted, with all three models focusing
on spatially-averaged, temporal dynamics. Simulating inflammatory interactions be-
tween leukocytes and cytokines and analysing their spatial development and spread
is crucial in understanding those mechanisms that still remain unclear and that could
potentially open the way to new effective therapeutic strategies. We take the homoge-
neous model of Dunster et al. (2014) as the starting point for our theoretical studies;
hence, we revisit the corresponding models in Chapters 2 and 3. In particular, we
present more detailed reviews of the governing equations of the first and third models
from this paper in Sections 2.1 and 3.2 respectively.
As the relevant literature (cited above) in the context of mathematical models
of inflammation shows, existing gaps emerge between the robust implementation of
mathematically complex models and their direct applicability in clinical contexts.
This is part of a more general gap investigating a variety of biological topics and
not specific of inflammation. The high interest in researching and developing ef-
fective models of biological processes is further motivated by the need to overcome
important limitations of both in vivo and in vitro approaches. Along with the most
immediate advantages in significantly optimising both costs and time and replica-
bility of results, mathematical models offer the possibility to assess quantities that
cannot be measured directly and to tailor patient-customised approaches by careful
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manipulation of parameters, which studies of inflammation cannot otherwise directly
address.
Narrowing our aims to contribute to the research of mathematical models of in-
flammation, we individuate the lack of studies in the spatial spread of damage and
how this affects the acute inflammatory response as an important limitation in the
current state of the art. As such, our main objective within this thesis is to ad-
dress, through mathematical models, how localised damage can spread and invade
into surrounding healthy tissues.
1.4 Pattern formation
Highly structured and regular patterns feature prominently in a variety of physical
and biological phenomena; it is thus of primary interest to understand the mecha-
nisms that lead to spontaneous patterning. Natural patterns arise from a wide range
of systems and, while the environmental contexts that frame spatial patterning can
vary greatly, specific features and characteristics in shape are easily encountered in
developed patterns that would otherwise have very little in common. Several straight-
forward examples can be given in this regard, by observing the striped nature of zebra
skin, sandy crests and meteorological convective rolls all exhibiting the same stripe
structure, including the characteristic merging of two stripes into one (Hoyle, 2006).
This strongly suggests that, in order to understand and analyse these phenomena, it
is important to focus on the symmetries, rather than the environmental surroundings,
and the mathematical theory that underlies these. Most spatiotemporal patterns that
are observed empirically can be described and reproduced mathematically, but while
the current state of the art in pattern formation modelling does not yet provide ex-
haustive details of these complex processes (Maini & Othmer, 2001), patterning and
structured forms emerge both from physical laws and in living systems (Chuong &
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Richardson, 2009) and can thus be mathematically analysed in depth.
The criticality of fully understanding the mechanisms that lead to structural mor-
phogenesis on, one hand, and that could potentially prevent or counter the devel-
opment of pathological and disruptive events on the other hand motivates the in-
terest in analysing pattern formation when mathematically modelling biological pro-
cesses (Maini & Othmer, 2001). A variety of mathematical structures are effective in
describing and characterising patterns that arise naturally in different biological sce-
narios. Among others, reaction-diffusion systems are particularly suited to describing
different patterning phenomena and have been deeply investigated to this purpose,
starting from the seminal work of Turing (1952). In particular, in its simplest form,
the interaction between the ligand and the morphogen of a reaction-diffusion systems
represent the patterning mechanism upon which the system generates spatial pat-
terns autonomously (Kondo & Miura, 2010). The Turing instability is defined as the
destabilisation of a stable homogeneous steady state by diffusion, resulting in stable
inhomogeneous static configurations. Turing instabilities are of significant relevance
in theoretical biology by providing an explanatory model for the formation of varied
patterns independent of their initial spatial configuration. The specific conditions for
Turing patterns to arise are detailed in appendix A.
More generally, the existence of spatially-inhomogeneous solutions to reaction-
diffusion (PDE) models is often associated with changes in the stability of steady
states in the corresponding homogeneous (ODE) models, as can be exposed by clas-
sical bifurcation analysis. In particular, the nature of those critical points marking a
change in the stability of fixed points informs on the possible existence of spatially
inhomogeneous solutions, thus providing an effective tool to explore the dependence
of the system on its parameters and a map of the solutions to be expected accordingly.
In particular, Hopf bifurcation points, that is bifurcation points where the stability
of fixed points changes and periodic orbits are created, are relevant in the character-
1.4. PATTERN FORMATION 36
isation of many systems’ spatial behaviour. This field of investigation is particularly
prominent in a number of classic dynamical systems that are extended to include more
complex scenarios. Shi et al. (2019) study patterns arising from Hopf bifurcation in
a delayed diffusive logistic model, while also diffusive extensions of the predator-prey
system are widely studied. In this regard, Lin et al. (2019) investigate the ecological
mechanisms that drive the formation of patterns within the predator-prey model,
determining how both spatially homogeneous and inhomogeneous periodic solutions
originate from Hopf bifurcations. Turing and Hopf instabilities are not mutually
exclusive, with a prominent example being the reaction-diffusion Gray-Scott model.
Mazin et al. (1996) detail the conditions under which the spatial patterning of this
model originates, while McGough & Riley (2004) particularly focus on the bifurcation
analysis supporting the nature of the patterns that the solutions exhibit. A detailed
investigation of pattern formation in inflammatory models is provided by Penner et al.
(2012), where the authors examine the conditions triggering spatial inhomogeneity
when chemotactic motion of a fixed population of immune cells is involved. In par-
ticular, with the aim of studying skin rash developments, Penner et al. (2012) model
the interactions between a group of cells, releasing both chemokines which serve as
chemoattractant and inhibitors which act on a slower time scale. In their study,
a combination of Hopf and Turing bifurcations prompt the development of varied
spatial configurations, with the instabilities arising upon low levels of the inhibitor.
In particular, the authors focus on defining the conditions on parameter values in
obtaining the different spatial configurations.
Finally, another broad modelling framework that can emit spatially inhomoge-
neous outcomes and particularly relevant to this work is Agent Based Model (ABM)
modelling. This modelling approach, which will be introduced and discussed in detail
in the dedicated chapters, is used in many multidisciplinary studies including theoret-
ical biology, effectively capturing a wide range of mechanisms prominent in evolving
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cellular systems, from morphogenesis to cancer growth and wound healing (Deutsch
& Dormann, 2016). In their book, Adamatzky & Martinez (2016) present a variety of
patterns arising from ABM models and the different implementing approaches that
give rise to them. In addition to the biologically relevant capability of these models
to generate spatially inhomogeneous structures, ABM frameworks are also used in
the detection of patterns, which serves as a key role in many biomedical applications
(Ahangaran & Beigy, 2009; Miranda et al., 2016).
1.5 Thesis overview and objectives
The aims of this study are to develop spatial models of inflammation and assess the
impact of its spatial spread through manipulation of related parameters. In particular,
we examine the scope for the formation of spatial patterns, and the extent to which
localised damage can spread into neighbouring healthy tissue. In this work, two
different approaches for modelling the acute inflammatory response at the tissue level
are deployed and compared; in Chapters 2 and 3, we take a PDE-based approach,
and in Chapters 4 and 5 we take an agent-based approach, and examine the extent
to which key conclusions are sensitive to the modelling approach used.
Firstly, in Chapter 2, we present a simple model of inflammation with the main
objective being to investigate pattern formation from an analytical point of view.
In particular, in Chapter 2, a basic model of inflammation is presented, where the
first ordinary differential equation (ODE) model of Dunster et al. (2014), describing
the mechanisms at play between immune cells and pro-inflammatory mediators, is
extended to include relevant interactions within a spatial domain. In this chapter, we
construct a partial differential equation (PDE) model in which cells and mediators
move diffusively. In order to facilitate analytical progress, we keep the model delib-
erately simple, including only a minimal set of biological interactions. We examine
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the extent to which the resulting reaction-diffusion equations exhibit spatial patterns,
including those potentially arising via Turing instabilities and Hopf bifurcations.
In Chapter 3, we build upon the model of Chapter 2 to include biological features
previously neglected, namely cellular chemotaxis, the presence of anti-inflammatory
mediators and the enhanced feedback of neutrophils in the production of pro-inflammatory
mediators. In doing so, we develop a model that we believe incorporates a full reper-
toire of biological feedbacks, and constitutes an extension of Model 3 of Dunster et al.
(2014) to a spatial domain. The primary objective in this chapter is to understand
the impact of these additional behaviours within a spatial setting, with particular em-
phasis on investigating the model’s capability of admitting spatially inhomogeneous
results and individuating possible therapeutic targets.
In Chapter 4, by moving to an agent-based modelling approach, we address the ob-
jective of evaluating whether our conclusions are sensitive to the modelling approach
used. To this end, a novel model of inflammation is built in Chapter 4, by using the
ABM framework, thus providing us the opportunity to further refine specific cellular
mechanisms that are not captured in our PDE descriptions of the inflammatory re-
sponse, while also overcoming the shortcomings of purely deterministic approaches.
We present simulations of our agent-based model, demonstrate how variations in key
parameters can switch the inflammatory outcome from health to chronicity, or vice
versa, and show a comparison between the two models of inflammation developed
in Chapters 3 and 4. To further quantify the dependence upon model’s parame-
ters, we perform a local parameter sensitivity analysis, to provide insight into which
mechanisms could potentially be manipulated in new therapeutic strategies.
The objectives of Chapter 5 are to focus specifically upon the role efficient chemo-
taxis of leukocytes has in resolving inflammation and to construct an accurate chemo-
taxis model that can be calibrated against experimental data. We construct a refined
model of chemotaxis (within our ABM framework) that integrates both sensitivity to
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the chemotactic gradient and persistence in cells directions of motion, and examine
how weaker chemotactic sensitivity or stronger directional persistence (such as is ob-
served in some inflammatory conditions or in ageing) can drive a switch from health
to chronicity. The model is calibrated against previously published experimental data
related to healthy patients and patients with the highly impacting chronic inflamma-
tory disease Chronic Obstructive Pulmonary Disease (COPD) (Sapey et al., 2011), in
order to effectively reproduce both healthy and pathological cellular directed motion.
We integrate this improved model of chemotaxis into our larger agent-based inflam-
matory model, assess the results and compare them to those yielded by the model in
Chapter 4.
Finally, Chapter 6 will present the main conclusions arising from this work, dis-
cussing all relevant results, summarising the key observations emerging from our
investigation into the spatial modelling of inflammation, and also addressing possible
directions for future works.
Chapter 2
Immune cell interactions with
pro-inflammatory mediators
In this chapter we aim to extend Model 1 of Dunster et al. (2014) to include a spa-
tial domain. Our primary objective is to analytically assess the models capability
of admitting spatially inhomogeneous results, for example via Turing instabilities or
via bifurcations in the dynamics of the underlying ODE model. To facilitate this, we
favour the simplicity of using the model of Dunster et al. (2014) as a starting point,
since it includes only a minimal set of basic biological interactions and thus allows the
greatest scope for analytical investigation. In this regard, a preliminary version of an
inflammation model is provided and analysed, focussing on the interactions between
immune cells and pro-inflammatory mediators. Firstly, a spatially-independent model
presented by Dunster et al. (2014) is reviewed in detail, before being later extended
by including terms representing spatial movement of the groups of cells and chemi-
cals featuring in the model. These interactions are studied at cellular level, by not
only focusing on the impact of inflammation in time but also on its spatial spread,
by deriving the conditions that lead to possible spatial patterning and highlighting
its relevance in biological terms. A key assumption that will hold throughout this
40
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chapter is the absence of pathogens. This allows us to focus on the progression of the
inflammatory response, with generic tissue damage considered as the physiological
trigger to the acute inflammation.
2.1 ODE model review
A first version of an inflammation model is presented in Dunster et al. (2014), in which
no pathogens are included, while interactions between three groups of generic cells
and mediators evolving in time (t˚) are considered (with stars denoting dimensional
variables), namely: active neutrophils n˚pt˚q; apoptotic neutrophils a˚pt˚q, which
are inactive, unable to move, have little phagocytic ability and release toxic chem-
icals when undergoing necrosis; macrophages m˚pt˚q, activating to clear apoptotic
neutrophils; and pro-inflammatory mediators c˚pt˚q, attracting both neutrophils and
macrophages.
The biological description of the chain of events leading to interactions of pro-
and anti-inflammatory nature in response to damage allows us to derive useful mod-
elling parameters. Following a generic trauma, a complex variety of chemical species
is released within the damaged tissue, comprising cytokines, chemokines and com-
plementary proteins, triggering proteolytic cascades resulting in the production of
effective pro-inflammatory mediators, as well as activating relevant cellular signalling
(Dunkelberger & Song, 2010; Aziz et al., 2013). In this sense, the overall release
and decay rates of any generic pro-inflammatory mediator (c˚) are defined as α˚ and
γ˚c respectively. Furthermore, upon a prolonged inflammatory state or new damage,
new concentrations of c˚ are released, with k˚a being the concentration of mediators
released on lysis of apoptotic neutrophils. This prompts the migration of neutrophils
to the damaged site, with a maximal incoming influx rate represented by χ˚n. Active
neutrophils (n˚) undergo a rapid apoptotic process while circulating in the blood
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stream (Cross et al., 2008), with apoptotic neutrophils a˚ appearing with rate ν˚,
i.e. the rate at which active neutrophils become apoptotic. These in turn undergo
secondary necrosis with rate γ˚a , spilling their internal toxic chemicals. This new
pro-inflammatory action presents a saturation level denoted by β˚a and is counter-
acted by the action of macrophages, appearing at a maximal rate of χ˚m, engulfing
the apoptotic neutrophils at a constant rate φ˚ and finally leaving the tissue at rate
γ˚m. Finally, as part of our modelling assumptions for this initial model (and its
following extensions), a sterile environment is considered for both neutrophils and
macrophages; that is, there is no direct pathogenic action affecting the physiological
leukocytes’ behaviour.
The dynamics between active and apoptotic neutrophils, macrophages and pro-
inflammatory mediators are described by the following spatially averaged ODEmodel:
dn˚
dt˚
“ χ˚nc˚ ´ ν˚n˚, (2.1)
da˚
dt˚
“ ν˚n˚ ´ γ˚aa˚ ´ φ˚m˚a˚, (2.2)
dm˚
dt˚
“ χ˚mc˚ ´ γ˚mm˚, (2.3)
dc˚
dt˚





´ γ˚c c˚ , (2.4)
with f being the model stimulus, describing physical damage to the tissue, as defined
by Dunster et al. (2014), with










1 if t˚ ă A˚π
0 if t˚ ą A˚π ,
(2.6)
in which A˚ represents the number of cycles of damage, approximating days of infec-
tion. The parameters involved are presented in Table 2.1, while initial conditions are
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set at zero, that is:
n˚p0q “ a˚p0q “ m˚p0q “ c˚p0q “ 0. (2.7)
While not all the above mentioned parameters are known and available in absolute
values, a few assumptions can be made and useful estimations can be derived from
the existing literature and experimental data. We review these parameter values in
detail in Section 2.2.1.
Figure 2.1 provides a schematic representation of model (2.1)–(2.4) in which all the
interactions between the system’s variables are shown by highlighting all non-spatial
parameters.
The initial analysis of this model focuses on assessing its qualitative behaviour
under different inputs in order to evaluate it in terms of the inflammatory response,
with the key results of the ODE model presented in Section 2.4.1. Our primary aim
is to investigate the effects of spatial dependency in the development and eventual
outcome of inflammation. In particular, two different outcomes, corresponding to
two different stable states, are expected: the first being the complete resolution of
the inflammation and the second being a chronic inflammatory state. To this end,
the dynamical analysis will be combined with the study of spatial patterning, by
modelling key biological features that directly affect the inflammation progression
and final outcome.
2.2 Adding spatial information
We now extend the model of Dunster et al. (2014), above, to incorporate spatial
movement of cells and mediators. For simplicity, we consider a 1D spatial domain
and assume that cells and mediators move diffusively. This assumption does not hold
for apoptotic neutrophils which instead do not move, being dying cells eventually
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Figure 2.1: Schematic diagram representing model (2.1)–(2.4) and illustrating the
constituent interactions between populations of healthy neutrophils (n˚), apoptotic
neutrophils (a˚) and macrophages (m˚) in response to pro-inflammatory mediators
(c˚), with associated parameters. Dashed lines indicate decay rates.
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cleared out by macrophages.. In fact, while diffusion of all inanimate depends to an
extent on their size, the temperature and their local environment, it is negligibly small
compared to that of macrophages and active neutrophils. Addition of diffusion into
the model in this spatial context provides a mechanism via which motility of cells and
mediators can act to smooth out strong inhomogeneities in the spatial distributions
of the model components. This has the potential to allow localised damage to spread
to neighbouring healthy tissue, and also to destabilise the homogeneous steady states
identified in the ODE model of Dunster via e.g. Turing instability (as discussed in
Section 1.4). In general, there is scope for cell diffusivities (in particular) to vary
temporally or in function of mediator concentrations; however, since we are primar-
ily interested in ascertaining whether addition of diffusion can yield inhomogeneous
steady states (patterns) in this model, we restrict attention to the case of constant
diffusivities for all model components here. Since the inflammatory response in the
model of Dunster, and our extension below, is driven by an initial stimulus f that van-
ishes in the longer term, we anticipate that the addition of time-dependent diffusion
would affect only early-time solutions, with long-term steady states being unaffected.
Denoting the diffusivities of active neutrophils, macrophages and mediators by D˚n,
D˚m and D
˚
c respectively, the ODE model of (2.1)–(2.4) is then transformed into the





˚ ´ νn˚ ` D˚n∇2n˚ , (2.8)
Ba˚
Bt˚ “ ν





˚ ´ γ˚mm˚ ` D˚m∇2m˚ , (2.10)
Bc˚
Bt˚ “ α





´ γ˚c c˚ ` D˚c∇2c˚ , (2.11)
where now the damage function depends on spatial coordinates, x˚, as well as time,
t˚. For simplicity, we here seek solutions on the one-dimensional spatial domain
x˚ P r0, L˚s; this is a natural pre-cursor to more complex two-dimensional simulations,
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which we examine later in the thesis. We seek solutions that are periodic on the
interval x˚ P r0, L˚s. .
2.2.1 Parameter values
Parameter values are derived from the literature, where already available, with most of
them in this work taken from Dunster et al. (2014), and are reported in Table 2.1. Due
to modelling constraints and simplifications, not all the parameters have a straight-
forward biological correspondence in terms of either experimental data or estimation.
This is due to limitations in measurements on one hand (constraints on timescales and
instrumentation) and the lack of straightforward correspondence between modelling
parameters and quantifiable biological processes on the other.
As for the diffusion constants, which are not considered by Dunster et al. (2014)
and are only introduced here, the available scientific literature does not provide much
in this regard because of two main reasons. On one hand, researchers have tradi-
tionally focused on the temporal dynamics of inflammation, while the importance of
its spatial spread and its dependence on localised concentrations has only recently
emerged and prompted more in-depth studies. Furthermore, there is a lack of simple
and standard tools to measure diffusion coefficients experimentally, while estimation
of these parameters through mathematical models has proven non-trivial. Despite
measurements of spatial parameters being relatively sparse in previous literature in
comparison to the vast numbers of published temporal studies of the inflammatory
response, some measures of these parameters are available from both experimental
studies and inferred from mathematical models. It should be noted, however, that
these measurements are subject to variability across tissues. Rates of mediator diffu-
sion reported in previous literature generally lie in the range 10´8 ´ 10´6 cm2 ¨ s´1
(Warrender et al., 2006; Weidemann et al., 2011; Ross & Pompano, 2018). In gen-
2.2. ADDING SPATIAL INFORMATION 47
Parameter Definition Range of values References
χ˚n maximal rate of neutrophil influx 10
6 ´ 107 cell ¨ pg´1 ¨ day´1 (Kim et al., 2008)
ν˚ neutrophil apoptosis rate 12 ´ 72 day´1 (Hannah et al., 1998),
(Summers et al., 2010)
γ˚a rate of necrosis of apoptotic neu-
trophils
9.6 ´ 48 day´1 (Mare et al., 2005)
φ˚ rate of apoptotic neutrophil
removal by macrophages (sec-
ondary necrosis)
10´3 cell´1 ¨ mm3 ¨ day´1 (Dunster et al., 2014)
χ˚m maximal rate of macrophages in-
flux
0.1¨106´1.17¨106 cell¨pg´1 ¨day´1 (Furth, 1985)
α˚ mediator production rate pg ¨ mm´3 ¨ day´1
k˚a mediator concentration produced
by apoptotic neutrophils
pg ¨ mm´3
β˚a apoptotic neutrophils saturation
constant (concentration of apop-
totic neutrophils required for half
maximal release of c˚ptq)
cell ¨ mm´3
γ˚m rate at which macrophages leave
the tissue
0.2 day´1 (Waugh & Sherratt, 2007)
γ˚c rate of mediator decay 0.7 ´ 20 day´1 (Smith et al., 2011),
(Su et al., 2009)
D˚n active neutrophil diffusion con-
stant
mm2 ¨ day´1
D˚m macrophage diffusion constant 8.64¨10´7´8.64¨10´1 mm2 ¨day´1 (Lauffenburger & Kennedy, 1983),
(Sozzani et al., 1991),
(Owen & Sherratt, 1997),
(Owen et al., 2004)
D˚c pro-inflammatory mediator diffu-
sion constant
8.64 ¨ 10´2 ´ 8.64 mm2 ¨ day´1 (Warrender et al., 2006),
(Weidemann et al., 2011),
(Ross & Pompano, 2018)
Table 2.1: Parameters appearing in system (2.8)–(2.11). When available, ranges of
parameter values are inferred from relevant literature, as specified.
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eral, we expect the rates of cell migration to be slower than those of inflammatory
mediators, with previous publications reporting macrophages to move diffusively at
rates of order 10´13 ´10´7 cm2 ¨s´1 (Lauffenburger & Kennedy, 1983; Sozzani et al.,
1991; Owen & Sherratt, 1997; Owen et al., 2004). Neutrophils, on the other hand,
are expected to move more rapidly owing to their smaller size.
Similarly, for the remaining parameters, we investigate results for a range of values
within the physiological scales, as provided in the scientific literature.
2.2.2 Nondimensionalisation
Restoring diffusive terms and considering the original PDE system (2.8)–(2.11) in-
troduces the critical problem of evaluating appropriate values for diffusion constants.
As already discussed in Section 2.2.1, valuable data can be inferred from the relevant
scientific literature where available, although spatial parameters are generally difficult
to quantify. Furthermore, in our simulations, we are interested in studying the system
upon varying spatial constants in order to characterise the model’s behaviour spatially
and to assess if and how localised damage can invade the surrounding healthy tissue.
In doing so, we also aim to evaluate if the system can sustain spatially inhomogeneous
steady states.
An accurate investigation of the available literature, as already exposed in Sec-
tion 2.2.1, reveals the difficulties and spuriousness of defining specific values for the
diffusive constants. In general though, in line with the range of values reported in
Table 2.1, diffusion terms are relatively small, as proposed by Pigozzo et al. (2013)
for a model studying the spatio-temporal dynamics of the human immune system.
Furthermore, it would be desirable to infer a relationship between the three diffusion
constants Dn, Dm and Dc characterising model (2.13)–(2.16). Although a general
relationship cannot be directly assumed from the available literature (Weavers et al.,
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2016; Graham et al., 2012), at this initial stage it is expected that Dm ă Dn ă Dc
to hold, that is, it is considered that pro-inflammatory mediators (c) diffuse faster
than active neutrophils (n), which in turn are quicker than macrophages (m). This
assumption is further backed by the set of values provided by Pigozzo et al. (2013).
We, here, have the flexibility to tune both the domain size L˚ and the timescale
γ˚c in our model, to enable us to relate our simulations to some specific inflammatory
condition. However, since we are more interested in examining the general case here,
we begin by defining a baseline set of dimensionless spatial parameters, which we
use in our simulations in the following sections. Considering a domain of width
L˚ “ 10 cm, taking γ˚c “ 3 day´1 (as in Dunster et al. (2014)), and taking typical
(dimensional) rates of diffusion of mediators and macrophages to be 10´7 cm2s´1 and
10´10 cm2s´1 respectively provides approximate dimensionless estimates of Dc “ 10´4
and Dm “ 10´6. Since we expect neutrophils to move more quickly than macrophages
but slower than mediators, we prescribe Dn “ 10´5.
























Having rescaled variables as above, substitution of these expressions into (2.8)–(2.11)
leads to the following dimensionless system:
Bn
Bt “ c ´ νn ` Dn∇
2n, (2.13)
Ba
Bt “ νn ´ γaa ´ φma, (2.14)
Bm
Bt “ c ´ γmm ` Dm∇
2m, (2.15)
Bc





´ c ` Dc∇2c , (2.16)
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Parameter Approximate Range Standard values used in simulations
in this chapter
ν 0.001 ´ 0.6925 10´1
γa 0.55 ´ 1 1
γm 10
´2 ´ 1.2375 ¨ 10´2 10´2
φ 0.001 ´ 1.38 10´3
βa 0.01 ´ 0.1 10´1
α 5 ¨ 10´2 5 ¨ 10´2
Dn 10
´5 ´ 10´3 10´5
Dm 10
´6 ´ 10´3 10´6
Dc 10
´4 ´ 10´3 10´4







, ν “ ν
˚
γ˚c




































Values for all dimensionless parameters are summarised in Table 2.2.
The initial conditions provided in (2.7) are also updated to their dimensionless
correspondents:
np0q “ ap0q “ mp0q “ cp0q “ 0. (2.18)
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2.3 Numerical approach
In order to solve the PDEs in (2.13)–(2.16), different approaches can be considered.
A straightforward method would consist of fully discretizing the system, both in
time and space; for example, by applying the three point formula of finite difference
approximations for second derivatives, thus computing the results by manually setting
an appropriate space step (dx) and iterating by time steps (dt). A quite restrictive
stability condition applies, however; for one-dimensional systems of parabolic PDEs







with D being the diffusion coefficient. Equation (2.19) guarantees stability for the
Forward-Time Central-Space (FTCS) scheme applied to PDEs (LeVeque, 2007).
Nevertheless, this method has an obvious underlying limitation, binding computa-
tional efficiency to numerical stability, through the time step value and spatial mesh.
Therefore, this approach has been discarded in favour of a more suitable computa-
tional method, as described below.
2.3.1 Method of lines
The method of lines offers an appreciably efficient solving approach, by discretizing
all but one dimension, thus reducing the PDE system to a system of ODEs.
In order to implement the method of lines, equations (2.13)–(2.16) are discretized
in space, as follows:
dniptq
dt
“ ´νniptq ` ciptq ` Dn
ˆ






“ νniptq ´ γaaiptq ´ φmiptqaiptq, (2.21)
dmiptq
dt
“ ´γmmiptq ` ciptq ` Dm
ˆ







“ αfiptq ` γa
aiptq2
aiptq2 ` β2a
´ ciptq ` Dc
ˆ




with i “ 0, 1, . . . , N , where N is the number of spatial meshpoints.
In order to efficiently implement it, the dimensionless system (2.20)–(2.23) is
rewritten in a more compact way, by writing (2.20)–(2.23) in vectorised form in
Matlab (details omitted).
The Matlab ODE solver ode15s is particularly useful when dealing with stiff
problems, as in this case. Generally, stiffness occurs when some solution compo-
nents present a much faster dynamics than others; it strongly affects stability in a
way such that the step length is constrained more by stability requirements rather
than accuracy (Ashino et al., 2000). It is a variable order algorithm, based on the
Backward Differentiation Formulae (BDF) method, the step size is adapted during
implementation with error estimation given by the local truncation error (Celaya
et al., 2014). The system of vectorised equations is then computed through Matlab
function ode15s, with initial conditions as in (2.18) and time spans r0 104s (Sec-
tion 2.4.1) and r0 7000s (Section 2.4.3). Matlab code for this model is available
online via Github1.
2.4 Simulations
2.4.1 No spatial dependence
We here examine solutions to (2.13)–(2.16) for the case Dn “ Dm “ Dc “ 0. In
particular, we are looking to recover the ODE results of Dunster et al. (2014), as
a code validation task. A first implementation of the dimensionless system (2.13)–
(2.16) offers graphical evidence of two possible inflammation outcomes, as presented




































































Figure 2.2: Solution of (2.13)–(2.16) for fpx, tq “ Hptq sin2ptq, periodic boundary
conditions and initial conditions as per (2.18), with parameters values as in Table 2.2.
Since fpx, tq is independent of x, solutions are homogeneous; setting A “ 1 here
prompts a resolution of inflammation.
as shown in Figure 2.2 and Figure 2.3. Both figures are obtained with parameters
from Table 2.2 and by only varying the number of cycles of damage A, with A “ 1 in
Figure 2.2 and A “ 4 in Figure 2.3. Computation of (2.13)–(2.16) (with zero diffusion)
highlights, as expected, a sensitive increase of pro-inflammatory mediators in response
to damage in both Figure 2.2 and Figure 2.3. Macrophages and neutrophils also
appear in correspondence with this rise, with the former being in turn partially cleared
by apoptotic neutrophils. The biological meaning of the solution in Figure 2.2 is that
of resolved inflammation, in which all cell populations and mediators return to healthy
physiological levels (zero). On the other hand, for a prolonged damage stimulus
(A “ 4), inflammation cannot be resolved, thus profiling a chronic inflammatory


























































Figure 2.3: Solution of (2.13)–(2.16), for fpx, tq “ Hptq sin2ptq, periodic boundary
conditions and initial conditions as per (2.18), with parameters values as in Table 2.2.
Since fpx, tq is independent of x, solutions are homogeneous; setting A “ 4 here
prevents full resolution, causing inflammation to be chronic.
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inflammatory mediators maintain high levels of concentration, thus resulting in a
continuous action of macrophages and active neutrophils.
The interest in investigating the impact of parameter φ upon the model’s be-
haviour comes from the paper of Dunster et al. (2014) in which manipulation of the
rate of the phagocytosis of apoptotic neutrophils is recognised as a possible therapeu-
tic target in resolving inflammation. An analogous analysis can be made by testing
different values of parameter the φ. Having fixed A “ 4, that is configuring a context
of initially sustained damage, we vary φ to elucidate the effect of the macrophage
clearance rate instead. We expect to have a prompt and more effective resolution
of inflammation for increasing values of φ, while choosing φ too small should com-
promise the healing process, eventually resulting in a chronic state of inflammation.
The results in Figure 2.4–2.6 confirm these predictions, showing that regulation of
the parameter φ is key to how quickly and effectively the inflammation is resolved.
In particular, increasing φ from the nominal value given in Figure 2.2, generally
improves the system’s response to inflammation, with φ “ 0.09 providing damped os-
cillations but still a chronic outcome (Figure 2.4), φ “ 0.2 resulting in full resolution
(Figure 2.5) and φ “ 0.4 resolving inflammation with even lower levels of cells and
mediators (Figure 2.6).
All of the above results recover the results of Dunster et al. (2014) exactly; this
provides us with confidence that the numerical code use to attain these results is
valid. We examine spatially-inhomogeneous solutions to our model using this code in
Section 2.4.3, after first examining the stability of the steady states observed above




























































Figure 2.4: Solution of (2.13)–(2.16) for fpx, tq “ Hptq sin2ptq, periodic boundary
conditions and initial conditions as per (2.18), with A “ 4, φ “ 0.09 and all other
parameters values as in Table 2.2. Since fpx, tq is independent of x, solutions are
homogeneous; setting φ “ 0.09 provides damped oscillations, but does not yield



























































Figure 2.5: Solution of (2.13)–(2.16) for fpx, tq “ Hptq sin2ptq, periodic boundary
conditions and initial conditions as per (2.18), with parameters values as in Table 2.2,
fixed damage duration with A “ 4. Since fpx, tq is independent of x, solutions are



























































Figure 2.6: Solution of (2.13)–(2.16) for fpx, tq “ Hptq sin2ptq, periodic boundary
conditions and initial conditions as per (2.18), with parameters values as in Table 2.2,
fixed damage duration with A “ 4. Since fpx, tq is independent of x, solutions
are homogeneous; setting φ “ 0.4 prompts here a more effective resolution of the
inflammatory state. We note that overall cell numbers and mediator concentrations
are lower than those attained for φ “ 0.2 in Figure 2.5 due to the enhanced phagocytic
action of macrophages here.
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2.4.2 Stability analysis
To fully determine how the system responds to varying values of key parameters, the
stabilities of steady state solutions are analysed below. In general, the stability of the
system is guaranteed to be stable if and only if all real parts eigenvalues are negative.
By computing the fixed points of (2.13)–(2.16) and evaluating the corresponding
Jacobian matrix at each point, three generic solutions and corresponding sets of
eigenvalues can be found. The latter can assume different values and particularly vary












´ν 0 0 1
ν ´γa ´ φm ´φ a 0

















The matrix J depends on the stationary points and, for each group of solutions, the
associated eigenvalues can thus be computed according to the values of parameters
ν, γa, φ, γm and βa.
In order to assess how the stability evolves with respect to these critical parame-
ters, bifurcation diagrams for each variable are plotted, as shown in Figures 2.7–2.11.
These plots assess in fact the existence and stability of steady state solutions with ref-
erence to a range of values for each parameter featuring in the Jacobian matrix (2.24),
thus potentially affecting stability. In these figures, solid lines represent stable steady
states and dashed lines represent unstable steady states. In this sense, the absence
of any evident bifurcation point in both Figures 2.7–2.9 suggests that (for biologi-
cally feasible choices of parameters) the respective parameters ν, γm and γa do not
have direct effect the stability of steady states. Conversely, plots for parameters
βa (Figure 2.10) and φ (Figure 2.11) exhibit bifurcations indicating a change in the
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number/stability of steady states, by marking the transition from unstable steady
states (dashed lines) to stable ones (solid lines). The bifurcation analysis thus sug-
gests that the most interesting parameters to investigate, with the greatest impact
to the system’s behaviours, are βa and φ. More generally, we are interested in study-
ing the stability of the states as an indicator of the solutions we expect the ODE
system associated to (2.13)–(2.16) to exhibit. In particular, solid lines representing
stable solutions are captured by the simulations in the form of either resolution to
the healthy state (corresponding to the trivial zero steady state) or a chronic state
of inflammation (non-zero steady states). Dashed lines represent unstable solutions
that the system theoretically supports but that, given their instability, cannot be cap-
tured in simulations. The additional presence of bifurcation points further informs
on possible oscillations exhibited by the ODE system, depending on the nature of
the bifurcation. In particular, Figure 2.10 presents a saddle node of bifurcation at
βa » 0.45, with the system admitting three possible solutions lying on the left of the
bifurcating point, two stable, corresponding to the healthy (zero steady state) and
unhealthy (non-trivial steady state) outcomes and one unstable which the system
cannot exhibit in simulations. For βa Á 0.45, inflammatory damage is guaranteed
to resolve. The bifurcation diagrams shown in Figure 2.11 instead present a Hopf
bifurcation at ν » 0.1, where the state of the solutions switches from stability (solid
lines) to instability (dashed lines). In general, Hopf bifurcations are also associated
with the existence of sustained temporal oscillations; however,the Hopf bifurcation in
Figure 2.11 is subcritical, so these oscillations are unstable in this case.
2.4.3 Spatial spread of damage and inflammation
We are particularly interested in regions of parameter space for which the ODE model
is bistable, since these regions exhibit the greatest scope for inhomogeneous solutions.
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Figure 2.7: Stability analysis for system (2.13)–(2.16), in function of parameter ν P
r0, 1s. All other parameters values are set as in Table 2.2. Each colour represents
one set of 3 stationary points. The three corresponding eigenvalues present either
negative real part (stable, solid lines) or positive real part (unstable, dashed lines).
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Figure 2.8: Stability analysis for system (2.13)–(2.16), in function of parameter γm P
r0, 1s. All other parameters values are set as in Table 2.2. Each colour represents
one set of 3 stationary points. The three corresponding eigenvalues present either
negative real part (stable, solid lines) or positive real part (unstable, dashed lines).
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Figure 2.9: Stability analysis for system (2.13)–(2.16), in function of parameter γa P
r0, 1s. All other parameters values are set as in Table 2.2. Each colour represents
one set of 3 stationary points. The three corresponding eigenvalues present either
negative real part (stable, solid lines) or positive real part (unstable, dashed lines).
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Figure 2.10: Stability analysis for system (2.13)–(2.16), in function of parameter
βa P r0, 1s. All other parameters values are set as in Table 2.2. Each colour represents
one set of 3 stationary points. The three corresponding eigenvalues present either
negative real part (stable, solid lines) or positive real part (unstable, dashed lines).
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Figure 2.11: Stability analysis for system (2.13)–(2.16), in function of parameter
φ P r0, 1s. All other parameters values are set as in Table 2.2. Each colour represents
one set of 3 stationary points. The three corresponding eigenvalues present either
negative real part (stable, solid lines) or positive real part (unstable, dashed lines).
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We note, here, that our choices of βa and φ in Table 2.2 (in particular) are positioned
in the bistable regime.
In order to study the model’s spatial behaviour, numerous simulations have been
run, by varying key parameter values and assessing the correspondent system’s out-
come, similarly to the analysis carried in Section 2.4.1. To this purpose, the damage
function introduced in (2.5)–(2.6) is here updated to include spatial dependence:














1 if t ă tmax{3
0 if t ą tmax{3.
(2.26)
with tmax denoting the final time of the simulation. The function fpx, tq is thus mod-
elled as a Gaussian shaped damage, persisting for one third of the total inflammatory
time. The model’s spatial behaviour is finally enhanced by restoring the diffusive
behaviour that had been neglected in the previous analysis for sake of simplicity. As
such, it is considered that mediators diffuse with Dc “ 10´4, while we set neutrophil
and macrophage diffusions at Dn “ 10´5 and Dm “ 10´6 respectively. The analysis
of the spatial spread of inflammation shows continuity with the dynamical analysis
of the previous section in terms of parameter’s regulation and effects on the model.
This is particularly evident by varying the rate of apoptotic neutrophil clearance by
macrophages, φ, with its enhancement providing a prompter and more effective reso-
lution of inflammation. Figure 2.12, analogously to Figure 2.3, highlights how upon
the initial damage 2.25, the nominal value of φ is too small to prevent the chronicity
of inflammation. Similarly to Figures 2.4–2.5, the simulations in Figures 2.13–2.14
also confirm the healing effects of enhancing the apoptotic neutrophils clearance. On
the other side, the addition of spatial dependence in terms of both the initial damage
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Figure 2.12: Solution of (2.13)–(2.16), with damage modelled as in (2.25)–(2.26),
φ “ 0.001 and all other parameters values as in Table 2.2, initial conditions as
per (2.18) and periodic boundary conditions. Figures on the left panel correspond
to the variables’ spatial representation at each time step, the right column presents
plots of the dynamics of the same variables in the middle of the spatial domain.
The nominal value of φ “ 0.001 prevents full resolution, causing inflammation to be
chronic.
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Figure 2.13: Solution of (2.13)–(2.16), with damage modelled as in (2.25)–(2.26),
with φ “ 0.09 and all other parameters values as in Table 2.2, initial conditions as
per (2.18) and periodic boundary conditions. Figures on the left panel correspond to
the variables’ spatial representation at each time step, the right column presents plots
of the dynamics of the same variables in the middle of the spatial domain. Setting
φ “ 0.09 provides damped oscillations, but does not yield complete resolution of
inflammation.
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Figure 2.14: Solution of (2.13)–(2.16), with damage modelled as in (2.25)–(2.26), with
φ “ 0.2 and with all other parameters values as in Table 2.2, initial conditions as
per (2.18) and periodic boundary conditions. Figures on the left panel correspond to
the variables’ spatial representation at each time step, the right column presents plots
of the dynamics of the same variables in the middle of the spatial domain. Setting
φ “ 0.2 results in full inflammation resolution.
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and the mediators diffusion is evident in the left panel graphs of Figures 2.12–2.14,
with a preliminary spatial heterogeneity given by the gaussian shaped damage even-
tually diffusing and settling to a homogeneous steady state. In general, throughout
our simulations, we observe that the damage triggering the inflammatory response
initially spreads within the tissue, persisting for a limited time and eventually being
cleared, restoring a homogeneously healthy state.
In each of Figures 2.12–2.14, we observe a rapid decline in the levels of each
of our model components at t » 2333. This occurs due to the sudden change in
the damage function imposed by (2.26). Prior to this point, the damage function
provides constant stimulus to the model in the centre of the domain, resulting in
the damage in this region being sustained. At t » 2333 “ tmax{3, the damage
function in (2.26) switches off, and we observe a short period of time over which the
damage spreads to become homogeneous. After homogeneity is reached, the results
recover the results of the corresponding ODE model of Dunster et al. (2014) exactly;
however, the model of Dunster et al. (2014) does not capture intermediate, spatially
inhomogeneous configurations.
An important key point arising from the spatial analysis of system (2.13)–(2.16) is
that, regardless of parameters, all long-term solutions are homogeneous. As observed
in the above figures, variations in key parameter values can cause changes in the way
that damage spreads across the tissue, and can ultimately yield switching between
globally healthy and globally chronic outcomes. Crucially, for the parameters studied
here, there is no emergence of persistent spatial patterns. We investigate the potential
for spatial patterns for more general parameter choices via Turing instability analysis
below.
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2.5 Turing instability analysis
We here conduct a Turing instability analysis to ascertain whether the model of (2.13)–
(2.16) can support spatially inhomogeneous steady states.
Analogously to the procedure and notation used in appendix A to identify Turing
instabilities and spatial pattern formation, let us firstly consider the system (2.13)–
(2.16) referring to its relevant homogeneous steady state, corresponding to solutions
of the system
nt “ ´νn ` c ” f1pn, a,m, cq “ 0 , (2.27)
at “ νn ´ γaa ´ φma ” f2pn, a,m, cq “ 0 , (2.28)
mt “ ´γmm ` c ” f3pn, a,m, cq “ 0 , (2.29)
ct “ αfptq ` γa
a2
β2a ` a2
´ c ” f4pn, a,m, cq “ 0 . (2.30)




































f1n0 0 0 f1c0
f2n0 f2a0 f2m0 0
0 0 f3m0 f3c0
















































and similarly for f1a0 , f1m0 and f1c0 and following rows.
2.5. TURING INSTABILITY ANALYSIS 72











´ν 0 0 1
ν ´γa ´ φm0 ´φ a0 0

















For the homogeneous steady state to be stable, we require
ℜpλipAqq ă 0 i “ 1, . . . , 4. (2.34)
The bifurcation analysis of Section 2.4.2 has already shown that the system sup-
ports up to two stable homogeneous steady states. Our interest here is in ascertaining
whether these steady states can be destabilised by diffusion, potentially resulting in
stable patterns.
By restoring diffusion in the model of (2.13)–(2.16), the system can accordingly



































f1n0 0 0 f1c0
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Dn 0 0 0
0 0 0 0
0 0 Dm 0







































or, in its compact matrix form
wt “ Aw ` D∇2w. (2.36)
Assuming a spatial dependence of the form described in Appendix A (equation (A.17)),
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f1n0 ´ k2Dn 0 0 f1c0
f2n0 f2a0 f2m0 0
0 0 f3m0 ´ k2Dm f3c0






















´ν ´ k2Dn 0 0 1
ν ´γa ´ φm0 ´φa0 0
0 0 ´γm ´ k2Dm 1











with X conveniently denoting p2a0γaβ2aq{pa20 ` β2aq2, as originally appeared in (2.33).
The characteristic polynomial of Ak is given by
pkpλq “ pν ` k2Dn ` λqrpγa ` φm0 ` λqpγm ` k2Dm ` λqp1 ` k2Dc ` λq ` φa0Xs
´ νpγm ` k2Dm ` λqX.
(2.39)
By conveniently renaming the factors as
t1 “ ν ` k2Dn, (2.40)
t2 “ γa ` φm0, (2.41)
t3 “ γm ` k2Dm, (2.42)
t4 “ 1 ` k2Dc, (2.43)
t5 “ φa0X, (2.44)
t6 “ νX, (2.45)
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and rearranging the terms, the characteristic polynomial can be expressed as
pkpλq “ λ4 ` pt1 ` t2 ` t3 ` t4q
looooooooomooooooooon
s1




` rt1t2pt3 ` t4q ` t3t4pt1 ` t2q ` t5 ´ t6s
looooooooooooooooooooooomooooooooooooooooooooooon
s3





having further simplified the notation, by introducing the terms s1, s2, s3 and s4 that
allow a shorter and straightforward representation of pkpλq:
pkpλq “ λ4 ` s1λ3 ` s2λ2 ` s3λ ` s4. (2.47)
Observation 1. Recalling that all elements in D as well as all the model parameters
and variables are positive, it follows that t1, t2, t3, t4, t5, t6 ą 0.
Observation 2. From observation 1 it follows that
s1 “ t1 ` t2 ` t3 ` t4 ą 0 (2.48)
s2 “ t1t2 ` t1t3 ` t1t4 ` t2t3 ` t2t4 ` t3t4 ą 0. (2.49)
Similarly to the analysis carried out in appendix A.2, the existence of spatial
instability is related to the system having eigenvalues with positive real part. This
problem is thus equivalent of studying the signs of the real parts of the polynomial
roots λi , i “ 1, . . . , 4. In order to do so, the Routh-Hurwitz criterion is applied (see
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In particular, according to the Routh-Hurwitz criterion, the number of eigenvalues
with positive real part is related to the number of sign changes within the elements
of the first column of R. Therefore, analysing the signs of elements ri1, i “ 1, . . . , 5
of the Routh matrix determines the system’s homogeneity in space. The analysis of
the actual elements ri1 of matrix (2.50) first column yields










s4 ` s23 ´ s1s2s3
s3 ´ s1s2
(2.52)
requiring further study. From expressions (2.51)–(2.52) it is clear that the sign of
s1s2´s3 eventually characterises both matrix elements. For simplicity, let us consider
the trivial steady state for which all variables are equal to zero, and thus X “ 0 and
t5 “ t6 “ 0 also. We can then write
s1s2 ´ s3 “ pt1 ` t2 ` t3 ` t4qpt1t2 ` t1t3 ` t1t4 ` t2t3 ` t2t4 ` t3t4q`
´ t1t2pt3 ` t4q ´ t3t4pt1 ` t2q,
(2.53)
which, in turn, can be rewritten as
s1s2 ´ s3 “ t1t2pt1 ` t2q ` t3t4pt3 ` t4q`
` pt1 ` t2 ` t3 ` t4qpt1t3 ` t1t4 ` t2t3 ` t2t4q`
` t1t2pt3 ` t4q ` t3t4pt1 ` t2q ´ t1t2pt3 ` t4q ´ t3t4pt1 ` t2q,
(2.54)
prompting the cancellation of all negative terms and resulting in
s1s2 ´ s3 “ t1t2pt1 ` t2q ` t3t4pt3 ` t4q`
` pt1 ` t2 ` t3 ` t4qpt1t3 ` t1t4 ` t2t3 ` t2t4q,
(2.55)
which, comprising only positive terms, is always positive. Thus, also r31 ą 0.
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An analogous analysis of element r41 requires studying the sign of its numerator
since we know from above that its denominator is negative. Noting (2.55), we have
s2
1
s4 ´ s3ps1s2 ´ s3q “ pt1 ` t2 ` t3 ` t4q2pt1t2t3t4q`
´ rt1t2pt3 ` t4q ` t3t4pt1 ` t2qsrt1t2pt1 ` t2q ` t3t4pt3 ` t4q`
` pt1 ` t2 ` t3 ` t4qpt1t3 ` t1t4 ` t2t3 ` t2t4qs .
(2.56)
Convenient arrangements of the terms provide the following:
s2
1
s4 ´ s3ps1s2 ´ s3q “ pt1 ` t2 ` t3 ` t4q2pt1t2t3t4q`









qpt1 ` t2qpt3 ` t4q`
´ pt1t3 ` t1t4 ` t2t3 ` t2t4qpt1 ` t2 ` t3 ` t4qrt1t2pt3 ` t4q ` t3t4pt1 ` t2qs,
(2.57)
from which it follows that
s2
1
s4 ´ s3ps1s2 ´ s3q “ pt1 ` t2q2pt1t2t3t4q ` pt3 ` t4q2pt1t2t3t4q`
` 2pt1t3 ` t1t4 ` t2t3 ` t2t4qpt1t2t3t4q`









qpt1t3 ` t1t4 ` t2t3 ` t2t4q`
´ pt1t3 ` t1t4 ` t2t3 ` t2t4qpt1 ` t2 ` t3 ` t4qrt1t2pt3 ` t4q ` t3t4pt1 ` t2qs .
(2.58)
Cancelling terms where possible then provides:
s2
1
s4 ´ s3ps1s2 ´ s3q “ pt1t3 ` t1t4 ` t2t3 ` t2t4qt2pt1t2t3t4q ´ pt21t22 ` t23t24q`
´ pt1 ` t2 ` t3 ` t4qrt1t2pt3 ` t4q ` t3t4pt1 ` t2qsu,
(2.59)
Which we may rearrange as follows:
s2
1
s4 ´ s3ps1s2 ´ s3q “ ´pt1t3 ` t1t4 ` t2t3 ` t2t4qtpt1t2 ` t3t4q2`
` pt1 ` t2 ` t3 ` t4qrt1t2pt3 ` t4q ` t3t4pt1 ` t2qsu,
(2.60)
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which is always negative, thus ensuring that s2
1
s4 ´ s1s2s3 ` s23 ă 0. This result,




s4 ´ s1s2s3 ` s23
s3 ´ s1s2
ą 0.
Finally, recalling that all elements ri1, i “ 1, . . . , 5 present the same sign, thus pre-
venting any change in sign between consecutive elements, the stability of the healthy,
homogeneous steady state is guaranteed, with all the associated eigenvalues having
negative real parts (appendix B).
This also implies that, even when diffusion values would lead to spatial instability
at the two remaining critical sets of fixed points, this instability eventually settles
and the stability guaranteed by the fixed points at zero prevail.
As such, this detailed analysis proves that, regardless of diffusion constants Dn,
Dm and Dc values, there is no scope for the model of (2.13)–(2.16) to support Turing
instabilities.
2.6 Conclusions
In this chapter an initial spatially-dependent model of inflammation developed by
Dunster et al. (2014) has been presented and analysed. We then extended this model,
adding the spatial description of the inflammatory response. In particular, we mod-
elled diffusion of mediators, active neutrophils and macrophages, neglecting apoptotic
neutrophils as dead cells thus unable to move.
The key results emerging from the associated ODE system and the bifurcation
analysis regard the system’s stability, with the model being either bistable or monos-
table, depending on the parameters. While a number of parameters regulate the wide
range of biological interactions between the system’s variables (namely active neu-
trophils n, apoptotic neutrophils a, macrophages m and pro-inflammatory mediators
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c), two main parameters emerge as critical, from both preliminary simulations in Sec-
tion 2.4.1 and the bifurcation analysis in Section 2.4.2; that is, φ and βa, accounting
for the apoptotic neutrophil removal rate and saturation constant respectively. In
particular, as Figures 2.4–2.6 show, an enhanced clearance of apoptotic neutrophils
by macrophages results in a more effective resolution of inflammation, while, on the
other hand, both parameters φ and βa show the most significant effects on the model,
in terms of stability of the steady states, as represented in the bifurcation diagrams
of Figures 2.10 and 2.11. Overall, for large values of βa, the model is monostable,
since fewer apoptotic neutrophils release pro-inflammatory mediators, meaning that
resolution is guaranteed. Analogously, the system is monostable also for large values
of φ, since apoptotic neutrophils are cleared by macrophages at a higher rate, thus
prompting the resolution of inflammation.
Analysing the numerical results, we observed how localised damage can spread
to neighbouring healthy tissue. For the parameters studied, we only observe inho-
mogeneous solutions while damage is being actively stimulated by an inhomogeneous
input fpx, tq. In the absence of f , long term solutions revert to those of the ODE
model. While long-term solutions are always homogeneous, and thus recover the re-
sults of Dunster et al. (2014) entirely, we note that the ODE model of Dunster et al.
is unable to capture the intermediate inhomogeneous configurations presented in Fig-
ures 2.12–2.14, which illustrate the manner in which localised damage spreads in to
neighbouring healthy tissue.
Aiming at studying the models potential for spatial patterning, we investigated
the scope for spatial patterns arising through the two most common mechanisms re-
ported in literature, namely Turing instabilities and Hopf bifurcations. In Section 2.5,
we illustrated that the structure of this model does not allow diffusion to destabilise
the homogeneous steady states of the corresponding ODE model. This eliminates the
scope for Turing instabilities to occur. Most pattern formation mechanisms that are
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reported to occur at Hopf bifurcations in existing literature do so when these Hopf
bifurcations are supercritical and give rise to stable oscillations in the corresponding
ODE model. (See, for example, Mazin et al. (1996) or Dilao (2005).) However, in
this model, the Hopf bifurcation is always subcritical, which seems to eliminate Hopf-
based patterns. Therefore, the model does not present any spatial inhomogeneity of
the steady states. This in turn prevents the development of possible spatial patterns
that would be of interest in biological terms. We note that extensions of the underly-
ing ODE model presented by Dunster et al. (2014), which include further biological
feedbacks, exhibit changes in the criticality of the Hopf bifurcation, and thus may
display scope for inhomogeneous solutions; this is one question that we address in
Chapter 3 below.
While we have observed that the model of (2.13)–(2.16) shows relatively limited
spatially inhomogeneous behaviour in the absence of sustained inhomogeneous forc-
ing, it is important to note that this model incorporates only a limited number of
cellular interactions, and hence lacks some more complex feedbacks that could render
spatially inhomogeneous solutions permissible. This model includes only one positive
feedback via apoptotic neutrophils and one negative feedback via macrophages. An
extension of the underlying ODE model, presented by Dunster et al. (2014), incorpo-
rates an additional positive feedback via production of pro-inflammatory mediators by
active neutrophils, which has significant impact upon the models dynamics, increas-
ing the size of the bistable regime. Furthermore, this model omits anti-inflammatory
mediators, which have been shown to play an important role in triggering the resolu-
tion of inammatory processes (Serhan et al., 2008; Rinaldi et al., 2011), and provide
an additional negative feedback. We anticipate that inclusion of these additional
behaviours could enable a broader range of spatially inhomogeneous behaviours, in
which localised damage may spread to healthy tissue. In addition, a key limitation
of this model is that active neutrophils and macrophages are assumed to move only
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diffusively, while in vivo the principal motion of these cells is chemotactic migration
toward high concentrations of pro-inflammatory mediators. This chemotaxis is omit-
ted here, but may be readily included in an extension of this model. In doing so,
we note that our focus upon a one-dimensional domain in this chapter could place
some restrictions on the spatial patterns attained. To overcome these limitations, it
is essential to widen the current model by adding to its complexity, both spatially
(via a 2D implementation) and biologically, by including the above described features
that will invariably involve a larger number of parameters and variables. We address
these deciencies in the following chapter. In particular, we present a thorough review
of the limitations of this model, and how they will be addressed in a corresponding
extension, in Section 3.1.
Chapter 3
Modelling the effects of
anti-inflammatory mediators
In this chapter we extend the previously developed PDE model in order to include
the impact of a second group of chemicals upon the system, representing of anti-
inflammatory mediators. Furthermore, more refined biological interactions such as
neutrophils’ inherently pro-inflammatory behaviour (Dunster et al., 2014) and the ad-
dition of chemotaxis are also provided in this new model. A new numerical approach
is also presented in order to tackle the complications introduced by the inclusion of
the chemotactic terms. A two-dimensional version of the model will be implemented,
in line with the biological assumption of analysing the surge and resolution of inflam-
mation of a generic two-dimensional tissue. The model will be analysed first in terms
of homogeneous steady states and then spatially by investigating the model’s abil-
ity to support patterning and inhomogeneous oscillations. Results will be gathered
and assessed in terms of the manipulation of key parameters and the corresponding
impact upon the final inflammatory outcome.
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3.1 Limitations and extensions of the model of Chap-
ter 2
The model introduced in Chapter 2 served to provide a basic representation of the
main features that characterise the acute inflammatory response. The actual biology
of such a complex event presents multiple aspects that have been neglected in the
previous model for the sake of simplicity and clarity. These included cells’ chemotaxis
and neutrophils’ contribution to promoting inflammation. While that model yields
effective simulations in terms of the dynamical outcome of an inflammatory process,
the lack of some significant biological interactions prompts for an extension of the
model in order to assess biologically meaningful results by including such features in
its mathematical description. Furthermore, the analysis of the model of Chapter 2
also excludes any kind of spatial patterning, while not being sufficiently rigorous in
terms of chemical interactions between the main inflammatory variables. Thus, the
extension proposed in this chapter, while yielding a more complicated model, takes
into account more accurate biological scenarios, possibly providing scope for spatially
inhomogeneous outcomes.
The equations provided for the model of Chapter 2 (2.1)–(2.7) configure apop-
totic neutrophils as the only active source of pro-inflammatory mediators (initially
triggered by generic damage, modelled by fpt˚q as in (2.6)). Biologically though
this is not completely accurate, since active neutrophils also serve as a positive feed-
back in terms of pro-inflammatory events (Xia et al., 2015) by being responsible for
an enhanced production of c˚. Furthermore, macrophage activity goes beyond the
basic phagocytosing task and presents a much more nuanced response throughout in-
flammatory processes, by releasing, upon their recognition of apoptotic neutrophils,
different specific chemicals that act as anti-inflammatory signals. While the range
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of species macrophages release to this scope is quite wide and diversified, both in
terms of timing and the specific nature these anti-inflammatory cytokines, there is
also a redundancy of the anti-inflammatory signals that are triggered by macrophage
activity (Duque & Descoteaux, 2014) that justifies modelling this varied multiple
group of mediators as a unique source of anti-inflammatory chemicals. Therefore, in
order to model this new sequence of mediators appearing in the inflammatory envi-
ronment that is being analysed, it is considered that macrophages are responsible for
the release of a generic anti-inflammatory mediator, that includes a group of different
cytokines and growth factors commonly present in inflammation (Liu et al., 2014).
Moreover, an essential feature that will be incorporated in this extension of the
model of Chapter 2 is chemotaxis, thus adding to the spatial characterisation of the
model as well as replicating a fundamental aspect of in vivo inflammatory processes.
In general, in chemical and biological systems, the phenomenon of cellular direc-
tional motion up chemical gradients is named chemotaxis (Delves & Roitt, 1998).
This is a common feature of many cells, including unicellular organisms such as
bacteria (Schaechter, 2009), but, with regards to inflammation, it is most promi-
nently expressed by leukocytes which are diverted from blood stream into the injured
area (Tani et al., 2001). A large group of chemicals, including small proteins and
chemokines, have been recognised to act as chemotactic agents, although the exact
mechanisms of signalling and transduction that result in cell migration have not been
completely clarified yet (Jin et al., 2008). Nonetheless, upon injury, as part of the
initial cascade of reactions and interactions triggered by the occurred damage, this
variety of particles, partly present on-site and partly released in response to the insult,
selectively attract neutrophils (in the earliest stages) and macrophages (during the
ongoing response), prompting their recruitment and deployment in the inflammatory
activity. The tightly controlled mechanisms of chemotaxis during inflammation and
their high specificity ensure the triggering and promotion of an effective and physio-
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logic acute inflammatory response. On the other hand, slight defects in this complex
and delicate cell signalling could easily result in chronic inflammation and possible
pathological complications (Turner et al., 2014).
3.2 The model
We extend the model of Chapter 2 to account for the above limitations by following
the corresponding model developments of Dunster et al. (2014), as described below.
Furthermore, we extend the existing ODE model of Dunster et al. (2014) to include
spatial information via diffusive and chemotactic terms in the governing equations.
The biological interactions described above are introduced into the model by de-
noting with k˚n the maximal rate of production of pro-inflammatory mediators by
neutrophils. We assume this feedback to be saturating in nature in the same manner
as production by apoptotic neutrophils was modelled in Chapter 2; we denote with β˚n
the associated half-maximal concentration level. A new equation accounting for the
anti-inflammatory mediators, g˚, is also added to the model; we introduce the new
parameters k˚g as the concentration of anti-inflammatory mediators produced upon
macrophage engulfment of apoptotic neutrophils, and γ˚g as the linear decay rate. The
anti-inflammatory activity affects in turn the apoptotic process that neutrophils un-
dergo by increasing the apoptosis rate through a saturation constant β˚g that acts on
anti-inflammatory mediators. Conversely, upon a concentration of pro-inflammatory
mediators of β˚c the apoptosis rate decreases. In this context, pro-inflammatory me-
diators c˚ further prolong neutrophils’ lifespan (McCracken & Allen, 2014). To model
these effects, the apoptosis rate ν˚ is amended such as to include the contributions
of both the anti-inflammatory mediators g˚ through the parameter β˚g and the pro-
inflammatory mediators c˚ through the parameter β˚c respectively. The effect of the
newly introduced anti-inflammatory mediators is further reflected on the neutrophils
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influx with parameter β˚gc controlling the concentration over which this rate decreases.
These additional interactions, introduced in ‘Model 3’ of Dunster et al. (2014), are
illustrated in Figure 3.1, which updates upon Figure 2.1 in Chapter 2. Once again,
we expand upon this existing ODE model via the addition of spatial terms, following
the procedure of Chapter 2. In order to incorporate spatial information for the new
variable g˚, a diffusion constant D˚g is introduced, thus considering anti-inflammatory
mediators as moving diffusively.
In order to mathematically incorporate chemotaxis, both active neutrophils n˚
and macrophages m˚ are considered to move towards higher concentrations of pro-
inflammatory mediators c˚. This movement of cells towards high concentrations of
pro-inflammatory mediators results in additional flux terms that are proportional to
both the local cell concentration and the gradient of the pro-inflammatory mediator
concentration. That is, we obtain the highest level of chemotactic flux when both the
cell number and the mediator gradient are large. We denote the associated chemotaxis
constants for neutrophils and macrophages by θ˚n and θ
˚
m respectively.

























˚ ´ γ˚mm˚ ` D˚m∇2m˚ ´ θ˚m∇ ¨ pm˚∇c˚q, (3.3)
Bc˚
Bt˚ “ α















˚m˚a˚ ´ γ˚g g˚ ` D˚g∇2g˚ , (3.5)
We retain the cells’ spatial description with active neutrophils and macrophages freely
diffusing within the tissue. As previously explained in Chapter 2, we do not prescribe
apoptotic neutrophils with diffusive motion assuming that the extent to which these
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inanimate particles could diffuse (despite varying dependent upon their local envi-
ronment, size and temperature) will always be negligibly small compared to that of
active neutrophils and macrophages.
We highlight, once again, that in the absence of diffusive and chemotactic terms in
(3.1)–(3.5) we recover the ODE model labelled as ‘Model 3’ in Dunster et al. (2014).
In Chapter 2 we initially modelled damage through a time dependent function
fpt˚q, (2.5), and subsequently a spatially dependent one fpx˚, t˚q, (2.25), that triggers
the inflammatory response. We retain f in (3.4) to make a comparison with Chapter 2,
but in later sections we set f “ 0 and consider damage driven by initial conditions.
3.3 Parameter values
The newly introduced parameters are presented in Table 3.1, with ranges of values
inferred from the available literature where possible. As can be seen from Table 3.1,
the scientific literature for diffusion constant of the anti-inflammatory mediators D˚g
gives a comparable range to the one provided for the diffusion of pro-inflammatory
mediators D˚c and reported in Table 2.1 of Chapter 2. As such, we consider the anti-
inflammatory mediators to diffuse at equivalent rate of pro-inflammatory mediators.
As for the chemotactic constants, as an initial point of reference we assume that
chemotaxis parameters are of a similar order to those of leukocytes’ diffusion that
remain unchanged from the considerations of Section 2.2.1, with specific dimensionless
values detailed in the following section.
3.4 Nondimensionalisation
Analogously to Section 2.2.2, we nondimensionalise (3.1)–(3.5) by substituting the
rescaled dimensionless variables of (2.12) as well as the new scaling g˚ “ β˚gcg, the
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Figure 3.1: Schematic diagram showing the spatially-independent interactions in
‘Model 3’ of Dunster et al. (2014), which form the basis of the PDE model pre-
sented in (3.1)–(3.5). The model includes populations of healthy neutrophils (n˚),
apoptotic neutrophils (a˚) and macrophages (m˚), interacting in response to pro- and
anti-inflammatory mediators (c˚ and g˚) with associated parameters as shown. Ar-
rowheads indicate up-regulation; flat-headed arrows indicate down-regulation; dashed
arrows indicate natural decay.
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Parameter Definition Range of values Unit measure
k˚n pro-inflammatory mediators production from active neutrophils (rate of
c˚ptq concentration produced in response active neutrophils presence)
750 ´ 4000 rpg ¨ mm´3 ¨ day´1s
(Dumas et al., 2016)
β˚n active neutrophils saturation constant (concentration of active neu-
trophils required for half maximal release of c˚ptq)
rcell ¨ mm´3s
k˚g anti-inflammatory mediators production from macrophages (concentra-
tion of g˚ptq produced in response macrophages presence)
10 ´ 750 rpg ¨ cell´1s
(Miles et al., 2009)
β˚gc inflammatory mediators saturation constant (concentration scale over
which neutrophils influx rate decreases)
rpg ¨ mm´3s
β˚g anti-inflammatory mediators saturation constant (concentration of anti-
inflammatory mediators over which apoptosis rate increases)
rpg ¨ mm´3s
β˚c pro-inflammatory mediators saturation constant (concentration of pro-
inflammatory mediators over which apoptosis rate decreases)
rpg ¨ mm´3s
γ˚g rate of anti-inflammatory mediators decay 3.6 ´ 52.56 rday´1s
(Reynolds et al., 2006)
D˚g anti-inflammatory mediators diffusion constant 8.64 ¨ 10´2 ´ 8.64 rmm2 ¨ day´1s
(Busse et al., 2010)
(Sherratt & Murray, 1990)
(Ross & Pompano, 2018)
θ˚n active neutrophils chemotaxis constant rmm2 ¨ day´1s
θ˚m active macrophages chemotaxis constant rmm2 ¨ day´1s
Table 3.1: New parameters appearing in the model (3.1)–(3.5). When available,
ranges of parameter values are inferred from relevant literature, as specified.
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As the expressions in (3.6) show, we follow the nondimensionalisation applied in
Chapter 2, by scaling time on 1{γ˚c , taking γ˚c “ 3 day´1, as in Dunster et al. (2014),
with γ˚c being the rate of decay of pro-inflammatory mediators. As in Chapter 2,
we scale space considering a domain of width L˚ “ 10 cm. The dimensional ranges
given by literature and reported in tables 2.1 and 3.1 allow us to provide dimension-
less estimates for both spatial and non-spatial dimensionless parameters as shown in








1 ` g ` Dn∇







n ´ γaa ´ φma, (3.8)
Bm
Bt “ c ´ γmm ` Dm∇
2m ´ θm∇ ¨ pm∇cq, (3.9)
Bc






´ c ` Dc∇2c, (3.10)
Bg
Bt “ kgφma ´ γgg ` Dg∇
2g . (3.11)
The above described system retains the periodic boundary conditions while the
zero initial conditions (2.18) provided for the model of Chapter 2 will later be updated
and presented throughout this chapter such as to include initial damage, as discussed
in Section 3.8.
From here on we will first proceed with a section investigating spatially-independent
simulations driven by the damage function f in (3.10). The computational implemen-
tation of (3.7)–(3.11) for this first set of simulations will thus be analogous to the
one presented in Section 2.3.1. We then analyse the homogeneous steady states that
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Parameter Approximate Range Standard values used in simulations
in this chapter
ν 0.001 ´ 0.6925 0.1
γa 0.55 ´ 1 1
γm 10
´2 ´ 1.2375 ¨ 10´2 0.01
φ 0.001 ´ 1.38 0.1
βa 0.01 ´ 0.1 0.1
Dn 10
´5 ´ 10´3 10´5
Dm 10
´6 ´ 10´3 10´6
Dc 10
´4 ´ 10´3 10´4
kn 1.9 ¨ 10´3 ´ 4 ¨ 10´2 0.01
βn 0.1 0.1
βg 8.33 ¨ 10´6 ´ 10´2 10´2
βc 0.12 0.12
kg 0.1 ´ 0.7128 0.1
γg 1 ´ 2.25 1
Dg 10
´4 ´ 10´3 10´4
θn 10
´6 ´ 10´4 10´5
θm 10
´6 ´ 10´4 10´6
Table 3.2: Dimensionless parameter values appearing in the model of (3.7)–(3.11).
New parameters introduced in this chapter are presented in bold.
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the model admits in the absence of spatial terms, and present a bifurcation analysis
to illustrate how the stability of these states depends upon model parameters. This
assessment is crucial in guiding us in through a further set of simulations in which the
spatial behaviour of both mediators and leukocytes is evaluated thoroughly. Further-
more, the implementation and simulation of a two-dimensional version of (3.7)–(3.11)
is anticipated by the introduction of a more robust numerical method that takes into
account the challenges posed by working with the chemotactic terms on a range of pa-
rameter values. The following two-dimensional simulations, presented in Section 3.8
will thus be implemented according to the newly defined numerical approach. Finally
the results will be analysed and commented and conclusions to the chapter provided.
3.5 Spatially-independent simulations
The model described in (3.7)–(3.11) presents added complexity, particularly in terms
of neutrophil apoptosis and inflammatory mediator interactions. We here aim to draw
comparisons with the model analysed in Chapter 2. In order to properly analyse
the newly introduced terms and assess how they affect the system, we first present
simulations in which all diffusion and chemotaxis terms are omitted and different
values of critical parameters are tested. In this preliminary spatially-independent
analysis the damage function (2.5) is retained, and the initial conditions of (2.18) are
extended to include the new anti-inflammatory mediators such that:
np0q “ ap0q “ mp0q “ cp0q “ gp0q “ 0. (3.12)
Firstly, it is of interest to evaluate how damage duration and possible repetition af-
fects the inflammatory outcome. In fact, with nominal values for the parameters, it
is expected from Chapter 2 that upon one single cycle of damage the inflammation
would resolve naturally, while the system would not be able to recover when under re-
peated or continuous damage. However, this is not completely true, as is evident from
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the results of Figures 3.2 and 3.3, which both show a similar pattern of a persistent
inflamed state, regardless of the damage duration. A key point of comparison here
with respect to the model of Chapter 2 is that the introduction of pro-inflammatory
mediator production by active neutrophils (with parameter kn) results in a previously
healthy outcome (as shown in Figure 2.2) becoming chronic, as shown in Figure 3.2,
with both systems being under one cycle of damage only. This is because of the
addition into the extended model of kn, whose inclusion causes a change of behaviour
and an immediate impact upon the system, with Figure 3.2 confirming that the ad-
ditional pro-inflammatory mediators provided by active neutrophils can be sufficient
to prevent resolution. Similarly to the results of Figure 2.3, variables also reach a
chronic steady state following four cycles of damage, as shown in Figure 3.3.
In order to better understand the model’s behaviour, different parameter values
are tested, indicating how some of these parameters are actually key to the progression
and evolution of inflammation. In particular, the simulations in Figure 3.4 show how
the tuning of parameters φ and kg regulates the oscillatory behaviour of the system.
Thus, for sensitive values of φ and kg, the introduction of the anti-inflammatory
mediator g provides a negative feedback loop that results in oscillations that are not
found in the model of Chapter 2. By further analysing (3.7)-(3.11), new simulations
highlight that the rate of mediator production due to active neutrophils (kn) also
impacts on the inflammation’s outcome. In this regard, for a smaller choice of kn
(kn “ 1.9 ¨ 10´2), the inflammatory outcome is dependent on the duration of the
damage; a healthy state is recovered upon a single cycle of damage, while there is no
resolution for consecutive damaging events. Therefore, for smaller values of kn the
results of Chapter 2 are recovered, with figures here omitted for brevity.








































































Figure 3.2: Solution of (3.7)–(3.12) in the absence of spatial terms, with one damage
cycle applied (A “ 1). All parameters values are as given in Table 3.2.








































































Figure 3.3: Solution of (3.7)–(3.12), in the absence of spatial terms, with four damage
cycles applied (A “ 4). All parameters values are as given in Table 3.2.






































































Figure 3.4: Solution of (3.7)–(3.12), in the absence of spatial terms, with four damage
cycles applied (A=4), for φ “ 0.08 and kg “ 0.65, and all remaining parameters
as given in Table 3.2. For these parameter values, the model exhibits sustained
oscillatory behaviour.
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3.6 Analysis of homogeneous solutions
We examine how the nature of the homogeneous steady states in (3.7)–(3.11) depends
upon choices of key parameters. We analyse a subset of the model’s parameters, in-
cluding a focus on the newly introduced ones. In particular, from the parameters
already featuring in Chapter 2, we retain here the stability analysis for the key pa-
rameters φ and ν and extend it to include the newly introduced anti-inflammatory
parameters kn and kg, while neglecting the bifurcation diagrams for the remaining
ones, already analysed in 2.4.2. It is important to consider how the bifurcation analy-
sis explains the stability of the solutions of the associated ODE system. As exposed in
Section 3.5, the system can either exhibit bistability (with healthy or chronic steady
states), be excitable (with sustainable oscillations) or monostable (with the healthy
steady state the only possible homogeneous outcome). Key parameters directly affect
the stability of the system’s fixed points.
In the following sections, we present bifurcation diagrams in terms of ν, φ, kn and
kg in turn, holding all other parameters fixed at the values in Table 3.2.
3.6.1 Varying rates of neutrophil apoptotis and macrophage
phagocytosis
In Figure 3.5 we show bifurcation diagrams that plot the coordinate of the steady-
state pro-inflammatory mediator concentrations, c, as functions of (a) φ and (b)
ν. Solid black curves illustrate stable steady states, dashed black curves illustrate
unstable steady states, and red curves illustrate the amplitudes of stable oscillations.
In Figure 3.5a, for ν “ 0.1, a supercritical Hopf bifurcation occurs at φ “ φHB » 0.09.
In 3.5b, for φ “ 0.1, this same supercritical Hopf bifurcation occurs at ν “ νHB »
0.07. For values of φ or ν that lie to the left of the Hopf bifurcation in either of
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Figure 3.5: Bifurcation diagrams for parameters ν and φ representing the rates at
which active neutrophils undergo apoptosis and are phagocytosed by macrophages,
respectively, as appearing in system (3.7)–(3.11), with respect to pro-inflammatory
mediators (a,b) and combined (c). All other parameters values are set as in Table 3.2.
Stable/unstable steady states are plotted in solid/dashed respectively, with stable
oscillations indicated in red.
these figures, the system is bistable, since both healthy and chronic steady states
are stable; the magnitude of the initial damage acts as a switch between these two
configurations. For values of φ or ν that lie to the right of the Hopf bifurcation, the
chronic steady state is unstable and the only permissible homogeneous configuration
is one of complete resolution of damage. In Figure 3.5c, we show the coordinates
of the Hopf bifurcation in pφ, νq–space. For parameter values below the illustrated
curve, the system is bistable; for parameter values above this curve, the system is
monostable since the chronic steady state is unstable.
3.6.2 Varying the neutrophil feedback rate
The model of (3.7)– (3.11) incorporates a positive feedback loop owing to the produc-
tion of pro-inflammatory mediators by active neutrophils, the associated rate constant
being denoted kn. In Figure 3.6, we briefly examine the extent to which this posi-
tive feedback loop impacts upon potential solutions. As discussed above, the facet
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of the model that is key in determining the long-term outcome is the position of the
Hopf bifurcation. For parameter combinations that lie prior to the Hopf bifurcation,
the model is bistable and we have the potential to obtain either healthy or chronic
steady states dependent upon initial conditions; for parameter choices beyond the
Hopf bifurcation, the only permissible solutions are the healthy homogeneous config-
uration or outcomes not captured by the associated ODE system. In Figure 3.6, we
illustrate how the position of the Hopf bifurcation depends upon our choice of kn.
In Figures 3.6a–3.6b we present two-parameter bifurcation diagrams that illustrate
how the φ– and ν–coordinates of the Hopf bifurcations evolve as kn is varied; the
non-trivial homogeneous steady state is stable for parameter combinations that lie
above the illustrated curves. As kn is increased from our baseline value of kn “ 0.01,
there is a narrowing window of φ–values (for fixed ν) for which the non-trivial steady
state is unstable (Figure 3.6a). As such, the enhanced pro-inflammatory mediator
production by neutrophils essentially acts to enhance the stability of the non-trivial
steady state, hence increasing the potential of attaining a chronic state. Holding φ
fixed and varying kn, the position of the Hopf bifurcation is an increasing function of
ν, since the enhanced apoptosis of neutrophils acts to counter the pro-inflammatory
mediator production by active neutrophils (Figure 3.6b). For the parameter values
of Table 3.2, choices of kn Á 0.07 result in the Hopf bifurcation being eliminated
completely. Figure 3.6c illustrates the curve in pφ, νq–space on which the Hopf bifur-
cation lies, for various choices of kn. Below the illustrated curves, the model attains
either healthy or chronic outcomes, identifying a region of bistability. Conversely,
increases in kn push the system toward the monostable region where the system’s
stable outcome is chronic.
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Figure 3.6: Bifurcation diagrams illustrating the effects of the neutrophil feedback
parameter kn upon locations of Hopf bifurcations as functions of (a) φ and (b) ν.
In (a,b), the non-trivial steady state is stable for parameter combinations above the
black curves. In (c) we show the position of the Hopf bifurcation in pφ, νq–space for
kn “ 0.01 (solid line), kn “ 0.04 (dashed line) and kn “ 0.07 (dash-dotted line). The
non-trivial steady state is stable below the illustrated curves; the areas of parameter-
space above the curves exhibit potential for inhomogeneous solutions. The cross
symbols demark the baseline parameter values of Table 3.2.
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3.6.3 The role of anti-inflammatory mediators
A further focus on the role of anti-inflammatory mediators is provided by Figure 3.7,
in which the impact of the manipulation of the parameter kg on the stability of homo-
geneous steady states is assessed. In particular, Figure 3.7a illustrates how the regions
of stability vary with respect to the production of anti-inflammatory mediators kg,
with those lying below and above the curves representing bistable and monostable
outcomes of the system respectively. The region of monostability grows by increasing
values of kg, with the healthy steady state being the only permissible stable steady
state for a wider range of parameters in pφ, νq-space. Figure 3.7b illustrates the loca-
tion of the Hopf bifurcation with respect to parameters kg and kn, while fixing all other
parameter values according to Table 3.2. Here, the region corresponding to bistabil-
ity of the solutions lies above the curve with both healthy and chronic homogeneous
outcomes being permissible. Below this curve, the only permissible homogeneous so-
lution is one of uniformly resolved damage. Analogously, bifurcation analysis of the
anti-inflammatory parameters γg and βg shows a qualitatively similar impact on the
system’s stability, with the corresponding Hopf bifurcations approaching the dashed
curve of Figure 3.7a (results are here omitted for brevity).
3.7 Incorporating chemotaxis: a modified numer-
ical approach
The inclusion of chemotaxis in our model poses a non-trivial numerical challenge. The
typical qualitative behaviour chemotaxis prescribes is best represented by hyperbolic
PDEs (Gerisch et al., 2001). Such equations, contrary to purely diffusive parabolic
PDEs, can present discontinuities even with smooth initial conditions (Rozhdestven-
skii, 1960), thus requiring careful numerical approaches in their approximation. Here
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Figure 3.7: Bifurcation diagrams illustrating the role of the anti-inflammatory medi-
ator. In (a) we show the position of the Hopf bifurcation in pφ, νq–space for kg “ 0.1
(solid line), kg “ 0.01 (dashed line) and kg “ 0 (dash-dotted line). The non-trivial
steady state is stable below the illustrated curves; the areas of parameter-space above
the curves exhibit potential for inhomogeneous solutions. In (b), we illustrate the
location of the Hopf bifurcation in pkg, knq–space. The cross symbols demark the
baseline parameter values of Table 3.2.
we introduce an effective numerical method that is specifically structured to tackle
the shortcomings that traditional finite difference methods face in order to provide
a robust approximation of systems comprising both diffusion and chemotaxis. What
follows in this section is directly taken from the methods developed and presented
by Gerisch et al. (2001). To this end, let us consider a generic hyperbolic-parabolic
system of the form:
Bu
Bt “ ´∇ ¨ puGpwq∇wq ` g1pu, wq (3.13)
Bw
Bt “ ∇
2w ` g2pu, wq (3.14)
with upx, y, tq and wpx, y, tq unknown functions defined in a unit square domain in
space and for t P r0, tf s. The functions G, g1 and g2 generalise the relationships
occurring between the quantities u and w. In order to analyse possible numeri-
cal approaches to tackling the discontinuities of (3.13)–(3.14), we supply the sys-
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tem with appropriate initial conditions u1px, y, 0q “ u10px, yq, u2px, y, 0q “ u20px, yq
and periodic boundary conditions in order to be consistent with the inflammatory
model (3.7)–(3.11). The variable u moves chemotactically up gradients of w, which
in turn diffuses within the domain. Such a system represents a simplified and generic
version of the interactions we are most interested in, focusing the attention on the
diffusion of one variable, namely w, as per (3.14), and the chemotaxis of the other,
formally defined as the convection of u by a velocity field and considering a nonlinear
dependence on variable w. As such, the sign of Gpwq determines the direction of
convection, thus reflecting the choice of a positive unitary constant for this function
with respect to the inflammatory model object of this investigation. Following the
analysis of Gerisch et al. (2001) and exploiting the parabolic-hyperbolic nature of
system (3.13)–(3.14), we tailor a dual numerical approach in the approximation of
these PDEs such that the hyperbolic and parabolic terms are decoupled and treated
separately, through explicit methods for the former and implicit ones for the latter.
Furthermore, we impose an additional constraint limiting the admissible solutions to
non-negative ones only. This is motivated by the biological nature of our problem
that refers particularly to concentrations of cells and chemicals within the inflamed
tissue, thus representing necessarily positive quantities only.
By splitting equations (3.13)–(3.14), we consider solving the diffusive equation (3.14)
through the numerical approach presented in Section 2.3, while for the new chemo-
tactic interactions introduced in (3.13) we follow the flux-limited second order ap-
proximation proposed in Gerisch et al. (2001). By denoting with i, j “ 1, . . . , N the
meshpoints xi and yj respectively, ui,j and wi,j represent approximations of upxi, yj, tq
and wpxi, yj, tq respectively. In the analysis of Gerisch et al. (2001), (3.13) is dealt
with using flux limiters or numerical flux functions, that is functions conveyed in a
form as to prevent converging to non-solutions (LeVeque, 1999). We now restrict our
analysis to the x-dimension only, for the sake of clarity in the following notation,
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with the extension to the second dimension being straightforward. In particular, by
conveniently renaming vpx, y, tq “ Gpwq∇w, (3.13) can be rewritten in terms of the
convection of the quantity u by the velocity field v, that is
Bu
Bt “ ´rvpx, y, tqupx, y, tqsx (3.15)
having preserved periodic boundary conditions for the newly introduced variable
vpx, y, tq, neglected the additional function g1pu, wq and assuming a unitary constant
value for the term Gpwq. Following Gerisch et al. (2001), we define the semi-discrete
flux function as
fi,jptq “ vpxi, yj, tqui,jptq . (3.16)
By denoting with Fi`1{2,j the approximation of the flux function (3.16), in compliance
with the constraint of allowing positive solutions only, the general flux function for
positive velocity fields is given by
Fi`1{2,j “ fi,j `
1
2
Φpri`1{2,jqpfi,j ´ fi´1,jq , (3.17)
while, conversely, for negative velocities, we refer instead to




i`3{2,jqpfi`1,j ´ fi`2,jq . (3.18)
The general flux functions (3.17) and (3.18) are defined with respect to the ratio r,





As for the flux limiter Φ, Sweby (1984) presents a comprehensive class of limiters,
by analysing both theoretical and numerical features. Among these, Gerisch et al.
(2001) select and propose the Van Leer flux limiter (Van Leer, 1974), carefully chosen
as to be Lipschitz continuous, continuously differentiable for all r ‰ 0 and preserving
the positivity of the solutions:
Φprq “ |r| ` r
1 ` |r| . (3.20)
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pFi`1{2,j ´ Fi´1{2,jq (3.21)






























pfi`1,j ´ fi,jq (3.23)
respectively.
With the discretising scheme for convecting equations provided in (3.22)–(3.23),






























Bt “ f1 ` f2 . (3.25)
Such a representation allows us to distinguish the purely convective contribution
of f1 to the system in contrast to its reactive-diffusive stiff part, given by f2. In
particular, (3.25) poses contrasting challenges in its resolution, with f1 best dealt with
via explicit methods allowing for restrictions on the time-step to preserve positivity
of the approximations, while f2 requires an implicit approach due to stability and
stiffness concerns. As such, instead of approximating (3.25) with a global numerical
approach, a splitting method is employed, by dealing with f1 and f2 separately, in the
form of:
uptk ` τq “ uk `
ż tk`τ
tk
rf1puptqq ` f2puptqqs dt














f1puptqq dt . (3.26)
Thus, at each time step, vectors f1 and f2 are approximated separately, through
explicit methods the former (Runge Kutta 4 in the implementation of our code)
and implicit ones the latter (through Matlab’s builtin solver ode15s). The numerical
scheme proposed in (3.26) guides the approximation of uptk `τq through intermediate
steps consisting of
• z11ptq “ f1pz1ptqq, with initial condition z1ptkq “ uk, approximating z1ptk`τ{2q;
• z12ptq “ f2pz2ptqq, with initial condition z2ptkq “ z1ptk ` τ{2q, approximating
z2ptk ` τq;
• z13ptq “ f1pz3ptqq, with initial condition z3ptk `τ{2q “ z2ptk `τq, approximating
z3ptk ` τq.
The stability and positivity of this Implicit-Explicit (IMEX) scheme is guaranteed as
detailed in Gerisch et al. (2001). Furthermore, particular attention is dedicated to
the time-step size: a fixed time step is avoided in favour of a variable one, allowing
us to keep its size large enough to be computationally effective and efficient while
also maintaining it small enough to prevent numerical errors and stability issues. In
practice, this is implemented by selecting time-step sizes for which the approxima-
tion’s local error is within a fixed tolerance and considering an adaptive time-step τk
controlling the step size tk`1 “ tk ` τk, with t0 “ 0 and k “ 0, 1, . . . . Approximations
of uptk ` τkq providing solutions to the splitting scheme (3.26) are computed with a





. The size of
















atoli ` rtoli |pukqi|
¸2
, (3.27)
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with n being the order of the ODE solver, m the dimension of the ODE system (3.25),
and atol and rtol being tolerances for the absolute and relative errors, respectively.
If ρ ď 1, the new step-size τknew , computed as
τknew “ τk ¨ mint2,maxt0.8ρ´
1
2n´1 , 0.25uu (3.28)
is accepted and uk`1 “ u2ˆ τk
2
is identified as the more accurate nth order approx-
imation. Otherwise, if ρ ą 1, the step-size is rejected and recomputed accordingly.
Matlab code for this model is available online via Github1.
3.8 Two-dimensional simulations
Considering the interactions of cells and chemicals in a two-dimensional spatial do-
main allows for a better representation of a generic tissue. The introduction of a
second spatial dimension does not change the formal representation of the system,
with the corresponding two-dimensional model still defined by equations (3.7)–(3.11),
but by explicitly defining the two independent dimensions x and y, each variable’s
dynamics is now analysed in terms of N2 mesh points, namely npxi, yj, tq, apxi, yj, tq,
mpxi, yj, tq, cpxi, yj, tq and gpxi, yj, tq with i, j “ 0, 1, . . . , N . With reference to (3.7)–
(3.11), the damage function f is neglected in favour of a set of two-dimensional initial
conditions that trigger the dynamics.
The full integration of chemotaxis into the model (3.7)–(3.11), along with the
fundamental biological implications discussed in Section 1.2, directly impacts the im-
plementation of our system, requiring the careful numerics introduced in Section 3.7.
The validity of this more refined numerical approach, as already presented in Gerisch
et al. (2001), is further tested and confirmed by multiple simulations run using initial
conditions that are independent of one spatial coordinate, with the results then being
1https://github.com/atihana/inflammation pde
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compared to equivalent 1D simulations. These simulations confirmed the validity
of the two-dimensional code, with further details of this analysis omitted here for
brevity.
Various initial conditions and parameter values have been tested to evaluate the
overall behaviour of (3.7)–(3.11) and assess its response towards different stimuli.
Initial values have been inferred from steady state values associated with the homo-
geneous form of the model (3.7)–(3.11). While it is not possible to analytically solve
the corresponding system of equations, explicit steady state values different than the
trivial ss1 “ p0, 0, 0, 0, 0q were derived by the numerical solution provided by Matlab
inbuilt function fsolve and are here indicated as the set of points ss2 “ pn̄, ā, m̄, c̄, ḡq.
The set of values ss1 and ss2 are then used to configure different sets of initial con-
ditions. The model’s assessment thus allows us to analyse how both diffusion and
chemotaxis affect the system behaviour, with a particular interest to a possible emer-
gence of spatial patterns. The results presented in this section account for simulations
run with initial conditions considering variable-dependent damages shaped as a circu-
lar area of uniform damage of radius r “ 0.25 and height pn̄, ā, m̄, c̄, ḡq (corresponding
to the values from the set of points ss2) centred in a unit-square domain, as specified
here below:
pn, a,m, c, gq “ pn̄, ā, m̄, c̄, ḡq, for px ´ 1{2q2 ` py ´ 1{2q2 ď 1{42 (3.29)
pn, a,m, c, gq “ p0, 0, 0, 0, 0q, for px ´ 1{2q2 ` py ´ 1{2q2 ą 1{42. (3.30)
A first representation of two-dimensional results is provided in Figure 3.8 in which
active neutrophils’ spatial behaviour at four specific time steps is shown. Active
neutrophils are initially concentrated in the middle of the two-dimensional domain,
as to model the occurred insult triggering the inflammatory response (Figure 3.8a).
During intermediate times the spatial distributions of active neutrophils continuously
evolves, as is evident from Figure 3.8b–3.8d, with prolonged simulations also showing













































































Figure 3.8: Solution of the two-dimensional system (3.7)–(3.11) with respect to vari-
able n. All parameters are as in Table 3.2; initial conditions are as in (3.29).
that the system undergoes sustained spatially inhomogeneous oscillations.
A variety of parameter combinations have been tested and assessed, with par-
ticular attention also to diffusion and chemotaxis constant values. The preliminary
detailed analysis of the corresponding 1D model and new extensive assessment of pa-
rameter values of the full two-dimensional system allowed to recognise fixed nominal
values for a group of parameters, while evaluating the model’s behaviour in response
to variations of the remaining key parameters, as illustrated in the following sections.
3.8.1 Effects of non-spatial parameters
Firstly, the system’s ability to support spatially inhomogeneous oscillations upon
sensitive ranges of its spatial parameters is tested and evaluated against two key
non-spatial parameters, the phagocytosis rate φ and the apoptosis rate ν. The bi-
furcation diagrams in Figure 3.5 exhibit how sensitive the system is to variations of
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non-spatial parameters ν and φ in particular. The choice of specifically focusing on
the two parameters φ and ν, accounting for the phagocytosis and apoptosis rates
respectively, is driven by the direct biological relevance of such features in the inflam-
matory dynamics, while also being central in the analysis of Dunster et al. (2014) in
their corresponding ODE model.
As a convenient representation of the two-dimensional system’s dynamics, a set
of plots exhibiting both the cross-sectional concentrations in time and snapshots of
the spatial profiles at specific times are shown in the context of the variation of
our identified key parameters, i.e. ν and φ, rates of apoptosis and phagocytosis,
respectively.
In the results presented in Figures 3.9–3.11 it is of particular interest to observe
how the system is susceptible to the key parameter ν accounting for the apoptosis rate
and how diffusion regulates spatial behaviour. The long-term outcome in Figure 3.9
(in which ν “ 0.1) corresponds to a spatially homogeneous steady state at zero, or
in biological terms to the resolution of inflammation throughout the tissue. With
reference to the bifurcation diagram in Figure 3.5b, we see that, for ν “ 0.1, the
non-trivial (chronic) steady state is unstable and in this case the model attains the
stable, healthy steady state.
In Figure 3.10, we plot solutions corresponding to ν “ 0.05, and observe that, in
this case, the system attains a homogeneous chronic steady state in which all variables
are non-zero and the inflammatory damage persists. Comparing this with Figure 3.5b,
we see that the homogeneous system is bistable when ν “ 0.05, which means that
the system may attain either chronic or homogeneous steady states. The selection of
which state is attained depends upon our choice of initial conditions. In Figure 3.11,
we plot solutions for ν “ 0.075 – a choice of ν which lies immediately to the right of
the Hopf bifurcation in Figure 3.5b, for which the chronic homogeneous steady state
is unstable. In this case we observe that the system displays sustained spatially-
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Figure 3.9: Solution of (3.7)–(3.11) on the cross-section y “ 0, with initial conditions
as in (3.29) and all parameters as in Table 3.2. The model attains a healthy steady
homogeneous steady state.
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Figure 3.10: Solution of (3.7)–(3.11) on the cross-section y “ 0, with initial conditions
as in (3.29). The rate of neutrophil apoptosis is updated to ν “ 0.05; all other
parameters are as in Table 3.2. The model attains a homogeneous steady state that
represents chronic damage.
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inhomogeneous oscillations solutions which are not permissible in the corresponding
ODE model or the analysis of Section 3.6. Figures 3.12 and 3.13 show snapshots of
the corresponding spatial profile at t “ 100 and t “ 2000 respectively.
In Figure 3.14, we summarise where in pν, φq–space we find each of the broad
solution types above, with the remaining parameters fixed at the values given in Ta-
ble 3.2. For all choices of ν and φ that fall to the left (or below) the Hopf bifurcation
curve (shown in black in Figure 3.14), the system converges to a stable homogeneous
steady state corresponding to uniform damage (demarked by green triangles in the
figure). For the majority of parameter choices that fall significantly to the right (or
above) the Hopf bifurcation curve, the system ultimately progresses toward the trivial
homogeneous steady state at zero, corresponding to damage being uniformly resolved
(as shown by black circles in the figure). We note that in these areas of parame-
ter space, the non-trivial homogeneous steady state is unstable, so uniform chronic
damage is not a permissible configuration. However, for suitable choices of φ, there
exists a narrow region of parameter-space immediately beyond the Hopf bifurcation
in which long-term spatially inhomogeneous configurations exist. For the parameter
choices represented by red squares in Figure 3.14, these configurations display os-
cillations temporally as well as spatially; however, spatially inhomogeneous steady
states can also be permissible for some choices of parameters. We note that these
spatially inhomogeneous configurations do not fall into the classical class of solutions
that typically arise through Turing instabilities, given their temporally oscillating na-
ture (in most cases), and that they do not result from changes in the stability of the
homogeneous steady states in the corresponding ODE model. These results are akin
to similar patterns driven by Hopf bifurcation in other models, such as that of Penner
et al. (2012), for example. Below, we examine how variations in the choices of spatial
parameters affect the spatially-dependent configurations observed here.
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Figure 3.11: Solution of (3.7)–(3.11) on the cross-section y “ 0, with initial conditions
as in (3.29). The rate of neutrophil apoptosis is updated to ν “ 0.075; all other
parameters are as in Table 3.2. The model displays sustained spatially-inhomogeneous
oscillations.
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Figure 3.12: Snapshot of the spatial profile at t “ 100 corresponding to the solu-
tion of (3.7)–(3.11) in Figure 3.11, with initial conditions as in (3.29). The rate of
neutrophil apoptosis is updated to ν “ 0.075; all other parameters are as in Table 3.2.
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Figure 3.13: Snapshot of the spatial profile at t “ 2000 corresponding to the solu-
tion of (3.7)–(3.11) in Figure 3.11, with initial conditions as in (3.29). The rate of
neutrophil apoptosis is updated to ν “ 0.075; all other parameters are as in Table 3.2.
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Figure 3.14: Summary of the types of solutions omitted by (3.7)–(3.7) for various
choices of ν and φ, and all other parameter values as given in Table 3.2. Green tri-
angles indicate that the system attains the non-trivial (chronic) homogeneous steady
state given by the ODE model; red squares indicate that the model exhibits spa-
tially inhomogeneous temporal oscillations; black circles indicate that the damage is
resolved uniformly. The black curve marks the location of the Hopf bifurcation.
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3.8.2 Effects of spatial parameters
The model is thoroughly evaluated with respect to its spatial parameters in order to
further expose and analyse arising spatially inhomogeneous outcomes. To this end,
we run an extensive set of simulations for varying values of both mediators’ and cellu-
lar diffusion constants as well as chemotaxis parameters, holding all other parameters
at the same values given in Table 3.2. The inflammation outcomes were shown to
vary accordingly, as reported in Figure 3.15, with Figure 3.15a in particular study-
ing conditions for patterning depending on the diffusion of chemicals. When either
pro- or anti-inflammatory mediators diffuse relatively quickly, namely quicker than
D “ 10´4, inflammation is homogeneously resolved, while spatially inhomogeneous
oscillations are appreciable upon smaller diffusion constants. Figure 3.15b further
investigates the spatial response of the model to the cellular activity, with larger
populations of macrophages in particular leading the way to heterogeneous steady
states and enhanced presence of neutrophils, conversely, smoothening the system to
the homogeneous resolution of inflammation. Decoupling the values accounting for
diffusion and chemotaxis, as in Figures 3.15c and 3.15d leads to mixed results. While
either a stronger attraction of neutrophils to sources of pro-inflammatory activities or
their quicker diffusivity within the tissue is enough to resolve to damage uniformly, as
visible in Figure 3.15c, the same does not hold for macrophages. Figure 3.15d in fact
exhibits a more complex structure of results in which larger values of macrophagic
diffusion lead to spatially inhomogeneous steady states, in accordance to the results
of Figure 3.15b, while a range of values for spatially inhomogeneous oscillations is
also individuated.
These results are biologically of particular relevance, providing a detailed spatial
characterisation of the tissue configuration upon healing times. Notably, we observe
that by individuating the ranges of cellular and mediators diffusivity upon which
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the system attains the spatially homogeneous trivial steady state, we determine the
conditions that guarantee a global recovery and the restoration of a healthy state.
This suggests that promoting the diffusivity of mediators within the tissue, as well
as that of neutrophils, is key to prevent the inflammation from becoming chronic.
Similarly, defects in the mediators’ and cells’ ability to diffuse causes the tissue to be
pervaded by inflammation without eventually recovering. Another important result
that emerges from the spatial analysis illustrated in Figure 3.15 is the peculiarity
of the role of macrophages in the healing process. In particular, given their larger
size and overall slower velocity (Barros-Becker et al., 2017), to ensure a homogeneous
healthy recovery, the therapeutic action on these cells in terms of diffusivity and
chemotactic strength, is shown to be effective on smaller scales compared to that of
neutrophils (Figure 3.15d).
3.8.3 Domain effects and dependence upon initial conditions
We, here, briefly assess the extent to which the patterns identified above are sensitive
to our choice of domain. Numerical simulations conducted on a number of rectangular
domains of varying aspect ratio, with ν “ 0.075 (ν ą νHB) and all other parameters as
in Table 3.2, reveal that the regions of parameter-space in which we attain uniformly
resolved, uniformly damaged, or spatially inhomogeneous configurations are exactly
as illustrated in Figure 3.14. (Results omitted for brevity.) However, changes in the
shape of the domain can impact on the resultant patterns themselves. In Figure 3.16,
we illustrate snapshots of two solutions attained on domains with y restricted to the
intervals (a) r0.15, 0.85s or (b) r0.25, 0.75s (with x P r0, 1s as previously). Comparing
these results to those attained on the square domain (Figure 3.13d), we observe that
moving to a domain with a higher aspect ratio can predispose the system to striped
patterns such as that shown in Figure 3.16b. Additional simulations also reveal












































































































(d) Dm vs θm.
Figure 3.15: Tables of simulations for varying spatial parameters, all other parameters
are as in Table 3.2. Red squares correspond to spatially inhomogeneous oscillations,
black circles to the zero steady state, blue diamonds to spatially inhomogeneous
steady states.
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Figure 3.16: Snapshots (at time t “ 2000) of temporally oscillating, spatially inho-
mogeneous configurations attained on rectangular domains comprised of x P r0, 1s
and (a) y P r0.15, 0.85s, and (b) y P r0.25, 0.75s, for ν “ 0.075 and all other param-
eter values as given in Table 3.2. Moving from a square domain (Figure 3.13d) to a
narrowing rectangular domain can drive the system from spotted to striped patterns.
that replacing periodic boundary conditions by Neumann boundary conditions on all
boundaries has negligible impact upon permissible patterns. (Once again, results are
omitted for brevity.)
In Figure 3.17, we examine the sensitivity of patterns to the size of the area of dam-
age imposed via the initial conditions described above. In the figure, we set ν “ 0.075
and φ “ 0.1 (a parameter choice for which we have demonstrated, in Figure 3.14, that
temporally oscillating patterns are permissible), fix all other parameters at the values
used given in Table 3.2, and examine results for various choices of the radius of the
initially damaged area. As the figure shows, while variations in the radius of the
initial damage give rise to some differences in the short term, long-term patterns are
largely insensitive to the size of the initially-damaged area. Starting with uniform
damage of course results in spatially homogeneous results (not shown), but since this
3.9. CONCLUSIONS 121
configuration is unstable in the ODE model, introducing even a small amount of
healthy tissue is sufficient to allow the PDE system to diverge from the unstable ho-
mogeneous configuration and instead attain stable, spatially-inhomogeneous periodic
orbits. Similar simulations (not plotted here for brevity) reveal that the model is also
largely insensitive to changes in the magnitude of the initial damage. For example,
on making all the initial conditions used above ten times larger or smaller, we attain
qualitatively equivalent spatially inhomogeneous solutions in the long-term, despite
some small variations in initial behaviour.
3.9 Conclusions
In this chapter the inflammation model has been further developed in order to in-
clude important features that improve upon the model of Chapter 2. Firstly, key
cellular interactions have been included, by modelling the positive feedback of active
neutrophils to the pro-inflammatory mediators and studying how the contribution of
anti-inflammatory mediators, g, affects the system’s behaviour. Chemotaxis has also
been added with cells modelled to move preferentially towards higher concentrations
of pro-inflammatory mediators.
The inclusion of chemotaxis, in particular, required a careful numerical approach
involving flux-limited approximations and a tailored use of implicit-explicit schemes,
as proposed by Gerisch et al. (2001) in order to ensure positivity and smoothness of
solutions.
Finally, the full system (3.7)–(3.11), comprising all the main biologically rele-
vant features of an inflammation process, has been implemented in a unit-square
two-dimensional domain, with the corresponding results assessed both in terms of
dynamics and spatial dependence. Guided by an existing focus in the literature upon
targeting the phagocytosing ability of macrophages (φ) in the hunt for new thera-
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Figure 3.17: The effect of changing the radius of the initial damage upon pro-
inflammatory mediator concentrations, c, for ν “ 0.075 and φ “ 0.1. In (a-c) we
plot the concentrations of c on the cross-section y “ 0 as functions of time, with
initially damaged areas of radius (a) 0.01, (b) 0.1, and (c) 0.25. In (d) we plot the
mediator distributions at the times demarked by the black lines in (a-c), with solid,
dashed and dash-dotted lines relating to panels (a), (b) and (c) respectively. The
long-term profiles are qualitatively similar for all three configurations.
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peutic strategies (see e.g. Porcheray et al. (2005), Serhan (2017)), together with the
fact that the analysis of Dunster et al. (2014) identified the neutrophil apoptosis rate
(ν) as a key parameter in determining the nature of long-term outcomes, our analysis
initially focused upon how variations in these two parameters can facilitate or inhibit
spatially inhomogeneous outcomes. While the ODE model shows that variations in
these two parameters that result in crossing the Hopf bifurcation curve in Figure 3.5c
act as a switch from bistability to monostability (i.e. guaranteed resolution of inflam-
mation), simulations of our spatially-dependent model illustrate (in Figure 3.14) that
crossing the same Hopf bifurcations can move the model into an area of parameter
space for which persistent spatially-inhomogeneous solutions exist – both steady state
solutions and solutions that oscillate temporally. These chronically inflamed solutions
lie in an area of parameter space for which the ODE model predicts full resolution of
damage. For the majority of parameters studied, our spatially inhomogeneous solu-
tions comprise disparate areas of damage whose severity oscillates temporally; while
one area of damage may be resolving, in that pro-inflammatory mediator levels are
reducing, other areas of damage are worsening due to the feedback from both active
and apoptotic neutrophil populations. Oftentimes, monitoring the pro-inflammatory
mediator concentrations alone would seem to indicate resolution, yet responses from
the other components of the system yield further flares of damage in due course. In
this sense, the temporal patterns that we observe are reminiscent of inflammatory
conditions that have relapsing–remitting characteristics, such as Crohn’s disease or
rheumatoid arthritis (Tibble et al., 2000; Firestein, 2003).
With the introduction of the neutrophil feedback, large values of the parameter
kn that controls this added feature can cause previously healthy outcomes of Chap-
ter 2 to become chronic. We here examined the extent to which the balance between
the pro-inflammatory feedback from active neutrophils (with rate kn) and the coun-
teracting role of the anti-inflammatory mediator (g) can have a key influence upon
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biassing the system toward globally inflamed (homogeneous) or spatially inhomoge-
nous solutions (as illustrated in Figures 3.6 and 3.7). For large choices of kn or small
concentrations of anti-inflammatory mediator (e.g. in the limit kg Ñ 0), spatial pat-
terns can be eliminated and the results of the corresponding homogeneous model are
recovered. While some drugs in current usage (such as methotrexate, sulphasalazine
and FK506) do act to mitigate against inflammation by triggering the synthesis of
anti-inflammatory mediators (Gilroy et al., 2004; Hasko & Cronstein, 2004), manipu-
lation of anti-inflammatory mediators remains an active area of focus in the hunt for
new therapeutic targets (Henson, 2005; Barnig et al., 2018; Back et al., 2019). Our
results indicate that, while increasing the concentrations of anti-inflammatory me-
diators can move the homogeneous system from a bistable regime (in which chronic
outcomes are permissible) to a healthy state, intermediate levels of anti-inflammatory
mediators can yield spatially inhomogeneous, non-resolving outcomes.
For spatially-independent parameter values that allow the model to emit spatially
inhomogeneous solutions, we have explored (in Figure 3.15) the extent to which varia-
tions in spatial parameters can influence the solutions obtained. For rapidly spreading
mediators (Dc and Dg large), the initial damage rapidly spreads to fill the entire do-
main, triggering a global response that results in a homogeneous, healthy outcome.
Similarly, large choices of the neutrophil motility parameters (Dn and θn) or small
choices of macrophage motility parameters (Dm and θm) result in a rapid spread of
damage driven by the apoptosis and eventual necrosis of neutrophils, the associated
positive feedback in pro-inflammatory mediator concentrations once again triggering
a global response that restores the healthy state. For small to moderate choices of
the neutrophil diffusion parameter Dn, our simulations reveal that strong neutrophil
chemotaxis (θn large) can drive resolution of inflammation, while weaker neutrophil
chemotaxis can result in a persisting spatially inhomogeneous outcome (Figure 3.15d).
The role of neutrophil migration in many different inflammation-related pathologies
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is of increasing interest (Brubaker et al., 2013; Cecchi et al., 2018); there is strong evi-
dence in the biological literature that a reduction in the rate of neutrophil chemotaxis
occurs under trauma and ageing and results in an otherwise healthy inflammatory
response being pushed into a persistent inflammatory response (Sapey et al., 2014b).
Indeed, neutrophil migration is now thought to be an attractive therapeutic target
for diseases such as chronic obstructive pulmonary disease, a chronic lung disease
characterised by aberrant neutrophil migration (Sapey et al., 2011; Jasper et al.,
2019).
It is pertinent to remark briefly that, while the model presented here incorporates
a reasonably thorough catalogue of biological interactions, this comes at the expense
of restricting the use of some key mathematical analyses that would commonly be used
in analysing pattern-forming systems. For example, our model does not lend itself
to travelling wave analysis, and does not allow spatially interesting configurations to
be determined analytically; we are therefore restricted to the use of robust numerical
schemes in order to identify the model’s spatially-dependent solutions. This is in
contrast to a broad range of existing models, the construction of which can often omit
key biological feedbacks in order to facilitate greater analytical progress. Furthermore,
we note that, while we regard the model described here to include the majority of
crucial biological interactions at play in a typical inflammatory response, there is
certainly scope for inclusion of further, more detailed mechanisms. To do so within
the confines of a PDE-based model would likely result in a model that is not easily
penetrable via mathematical analysis. This potentially motivates the need for a
shift to an alternative modelling paradigm, via which the full remit of biological
interactions can be easily incorporated. In Chapter 4 we further investigate this
through agent based models, where cells are accounted for individually, allowing us
to study their interactions with greater insight.
Chapter 4
Modelling the inflammatory
response via agent based models
In this chapter, a new modelling approach will be introduced in which the cells fea-
turing in the inflammatory process will be accounted for individually. This new
‘agent-based’ model of inflammation will replicate and extend all the biological in-
teractions outlined in the model of Chapter 3, in order to investigate further those
inflammatory mechanisms that still remain unclear from both the available literature
and the analysis presented in the previous chapters. More importantly, by modelling
the inflammatory process under conceptually and mathematically different terms to
the PDE framework, we investigate how sensitive the conclusions are to the modelling
approach.
4.1 Introduction
Agent-based modelling is a parallel computational paradigm based on a uniform, lo-
cally detailed and synchronous structure. Agent-based modelling provides a robust
and innovative alternative to differential equation based dynamical systems represen-
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tations, by relying on a fundamentally simple concept of cell units updating their
states according to synchronised local sets of rules, underlying the potential complex-
ity in structures and dynamics that such a paradigm delivers (Schiff, 2008). As such,
while analogous to PDEs in purpose, that is in representing complex systems, agent-
based modelling presents important advantages in terms of stability, convergence and
approximation of the results (Hoekstra et al., 2010). In addition, this valuable mod-
elling approach provides a reliable and valid bridge between the microscopic level and
emerging patterns or behaviours of interest. This further underlines how ABMs are
not necessarily substitutes for PDE ones but can actually offer an integrating ap-
proach in clarifying specific conditions that arise from microscopic mechanisms that
would otherwise be missed or remain under appreciated.
Formally, ABM are defined as discrete, both in time and space, dynamical systems
in which single cells (automata) exhibit one from a finite set of states according to
homogeneous local rules of interactions (Kari, 2013). More precisely, let d P N, then
L “ Zd (4.1)
is a discrete cellular space, with elements of L being cells. Let S be a finite state set;
then elements σ P S are called states. The local value space S basically defines all
the possible states for each cell of L. The ABM configuration of the d-dimensional
ABM is then defined as the function
c : Zd Ñ S , (4.2)
with c describing all possible compositions of all cells within the state space L. For
additional clarity, let us highlight that when referring to ABM, the entity ‘cell’ does
not necessarily refer to a biological cell, and has to be intended instead as a single
agent or basic unit of the model. With respect to the topology of each individual cell,
a neighbourhoodN is determined as the set of its N neighbouring cells. The definition
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(a) Von Neumann, r “ 0. (b) Von Neumann, r “ 1. (c) Von Neumann, r “ 2.
(d) Moore, r “ 0. (e) Moore, r “ 1. (f) Moore, r “ 2.
Figure 4.1: Examples of different 2D neighbourhood configurations with varying
ranges r. Von Neumann neighbourhoods (first row) are diamond-shaped and include
1`2rpr`1q cells, while Moore neighbourhoods (bottom row) are square-shaped with
the total number of cells given by p2r ` 1q2.
of neighbourhoods can vary according to their shapes and ranges, with examples of
typical configurations shown in Figure 4.1. Configurations are in turn determined with
respect to the boundary conditions that can be periodic, reflective or fixed (Hoekstra
et al., 2010). Periodic boundary conditions implement a periodic extension of the
lattice, thus simulating an infinite lattice (in 2D this corresponds to the topology of a
torus). Reflective boundary conditions, as the name suggests, implement the reflex of
the lattice at the boundary, providing the equivalent to Neumann boundary conditions
typical of diffusive systems, while fixed boundary conditions implement the Dirichlet
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conditions within the ABM frame, by setting a fixed value at each boundary cell. A
further step in determining the ABM paradigm consists in specifying a transition (or
local update) rule φ defined as the function describing the change in state that cells
in the N -sized neighbourhood undergo:
φ : SN Ñ S . (4.3)
All cells follow the same transition rule simultaneously, according to an external time
step (tick). Therefore, a cellular automata A is defined as the 4´tuple
A “ pd, S,N , φq , (4.4)
with respect to a dimension d P N, a finite state set S, a neighbourhood N and a
transition rule φ.
4.1.1 Implementation
Agent based modelling implies a shift in the typical modelling approach in which
agents are structured with respect to their activity, rather than attributes and meth-
ods (Abar et al., 2017). In practice, this translates into building the model around
agents’ responses, with their behaviour being characterised in terms of cells’ actions
instead of their defining properties. As such, agent-based modelling can be seen as
an extension of object-oriented programming, by defining agents as objects in control
of their execution (Abar et al., 2017). More specifically, with agents being charac-
terised as objects, their behaviour is shaped and controlled through sets of states and
functional rules.
There is a wide choice of available agent-based modelling software tools, with
mostly similar capabilities but varying features and programming language imple-
mentations. While Abar et al. (2017) provide an exhaustive review of eighty-five
agent-based toolkits, including non-commercial, academic-focused packages, all our
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ABMs and simulations are implemented with the Repast Simphony software tool.
This software relies on Java as source code, with object-oriented agents, and allows
for both 2D and 3D simulations (North et al., 2007, 2013).
4.1.2 Agent based models in inflammation – a literature re-
view
ABMs offer a varied set of desirable features that allow us to investigate specific
mechanisms that more traditional modelling approaches often fail to take into ac-
count. As such, ABM are increasingly deployed in many multidisciplinary research
areas, including economics, biology, ecology, sociology, just to name a few, by defining
the complex systems of interest in function of the interactions of their agents (seen as
entities). The versatility of the ABM paradigm allows for the integration of a variety
of modelling strategies, with the set of rules defining the agent states spanning from
simple Boolean interactions to full approximation of PDE. The integration of PDEs
in ABMs results in Hybrid Cellular Automata (HCA). These models are of particular
importance in the investigation of biological problems by providing both accuracy and
effectiveness in capturing mechanisms of interest typically arising in many of these
areas involving both spatial and temporal dynamics such as cancer treatment efficacy
(Ribba et al., 2004), bone remodelling and synthesis upon mechanical stimuli (To-
var et al., 2004), tumour growth (Gerlee & Anderson, 2007), cartilage regeneration
within a porous scaffold (Cassani & Olson, 2018). This adaptability is of great use in
many different biological applications, capturing multi-scale interactions and complex
dynamics that are often missed in traditional equation-based models. As such, there
is growing interest in modelling a variety of biological systems for which previous
and on-going research based on more traditional tools does not offer an exhaustive
understanding of more subtle and key mechanisms that still remain unclear. This
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is particularly true for all those applications that rely on cells’ self-organisation and
multi-scale dynamics (Alber et al., 2003), two of the key features of ABMs. One such
phenomenon is morphogenesis; that is, the complex and ordered way in which cells
organise, through controlled proliferation and motility, practically shaping an organ-
ism since the earlier embryological stages of its formation. Alber et al. (2003) present
a detailed analysis of various morphogenetic processes in their review of ABMs of
cell aggregation and migration. An account of many ABM capabilities in describing
a variety of biological events is given by Ermentrout & Edelstein-Keshet (1993). In
particular, the authors illustrate the suitability of agent-based models in the field of
developmental biology. An et al. (2009) provides an insight into different ABMs that
have been crucial in determining mechanisms that could not be otherwise captured by
traditional equation-derived models. Again, the key feature in such breakthroughs is
the simultaneous consideration of both spatial and multi-scale dependency that agent-
based models typically offer. More specifically, this approach has successfully been
used to determine a number of molecular mechanisms in the intracellular signalling
occurring at cytoplasm level, as well as clarifying the role of cells’ spatial propagation
as a leading event in a variety of physiological and pathological processes such as
morphogenesis, angiogenesis, inflammation, tumour growth and infections (An et al.,
2009).
Of more direct relevance to this project, a number of researchers have also been
working on ABM based models to study a variety of pathophysiological issues that
closely involve inflammatory mechanisms, ranging from wound healing to infection
and acute inflammation, amongst others. With respect to infectious mechanisms in
particular, Gorochowski et al. (2012) develop a ABM-based tool to model bacterial
populations. This framework accounts for both lower-scale interactions such as gene
regulatory networks and cell to cell dynamics and the heterogeneous behaviours at
population level that arise from such mechanisms, with simulations capturing the
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expression of both single cells and the collective population. The ABM system pre-
sented by An (2001) models the inflammatory response at the capillary level, with
agents accounting for different groups of both cells and molecules. A first class of
cells for endothelial agents exhibits either a healthy or injured state, with the lat-
ter triggering adhesion mechanisms, practically modelling the mediators’ behaviour,
with the system’s damage assessed as a measure of the agents in an injured state.
Agents representing neutrophils are characterised by a lifespan after which the cells
die and random movement. They exhibit sequential states in response to the local
endothelial agents’ activity, with the last of such states acting as chemoattractant
for a third class of agents accounting for mononuclear cells. Mononuclear agents’
activity is in response to the endothelial agents’ damage that, in turn, is cleared by
mononuclear cells, resetting the endothelial ones back to the uninjured state. An-
other class of agents representing Reactive Oxygen Species (ROS) is also included,
promoting the spread of damage within the different cells. This model accounts for
both damage related inflammations and infections, with the former triggered by the
initial distribution of injured epithelial agents and the latter by a class of infectious
carrier agents as vectors that are in turn cleared by the agents representing ROS.
This last interaction highlights the dual nature inflammatory-driven mechanisms in
which the promotion and spread of damage is key to the activation of the resolu-
tion pathways. The model is assessed by qualitatively comparing the simulations
resulting from both the infectious and sterile injury as well as analysing the system’s
outcome upon varying degrees of each injury type. The high degree of abstraction
of this model only allows for preliminary qualitative analysis of the results, with the
authors suggesting the need for models describing the inflammatory response with
greater detail and to be validated against the available experimental data. In par-
ticular, this ABM of inflammation lacks any anti-inflammatory mechanism, as well
as the system’s pro-inflammatory feedback and the repercussions of apoptosis on the
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healing process. Building up from this model, An (2008) extended this ABM sys-
tem to a multi-scale architecture to include tissue and organ functioning levels, along
with the cell to cell interactions described in An (2001). In particular, the former
model is extended by including the pro-inflammatory mechanisms and agents repre-
senting epithelial cells. Finally, another ABM system representing individual organs
and their systemic inflammation leading to failure is introduced and implemented as
a layered configuration of the previous models accounting for cells and tissues respec-
tively. The resulting model simulates inflammatory mediators acting on a barrier of
epithelial cells which, in turn, respond to the inflammatory trigger with a disruption
in both shape and functioning, signalling the local failure of the epithelial junction.
Following the same scheme, a further extension linking two layered ABM working in
parallel is proposed as a multi-organ model. The relative simulations focus on spe-
cific scenarios replicating gut ischemia and a generic inflammatory pulmonary disease.
These models, though, do not provide any new insight into the biological mechanisms
they simulate and are intended instead as a qualitative tool in representing relevant
multi-scale problems.
As discussed above, existing agent-based models of inflammatory systems gener-
ally place significant focus upon specific tissues or inflammatory conditions. How-
ever, as discussed in Chapter 1, the fundamental mechanisms that underlie the acute
inflammatory response are broadly consistent across scenarios. There is a lack of
existing agent-based models of inflammation that incorporate a full repertoire of cel-
lular interactions, while also being suitably generic to be transferrable to multiple
conditions. Thus, in the following section, we construct a novel ABM aiming to in-
vestigate the emergence and spread of inflammation by accounting for neutrophils and
macrophages separately and by highlighting the nuanced role each of these groups
of cells has in initiating the anti-inflammatory response. In doing so, we are also
interested in addressing the question of whether the conclusions of previous chapters
4.2. MODEL CONSTRUCTION 134
are sensitive to the modelling approach. We thus draw direct comparison between the
ABM developed below and the corresponding PDE model of Chapter 3 in particular,
once again examining the extent to which localised tissue damage can invade neigh-
bouring healthy tissue, and the extent to which spatial aspects of the inflammatory
response contribute to the switch between healthy and chronically inflamed outcomes.
4.2 Model construction
We, here, describe the assembly of a hybrid PDE-ABM of the inflammatory response.
Such an approach improves upon the PDE-based models of the previous chapters by
modelling the behaviour of individual cells in function of their location and neigh-
bourhood within the modelled tissue.
Our model incorporates components that replicate each of the variables featured
in the model of (3.7)–(3.11). In particular, variables accounting for cell groups n, m
and a (active neutrophils, macrophages and apoptotic neutrophils respectively) are
replaced by an agent-based description involving instances of the classes Neutrophil,
Macrophage and Apoptotic. Chemical mediators (both pro- and anti-inflammatory)
are modelled within a separate class named Environment in which the PDE descrip-
tions of Chapter 3 are retained and implemented. This class, as suggested by its name,
also implements those methods that directly act on cellular concentrations in response
to the mediators’ interactions (i.e. recruitment of neutrophils and macrophages in
response to damage). Finally, a class InflammationBuilder is also defined, which
has the role of setting up the spatial domain in terms of dimensions, boundaries and
visualisation, implementing the initial conditions of the model at time (tick) t “ 0,
instantiating the required agents, and scheduling their interactions. In practice, the
definition of classes and their methods closely follows the interactions highlighted in
equations (3.7)–(3.11). These are summarised for clarity in Table 4.1 and explained
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in detail in the following sections.
Finally, to summarise the structure of the ABM outlined below, Figures 4.2 and 4.3
provide a graphical representation of the system’s main features, parameters, links to
the previous PDE model and intrinsic functioning. Figure 4.2 in particular describes
the structure of the model in terms of agents and parameters, by highlighting the
points of control of inflammation. Figure 4.3 represents a flow chart with a schematic
illustration of the model’s general structure, while the set of changes that agents
undergo at each tick according to their state and the class they belong to will be
presented in figures 4.4–4.6 and discussed in later sections.
4.2.1 Domain and initial conditions
The above classes define a framework to create objects (agents), each with a specific
set of properties, whose behaviour is characterised by methods that are called in re-
sponse to interactions with other agents. Agents are placed within a square region
that represents the model’s spatial domain. Formally, this is defined as a combination
of a grid that contains the agents with respect to cartesian coordinates and allows
for queries within their Moore neighbourhood (i.e. the central cell and its eight sur-
rounding cells) and a continuous space in which the cells are visualised in simulations,
neglecting, as the name suggests, the domain’s discretisation. The square domain is
subject to periodic boundary conditions, with initial conditions slightly differing from
those described in (3.29). In particular, the system is initialised with the inflamma-
tory response triggered by the presence of pro-inflammatory mediators concentrated
initially in the centre of the domain, modelling a circular damage of radius r and
severity c0. In contrast with Chapter 3, the system’s initial conditions do not include
any concentration of anti-inflammatory mediators or leukocytes in the ABM starting
configuration.
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recruitNeutrophil in in `
recruitMacro in `
Table 4.1: Scheme of the ABM interactions. Columns marked with in represent
instances of that object sensed within the execution of the method. Plus/minus signs
correspond to increase/decrese in the number of objects within the grid. Methods
can be scheduled (italics) and be called upon probabilities (blue).
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Figure 4.2: Schematic diagram representing the ABM of inflammation and illustrat-
ing the constituent interactions between populations of healthy neutrophils, apop-
totic neutrophils and macrophages, modelled as agents, in response to pro- and anti-
inflammatory mediators, modelled through PDEs. Interactions are shown by arrows
and can be in turn regulated by parameters. Parameters are differentiated by colour
and refer to probabilities in red, increments in blue, thresholds in green, with PDE
parameters in black.
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Figure 4.3: Flow chart representing the ABM of inflammation and illustrating the
cyclic chain of actions with respect to the tick count. Diamonds represent decision
points, green diamonds represent thresholds, red diamonds represent probabilities.
Here, p represents a random number drawn uniformly from the interval r0, 1s.
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4.2.2 Modelling mediators
The mediators’ behaviour is rendered by explicitly defining the expression of both
pro- and anti-inflammatory properties through PDEs. Their representation, and the
inflammatory properties that can either promote the acute response or dampen it
according to the ongoing cellular interactions, are thus regulated with respect to
both decay rates for pro- and anti-inflammatory mediators, modelled through tunable
parameters γc and γg respectively, and diffusive behaviour controlled by parameters
Dc and Dg respectively. These parameters relate directly to their counterparts in the
model of Chapter 3, both theoretically but also practically, being implemented in a
similar fashion. In particular, to model pro-inflammatory mediators c, we implement
a finite difference approximation of the PDE
Bc
Bt “ Dc∇
2c ´ γcc ` Γc , (4.5)
by retaining the numerical approach first used in Section 2.3.1. Equivalently, the
distribution of anti-inflammatory mediators g is governed by
Bg
Bt “ Dg∇
2g ´ γgg ` Γg . (4.6)
In the above, Γc and Γg incorporate any sources/sinks in the mediator concentrations
owing to the actions of the agents described below.
Equations (4.5) and (4.6) are solved numerically on the discrete grid described
in Section 4.2.1, in exactly the same manner as was described in Chapter 3. The
numerical scheme employs a five-point Laplacian for the diffusive term as before, and
an associated timestep dt. Note that we tune dt to ensure numerical stability, and in
doing so take multiple numerical timesteps per tick.
Finally, the remaining classes, detailed in the following subsections, define the
agents’ behaviour through scheduled methods, that is methods that are called at
fixed intervals, starting from an initial tick t. This allows us to characterise each
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agent with respect to both its intrinsic biological properties and possible interactions
with other agents, according to specific conditions and/or probabilities for an action
or method to be called.
4.2.3 Macrophages
Overview
Macrophages are defined with respect to a grid location, a continuous space location
and an integer field named lifespan. While the first two fields are intrinsic to the
ABM system’s setting, the latter describes the duration for which leukocytes are in
a biologically active state (Parihar et al., 2010). This is typically within days and
in general is observed to be longer than for neutrophils (Patel et al., 2017). We will
discuss the implications of these scales in the parametrisation of our model in the
following dedicated Section 4.3. At each tick the Macrophage agent carries out four
actions: it decides whether to move (and, if so, where to); it attempts to remove
apoptotic neutrophils in its neighbourhood; it attempts to release anti-inflammatory
mediators, and it decides whether to vacate the tissue (if inflammation is sufficiently
resolved). We expand upon how these behaviours are implemented below.
Macrophage recruitment
Reflecting the biological implications of the mediators’ activity, in response to the en-
hanced concentration of active neutrophils prompted by pro-inflammatory mediators,
macrophages are recruited to effectively counteract the inflammation. The recruit-
ment, scheduled at every t “ 5 ticks in order to best model the delayed feedback in
the anti-inflammatory response initiated by macrophages, becomes effective only sub-
ject to both a probability pmr and if the punctual concentration of pro-inflammatory
mediators c at the grid point being considered is greater than a threshold value αmr.
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In substance, at each grid point and at every 5 ticks, if c ą αmr, macrophage agents
are recruited with probability pmr.
Finally, to avoid the biologically unrealistic event of infinite recruitment and ac-
cumulation of cells, we prescribe a maximum global number of macrophages mmax to
be recruited within the tissue. We will infer this saturation level threshold from the
available experimental data, as explained in Section 4.3, below.
Chemotactic motion
Macrophage motion is regulated such that agents move preferentially towards a neigh-
bouring location containing apoptotic neutrophils. Such behaviour is in itself of
chemotactic nature, driven by chemicals released by apoptotic neutrophils and re-
flecting a fundamental biological aspect with respect to the more subtle details at
play during the phagocytosing process and its wider implications on the inflamma-
tory outcome, as exposed by Hawkins & Devitt (2013). This feature had been ne-
glected in the PDE models of the previous chapters, in which macrophage chemotaxis
is directed toward pro-inflammatory mediators only, but is now included in this new
ABM, thus marking an important difference both in terms of practical implementa-
tion between the two systems but also more importantly rendering the model subject
of this chapter more interesting, by adding a biological behaviour that is central to
the inflammatory response but was missing in PDE analysis.
In the absence of any apoptotic neutrophils in the macrophage’s neighbourhood,
its preferential action is that of sensing pro-inflammatory mediators (always consid-
ering neighbourhood proximity), practically implementing leukocytes’ chemotaxis to-
wards higher concentrations of pro-inflammatory chemicals. For a given macrophage
mi, we begin by examining the pro-inflammatory mediator concentrations in each
position in its neighbourhood Ni. For each position j P Ni, the macrophage moves
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where cj denotes the pro-inflammatory mediator concentration at position j.
Finally, in the absence of both apoptotic neutrophils and pro-inflammatory medi-
ators in the agent’s neighbourhood, the macrophage moves to a random neighbouring
location. Such a characterisation of the macrophage movement within the domain re-
flects their biological activity in being highly responsive to the presence of apoptotic
neutrophils, in order to phagocytose them, and to generally move chemotactically
towards pro-inflammatory mediators.
Phagocytosis
Macrophages also act to clear apoptotic neutrophils, implemented through a dedicated
method that models the phagocytosing action, and in doing so can promote the anti-
inflammatory response. The phagocytosis of apoptotic neutrophils by macrophages
is scheduled at every tick and simply consists, for each individual macrophage, of
randomly selecting an apoptotic agent at its current position, if there are any, and
removing it with probability pma.
Release of anti-inflammatory mediators
The active initiation of the anti-inflammatory feedback mediated by macrophages oc-
curs in response to the change in phenotype these leukocytes undergo upon environ-
mental stimuli (Ponzoni et al., 2018). We thus model the release of anti-inflammatory
mediators subject to macrophages’ engulfment of apoptotic neutrophils, individuating
in a macrophage first phagocytic action the switch to its anti-inflammatory activity,
i.e. macrophages do not release any g before their first phagocytosis. On removing
an apoptotic cell, the macrophage yields an anti-inflammatory response by enabling
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this change in phenotype such that, after the first phagocytosis event, macrophages
steadily increase the concentration of anti-inflammatory mediators by a quantity δmg
(per tick) at the macrophage agent’s grid location, with probability pmg. This be-
haviour echoes the function of parameter kg in (3.7)–(3.11). It thus models the
macrophage’s active role in initiating the anti-inflammatory response by prompting
the release of anti-inflammatory mediators (Wynn et al., 2016). It is also important
to highlight how the ability of macrophages to release anti-inflammatory mediators
is not intrinsic to these agents and is only activated upon their first phagocytosing
action, indicating the change in their phenotype.
Macrophage death/departure
Finally, a specific method is created for macrophage agents to decide whether to leave
the tissue. In order to do so, the total concentration of pro-inflammatory mediators
in the agent’s neighbourhood is assessed and if this is below a threshold αml the
macrophage agent leaves the tissue with probability pml.
Summary
In summary, macrophages retain all their main features from the previous PDE model
of Chapter 3, with the added behaviour of chemotactically moving towards apoptotic
neutrophils preferentially. In particular, each agent individually carries out (or at-
tempts to carry out, in hierarchical order of priority) the following set of actions at
every tick:
• move chemotactically towards apoptotic neutrophils;
• move chemotactically towards pro-inflammatory mediators;
• phagocytose an apoptotic neutrophil at its current position;
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• release anti-inflammatory mediators;
• leave the tissue.
Additionally, at every t “ 5 ticks, large concentrations of pro-inflammatory mediators
result in the recruitment of new macrophage agents that are added to the inflamed
tissue in order to counteract the acute inflammation and in particular the enhanced
concentration of active neutrophils prompted by it.
The illustration of the macrophage agents’ action is further summarised in the
flow chart represented in Figure 4.4.
Finally, it is important to highlight that macrophages, or agents in general, do
not implement a diffusive behaviour immediately comparable to the one defined in
model (3.7)–(3.11). In fact, more in line with the definition of ABMs, agents of
the Macrophage class move at each tick according to the set of actions and rules




Analogously to macrophage cells, active neutrophils are also defined in terms of the
cells’ motion and activity within the domain. In particular, at each tick the ac-
tive neutrophil agent moves chemotactically towards higher concentrations of pro-
inflammatory mediators and, upon depletion of its lifespan, it becomes apoptotic.
Neutrophils have widely been observed to have considerably short lifespans, in the
range of hours to few days but overall shorter than that of macrophages (McCracken
& Allen, 2014; Bekkering & Torensma, 2013). Further details are given below in
Section 4.3.
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Figure 4.4: Flow chart representing the cyclic chain of actions each agent of the
Macrophage class undergoes according to its state at each tick count. Green triangles
represent thresholds and red triangles represent probabilities. Here, p represents a
random number drawn uniformly from the interval r0, 1s.
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Neutrophil recruitment
During the acute inflammatory response, as a feedback to higher concentrations of
pro-inflammatory mediators, we, again, prescribe the enhanced recruitment of active
neutrophils. The implementation is slightly different to the one described for the
recruitment of macrophage agents though. In particular, the recruitment of neutrophil
agents is scheduled at every t “ 2 ticks via the preliminary assessment of both a
minimum threshold of pro-inflammatory mediators αncr and a maximum threshold of
anti-inflammatory mediators αngr and takes place only if both c ą αncr and g ă αngr
hold. Under this condition, subject to a further probability pnr, the pro-inflammatory
activity is further enhanced by creating a new instance of the neutrophil agent. In
practice, at each grid point, every 2 ticks, upon a preliminary assessment of the levels
of pro- and anti-inflammatory mediators, if c ą αncr and g ă αngr, then neutrophils
are recruited with probability pnr.
Similarly to macrophages, neutrophils are also capped at a critical level nmax to
avoid the infinite recruitment and accumulation of cells within the tissue. Further
details and the proportionality to the maximum number of macrophages are provided
in the dedicated parametrisation Section 4.3.
Chemotactic motion
In a similar fashion to macrophages, the chemotactic motion of neutrophils is modelled
by analysing, for each cell ni, the concentrations cj of pro-inflammatory mediators
at each position j of the neighbourhood Ni. The final choice of the new position to
move to, dictated by levels of chemoattractant within the cell’s neighbourhood, is
based upon probability (4.7).
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Release of pro-inflammatory mediators
In line with their biological function of promoting inflammation and echoing a key
feature from the PDE model of Chapter 3, we identify neutrophil agents as a source
of pro-inflammatory mediators. At each tick, active neutrophils release an increment
δnc of pro-inflammatory chemicals with probability pnc.
Apoptosis
Finally, the physiological cellular death that neutrophils naturally undergo is de-
scribed by a dedicated method. The biological implications of a neutrophil’s apop-
tosis in the inflammatory context are multiple and directly affect the complex chain
of cellular and chemical interactions, as already highlighted in Section 1.2.1. The
cell’s death through apoptosis is modelled by removing the original agent from the
system and replacing it with a new agent from the Apoptotic class (described below)
instead.
Summary
In conclusion, at every tick, agents from the Neutrophil class
• move chemotactically towards pro-inflammatory mediators;
• release pro-inflammatory mediators;
• decide whether to become apoptotic.
Moreover, neutrophils are prescribed with the added feature of a background release
of pro-inflammatory mediators, in order to further promote inflammation. This be-
haviour reflects the additional terms introduced in the extension of the PDE model
from Chapter 2 to Chapter 3 as well.
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A schematic representation of the set of rules regulating each neutrophil’s activity
is provided in Figure 4.5.
4.2.5 Apoptotic neutrophils
Overview
Once again, apoptotic neutrophils are defined with respect to a grid, a continuous
space and a lifespan, in this case representing the delay between the cell becoming
apoptotic and necrotic. At the point of necrosis, the cell releases its toxic content
and further promotes the inflammatory activity, provided they have not already been
phagocytosed by macrophages.
Necrosis
At each tick, the Apoptotic agent’s lifespan is consumed and, upon complete de-
pletion, the cell finally becomes necrotic, with a dual action of incrementing the
concentration of pro-inflammatory mediators at the agent’s location by a quantity
δac, and the apoptotic cell being finally removed from the system. It is important to
observe that, unlike the release of pro-inflammatory mediators by active neutrophils,
the splurge of chemicals by apoptotic neutrophils upon necrosis is not subject to a
probability and is generally intended to be more disruptive. While the release of pro-
inflammatory mediators by active neutrophils is physiological and a fundamental part
of the chain of interactions that regulate the acute inflammatory response, apoptotic
neutrophils are ideally efficiently cleared and phagocytosed by macrophages, with
their necrosis playing a major role only in critical pathological contexts.
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Figure 4.5: Flow chart representing the cyclic chain of actions each Neutrophil agent
undergoes according to its state at each tick count. Red triangles represent prob-




In short, apoptotic neutrophils do not move but if not phagocytosed by the time
they become necrotic, spill their toxic content, further enhancing the inflammatory
activity by releasing new pro-inflammatory mediators. Figure 4.6 summarises the
limited activity of apoptotic neutrophils with respect to the system’s tick count.
4.3 Parametrisation
We here pay particular attention to the spatial and temporal scales associated with
the agent based model described above, to both ensure biological realism and facilitate
comparison of results with the model of Chapter 3.
It should be noted here that the spatial scale associated this model is much smaller
than that of Chapter 3, since we are interested in the interactions of individual cells.
Within our agent based model, it is natural to consider the resolution of the grid to
be such that each grid space corresponds to one cell diameter. We choose to set each
grid space to correspond to the diameter of a macrophage, which is approximately
20 µm. For a 100 ˆ 100 grid, this corresponds to a square domain of width 2 mm.
When considering the nondimensionalisation required to arrive at the dimensionless
PDEs (4.5) and (4.6) from a dimensional analogue, it is computationally convenient
to scale lengths against the size of one grid space (since this provides a mesh with
unit spacing that can be coupled easily to the agent-based portion of the model). We
therefore choose L˚ “ 20µm (as opposed to the larger choice L˚ “ 10cm in Chapter 3)
and run simulations on the domain r0, 100s ˆ r0, 100s.
Similarly, we are required to choose an appropriate scaling of time, T ˚. In doing so,
we configure the cell velocities against data reported in the literature. As summarised
in Table 4.2, macrophage velocities are reported to lie in the range 0.5 – 30 µm min´1.
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Figure 4.6: Flow chart representing the cyclic chain of actions each agent of the
Apoptotic class undergoes according to its state at each tick count.
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We therefore set each tick to be equivalent to 1 minute (i.e. T ˚ “ 1 min) and allow
macrophages to move once per tick, resulting in a typical macrophage velocity of
20 µm min´1. Meanwhile, neutrophils are reported to move roughly twice as fast
as macrophages, as the data in Table 4.2 shows, with average velocities between
4.5 – 63.5 µm min´1. We therefore allow neutrophils to move twice per tick with
a corresponding neutrophil velocity of 40 µm min´1. We note that, through this
rescaling of time, 1 unit of dimensionless time in the model of Chapter 3 corresponds
to 480 ticks in this model.
As discussed in previous chapters, typical (dimensional) mediator diffusion rates
are reported to be of order D˚c » D˚g » 10´7cm2{sec ” D˚. Following the nondi-
mensionalisation procedure described in previous chapters, but with the new length
and time scales described above, we calculate appropriate dimensionless diffusion
coefficients as




We take this as our standard baseline value for Dc and Dg in the simulations below.
Similarly, the decay rate parameter γc in (4.5) is related to its dimensional equivalent
according to γc “ γ˚c T ˚. Since we know from the literature that γ˚c » 3 day´1 Dunster
et al. (2014), we have γc » 0.002. Again, we take this as our baseline value for γc in
simulations below, and for ease we also assume γg “ γc.
It then remains to consider the scaling of mediator concentrations themselves. In
Chapter 3, pro-inflammatory mediator concentrations were scaled against the param-
eter k˚a , which is related to the production of pro-inflammatory mediator by apoptotic
neutrophils on necrosis. Whilst it is difficult to recover this scaling exactly, we can
make a qualitative comparison by setting the amount of pro-inflammatory media-
tor released by an apoptotic neutrophil (δac) equal to one in our model. It is then
intuitive to trigger our simulations with an initial condition that represents an in-
termediate level of damage. We therefore choose our initial conditions to include a
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central circular area of damage of radius r in which c “ c0 (c0 P r0, 1s), surrounded by
healthy tissue in which c “ 0. For ease, we assume that there is no anti-inflammatory
mediator initially, so that g “ 0 everywhere in the domain.
The remaining parameters in our model are not known exactly, but some can
be inferred qualitatively from biological intuition. For example, we expect the pro-
duction of pro-inflammatory mediators by active neutrophils to be on a scale much
smaller than that by apoptotic neutrophils, so δnc ! δac. Similarly, due to the scal-
ing of mediator concentrations, we intuitively expect δmg, αnr, αmr, αml P r0, 1s. We
investigate the sensitivity of the model to variations in key parameters in Section 4.5
below.
Furthermore, in order to ensure that a finite number of cells is recruited, we pre-
scribe both macrophage and active neutrophils agents with a maximum number of
instances within the domain, as mentioned in Sections 4.2.3 and 4.2.4. In order to infer
a biologically realistic proportionality between the maximum number of macrophages
and neutrophils within the tissue, we refer to standard measurements of human dif-
ferential white blood cells. In particular, neutrophils account for 40% to 80% of the
total leukocyte population while macrophages have considerably lower proportions,
with typical values between 2%´ 10% (Curry, 2015). As such, by recalling that grid-
points are scaled with respect to the diameter of macrophages („ 20µm) and that we
operate over a 2mm ˆ 2mm domain, we fix the maximum number of macrophages
at mmax “ 1000 and a limit number of neutrophils four times larger at nmax “ 4000.
Finally, we consider appropriate choices for leukocyte lifespans. As already re-
ported in Sections 4.2.3 and 4.2.4, macrophages and neutrophils are typically active
for a variable amount of time that depends on the tissue and phase of inflamma-
tion, with the former spanning from several days to months (Takahashi, 2001) and
the latter being considerably shorter, from within hours to few days (Pillay et al.,
2010; Tak et al., 2013). Thus, recalling that according to our parametrisation one
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Literature reference Neutrophil velocity pµmmin´1q Literature reference Macrophage velocity pµmmin´1q
Qasaimeh et al. (2018) 4.77 ˘ 2.27 Hind et al. (2014) 5 ´ 20
Hoang et al. (2013) 19 ˘ 6 Shi et al. (2018) 2 ´ 30
Rainger et al. (1997) 9.8 ˘ 0.95 Toth et al. (2014) « 1
Jung et al. (1996) 63.5 ˘ 41.32 Nguyen-Chi et al. (2015) 0.5 ´ 1
Skoge et al. (2016) 18 Li et al. (2017) 8 ´ 12
Raymond et al. (2017) 12.7
Burton et al. (1987) 21.7 ˘ 6.2
Table 4.2: Leukocyte velocities in the literature.
tick is equivalent to one minute, we model this information by randomly assigning
lifespan a value taken from a uniform distribution on the interval r1440, 86400s for
macrophages and the interval r60, 1440s for neutrophils, respectively. For apoptotic
neutrophils, there is a lack of experimental methods to properly detect and measure
the necrosis timescales (Iba et al., 2013), but it is generally understood that this a
rapid process (Vanden Berghe et al., 2010). We thus prescribe an approximate lifes-
pan for apoptotic neutrophils randomly assigned from a uniform distribution on the
interval r60, 720s.
4.4 Simulations
The implementation of the ABM described above provides the opportunity to assess
multiple simulations. The model’s response is modulated through a set of parameters
that can be manipulated in order to lead the system towards either the resolution
of inflammation or its chronicity. In this sense it is interesting to observe that the
intrinsic structure of the ABM paradigm provides a degree of randomness to each
simulation, thus replicating those natural biological features that do not necessarily
follow a strict set of fixed numerical parameters. As such, while the tuning of pa-
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rameters affects the overall outcome of batches of simulations, it is nonetheless not
surprising that a fraction of those simulations could yield an opposing result than
the one set by the parameter values. In the analysis that follows we run batches of
100 repeated simulations per parameter set and report the main outcomes. All the
parameters controlling the ABM behaviour are defined in Table 4.3. Through careful
regulation of the parameter values and assessment of the resulting simulations, two
main behaviours emerged: the overall resolution of inflammation (which we define as
the simultaneous elimination of active/apoptotic neutrophils and pro-inflammatory
mediators), detailed in Section 4.4.2, and a chronic non-resolved outcome, as de-
scribed in the following section. Table 4.4 summarises the parameter values used in
the following simulations and, as it can be observed from the bold rows, the shift in
the overall outcome of the acute inflammatory response is achieved by manipulat-
ing those parameters that directly regulate the inflammatory activity. In particular
a number of parameters that specifically target the severity of the initial damage
(c0), the size of the initial damage (r), the regulation of neutrophil recruitment (αncr,
αngr), and the efficiency of macrophages recruitment (αmr) provide a switch between
the chronicity of inflammation and the restoration of a healthy state. This further
reinforces on one hand the impact of the initial damage upon the spatial spread of
inflammation and its eventual outcome and on the other hand the key role of neu-
trophils in promoting inflammation and macrophages in actively resolving it, which
is tightly dependant on the mediator’s presence and action.
4.4.1 Chronic outcome
While each single simulation plays out differently in terms of the agent locations and
the interactions conditioned by probabilities, fixing the parameters accordingly with
the second column of Table 4.4 provides a set of baseline values that yield an overall
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Parameter Definition Class
c0 initial pro-inflammatory mediators concentration (damage severity) InflammationBuilder
r initial damage radius (damage size) InflammationBuilder
Dc diffusion of pro-inflammatory mediators Environment
Dg diffusion of anti-inflammatory mediators Environment
γc decay of pro-inflammatory mediators Environment
γg decay of anti-inflammatory mediators Environment
δac increment of pro-inflammatory mediators upon apoptotic neu-
trophils undergoing necrosis
Apoptotic
δnc increment of pro-inflammatory mediators upon active neutrophils
activity
Neutrophil
δmg increment of anti-inflammatory mediators upon macrophagic activ-
ity
Macrophage
pnr probability of recruitment of new neutrophils Environment
pnc probability conditioning release of pro-inflammatory mediators
upon neutrophils activity
Neutrophil
pmr probability of recruitment of new macrophages Environment
pmg probability upon which macrophages initiate the anti-inflammatory
response
Macrophage
pml probability at which macrophages leave the tissue Macrophage
pma probability at which macrophages phagocytose apoptotic neu-
trophils
Macrophage
αncr threshold of pro-inflammatory mediators above which new neu-
trophils are recruited
Environment
αngr threshold of anti-inflammatory mediators below which new neu-
trophils are recruited
Environment
αmr threshold of pro-inflammatory mediators above which new
macrophages are recruited
Environment
αml threshold of pro-inflammatory mediators below which macrophages
leave the tissue
Macrophage
Table 4.3: Parameters of the ABM inflammatory model.
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Parameter
Chronic outcome Healthy outcome Healthy outcome Healthy outcome Healthy outcome Healthy outcome
(baseline values) (switch: damage severity) (switch: damage size) (switch: neutrophil recruitment via c) (switch: neutrophil recruitment via g) (switch: macrophage recruitment)
c0 1 0.5 1 1 1 1
r 10 10 5 10 10 10
Dc 1.5 1.5 1.5 1.5 1.5 1.5
Dg 1.5 1.5 1.5 1.5 1.5 1.5
γc 0.002 0.002 0.002 0.002 0.002 0.002
γg 0.002 0.002 0.002 0.002 0.002 0.002
δac 1 1 1 1 1 1
δnc 0.001 0.001 0.001 0.001 0.001 0.001
δmg 0.001 0.001 0.001 0.001 0.001 0.001
pnr 0.02 0.02 0.02 0.02 0.02 0.02
pnc 0.5 0.5 0.5 0.5 0.5 0.5
pmr 0.04 0.04 0.04 0.04 0.04 0.04
pmg 0.8 0.8 0.8 0.8 0.8 0.8
pml 0.8 0.8 0.8 0.8 0.8 0.8
pma 1 1 1 1 1 1
αncr 0.05 0.05 0.05 0.1 0.05 0.05
αngr 0.015 0.015 0.015 0.015 0.0015 0.015
αmr 0.25 0.25 0.25 0.25 0.25 0.05
αml 0.02 0.02 0.02 0.02 0.02 0.02
Table 4.4: Parameter values modelling the resolution of inflammation (third to sev-
enth column) and its chronicity (second column).
behaviour towards the chronic state of inflammation that clearly emerges through
multiple simulations. Snapshots of one such simulation, as shown in Figure 4.7, pro-
vide a visual understanding of the biological mechanisms unfolding at tissue level that
cannot otherwise be easily captured by PDE models. Setting the parameters as in
the second column of Table 4.4 disrupts the physiological progression of acute inflam-
mation, resulting in continuous neutrophil activity which in turn further enhances
the pro-inflammatory mediators’ action, thus eventually preventing the resolution of
inflammation and leading to its periodic recurrence or non-resolution altogether.
In order to appreciate how the system’s outcome is modulated by the parameter
values, a series of 100 simulations were run, in which the agent counts of cells (active
neutrophils, macrophages, apoptotic neutrophils) and maximum concentrations of
pro- and anti-inflammatory mediators were monitored. Figure 4.8 thus results from
the averaging of all the collected data, highlighting a trending behaviour for each
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Figure 4.7: Simulation of the chronic outcome of the ABM running from t “ 0
(upper left corner) to t “ 5000 (bottom right corner), with parameters as in the
second column of Table 4.4. Macrophages are represented with blue circles, active
neutrophils with green triangles and apoptotic neutrophils with orange triangles.
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(a) Active neutrophils. (b) Apoptotic neutrophils.
(c) Macrophages. (d) Pro-inflammatory mediators.
(e) Anti-inflammatory mediators.
Figure 4.8: Plots for the ABM corresponding to the average results of the batch of 100
simulations, with parameters as in the second column of Table 4.4. Shades around
the plots represent standard deviations.
group of cells and mediators that could not otherwise be captured and analysed. Fig-
ures 4.8a and 4.8c in particular highlight how both neutrophils and macrophages
exhibit a steady increase, rapidly settling to constant levels that are maintained
throughout the simulations. Apoptotic neutrophils start appearing gradually with
a delay corresponding to the lifespan of active neutrophils (Figure 4.8b). Inflamma-
tory mediators present a different temporal pattern, in line with their specific biolog-
ical behaviour. Figure 4.8d shows an immediate drop of pro-inflammatory mediators
corresponding to the combined effect of diffusion and decay from the initial concentra-
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tion modelling the damage. The levels of c are then sustained by neutrophils’ activity,
as prescribed by the background release of pro-inflammatory mediators provided by
these cells and described in Section 4.2.4. Recurrent peaks of pro-inflammatory me-
diators signal the necrosis of an apoptotic neutrophil and the resulting spilling of its
toxic content within the tissue, causing further disruption and promoting the pro-
inflammatory activity. Conversely, anti-inflammatory mediators (Figure 4.8e) start
appearing in the system only via mature macrophages, i.e. macrophages that have
already phagocytosed apoptotic neutrophils and have thus undergone a change in
phenotype. Such behaviour signals the active role of these leukocytes in promoting
healing. The stable level of anti-inflammatory mediators observed in prolonged times
of simulations is contrasted by the continuous recruitment of neutrophils and their
pro-inflammatory activity that effectively counteracts the anti-inflammatory action.
This results in an impaired healing process, with both cells and mediators maintain-
ing high levels of concentration throughout, eventually preventing the resolution of
inflammation. We note that, while the pro-inflammatory mediator concentration in
Figure 4.8d occasionally approaches or reaches zero in some simulations, this does not
signify a switch to a healthy outcome since (in all simulations) there is a sustained
presence of both active and apoptotic neutrophils (Figures 4.8a and 4.8b), which re-
sult in damage persisting. As such, these low levels of pro-inflammatory mediators
are not representative of emergent behaviours here.
4.4.2 Healthy outcomes
The crucial role of macrophages in promoting the resolution of inflammation (Hesketh
et al., 2017) suggests that, in order to model an effective healing process, leading to
the resolution of inflammation, those parameters that regulate the anti-inflammatory
mediators’ action are key to switching the system’s behaviour. Similarly, with neu-
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trophils enhancing the pro-inflammatory activity, a careful modulation of the levels of
neutrophils infiltrating the injured tissue emerges as decisive point of control for the
resolution of inflammation (Ortega-Gomez et al., 2013). As such, two main parame-
ters from the ones listed in Table 4.3 are individuated to best tackle the disruption of
the healthy state prompted by the physiological acute response and promote recovery,
namely the threshold of pro-inflammatory mediators upon which neutrophils are re-
cruited (αncr) and the threshold of pro-inflammatory mediators allowing recruitment
of macrophages (αmr). Furthermore, we also investigate the effects of the initial dam-
age on the final outcome of the inflammatory response, by focusing on its severity,
c0, and its initial initial radius, r. Through manipulation of each of these parameters
individually, we determine sets of key parameter values that act as switches between
chronic and healthy scenarios, as highlighted in Table 4.4 and further detailed in the
sections below.
Finally, we will investigate the efficacy of phagocytosis in the healing process, by
assessing how the tuning of parameter pma impacts upon the resolution of inflamma-
tion.
Neutrophil recruitment
The careful assessment of repeated simulations resulting in non-resolved inflamma-
tion, as well as the biological evidences highlighting the prime role of active neu-
trophils in enhancing the release of pro-inflammatory mediators motivate us to focus
our attention on the recruitment of these cells as a possible target for resolution of
inflammation. Simulations reveal that increasing αncr from 0.05 to 0.1 results in a
sufficiently reduced neutrophil recruitment to generate a healthy outcome. Figure 4.9
shows the initial trigger of acute inflammation, in response to the immediate release of
pro-inflammatory mediators at the site of injury and its progression in time. Firstly,
it is straightforward to observe how the resolution of inflammation is reached well
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Figure 4.9: Simulation of of the chronic outcome of the ABM running from t “ 0
(upper left corner) to t “ 5000 (bottom right corner), with parameters as in the
fifth column of Table 4.4, where αncr “ 0.1. Macrophages are represented with
blue circles, active neutrophils with green triangles and apoptotic neutrophils with
orange triangles. Increases in concentrations of pro-inflammatory mediators in red
are gradually dampened by anti-inflammatory chemicals.
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before the end of the simulation at t “ 5000, as the last row of Figure 4.9 shows, with
lower levels of pro-inflammatory mediators prompting the remaining macrophages
to leave the tissue. When not phagocytosed in time, apoptotic neutrophils can also
be seen undergoing necrosis and releasing additional quantities of pro-inflammatory
mediators, as represented by the red bursts visible throughout Figure 4.9. The occa-
sional necrosis of neutrophils does not prevent the overall resolution of inflammation
thanks to the efficient recruitment and action of macrophages that preferentially move
toward apoptotic cells. The controlled recruitment of neutrophils prevents a surge
in the background level of pro-inflammatory mediators, with the increasing levels of
anti-inflammatory mediators released by mature macrophages proving decisive in the
healing process and final healthy outcome.
Similarly, simulations resulting from decreasing αngr from 0.015 to 0.0015 exhibit
a resolved inflammatory outcome. Restoration of health is, in this case, prompted by
lowering the threshold of anti-inflammatory mediators, g, that controls the recruit-
ment of neutrophils. Thus, significantly smaller amounts of g are enough to signal
the system is headed towards the resolution of inflammation and no new neutrophils
are needed at the site of the original injury.
Overall, this dynamic balance between pro- and anti-inflammatory activity, ob-
tained by adjusting the recruitment of neutrophils in response to local concentrations
of c and g, eventually leans towards the anti-inflammatory mediators that prompt
the resolution of inflammation and restoration of a healthy state.
Macrophage recruitment
Conversely, macrophages actively lead to the resolution of inflammation. Thus, from
our simulations it emerges that decreasing the minimum threshold value of pro-
inflammatory mediators required for the recruitment of macrophages to αmr “ 0.05,
i.e. enhancing the recruitment of macrophages, the system’s behaviour switches from
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a previously chronic outcome to the healthy one. In practice, as soon as the local
concentration of c is above this updated threshold of αmr “ 0.05 (less constraining
than the original baseline value of αmr “ 0.25), new macrophages are recruited, with
their additional contribution of anti-inflammatory mediators eventually proving key
to the resolution of inflammation.
Damage severity
As the baseline values reported in Table 4.4 suggest, an initial damage of radius
r “ 10 and concentration of pro-inflammatory mediators of c0 “ 1 is enough to
prompt an inflammatory response, with the system yielding a perpetual inflamed
state. In investigating the impact of the severity of the initial damage over the
strength of the inflammatory response, we observe that upon a diminished quantity
of pro-inflammatory mediators within the injured site the overall outcome can also be
affected, prompting the restoration of a healthy state. As such, through simulations
we determined that a decreased initial concentration of c0 “ 0.5, while keeping all
other parameters unchanged, as visible in Table 4.4, is enough to ensure a healthy
outcome.
Damage size
Similarly, by manipulating the radius of the initial damage, from a baseline set of
parameter values resulting in a non-resolved inflammation, we can provide the system
with a switch to a healthy outcome by only tuning the initial radius of the damage to
r “ 5. Thus, as reported in Table 4.4, halving the size of injury ensures the clearance
of inflammation and restoration of the healthy state.
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Phagocytosis
As already emerged in Section 1.2 and largely confirmed in the results from Chap-
ter 2–3, the phagocytosing actions of macrophages and their role in clearing apoptotic
neutrophils is key in the inflammatory process. In particular, analogously to the anal-
ysis of the previous PDE model in which a specific focus was put on the effects of
parameter φ accounting for the rate at which macrophages phagocytose apoptotic
neutrophils, we here investigate the impact of parameter pma, which represents the
probability of the phagocytosing action. By considering each of the parameter sets
that results in a healthy scenario, as reported in Table 4.4, we reassess and com-
pare the results yielded by tuning the probability of phagocytosis to pma “ 0.01,
from its original baseline value of pma “ 1. In doing so, we drastically affect the
macrophage efficiency in clearing apoptotic neutrophils, with expecting deteriorating
results to the inflammatory outcome. Interestingly, all simulations with either set
of parameters ensuring restoration of the healthy state, when run with the updated
value of parameter pma “ 0.01 continued to guarantee the complete resolution of
inflammation with the introduction of a considerable delay in the healing process.
The longer healing times are caused by the drastic inhibition of the phagocytic ac-
tion of macrophages that move preferentially toward apoptotic neutrophils and when
fetching them are not able to immediately engulf them. In fact, in this new scenario,
phagocytosis happens with probability pma “ 0.01, thus causing a delay between the
time a macrophage moves to and reaches an apoptotic neutrophil and the time that
probability pma is met, when the former can finally phagocytose the latter. These
delays accounted for an approximate number of 500 ticks, with the overall healing
period varying depending on the specific healthy scenario that was being tested, as
detailed in table. It should be noted that the timespans reported in Table 4.5 provide
approximate intervals and not exact durations of simulations. This further highlights
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Approximate standard healing time (ticks) Approximate delayed healing time (ticks)
(via pma “ 0.01)
Healthy outcome
1500 ´ 2000 2500 ´ 3000
(via damage severity)
Healthy outcome
1000 ´ 1500 1500 ´ 2000
(via damage size)
Healthy outcome
1000 ´ 1500 1500 ´ 2000
(via neutrophil recruitment over c)
Healthy outcome
3000 ´ 3500 3500 ´ 4000
(via neutrophil recruitment over g)
Healthy outcome
2000 ´ 2500 2500 ´ 3000
(via macrophage recruitment)
Table 4.5: Approximate healing times upon individual tuning of selected parameters.
the random component in the ABM paradigm, marking a strong difference with the
PDE modelling approach in which all the analyses, even upon repeated simulations,
yields strictly deterministic results.
4.4.3 Discussion
In addition to exposing the role of the effects of phagocytosis on the inflammatory
response, Table 4.5 also provides an assessment of the efficacy of each individual pa-
rameter in the resolution of inflammation, namely those accounting for the initial
damage (c0 and r) and the ones modelling the recruitment of leukocytes (αncr, αngr
and αmr) as possible therapeutic targets and their benefit in terms of healing times.
In particular, we can conclude that therapies acting on the controlled recruitment
of neutrophils and the enhanced recruitment of macrophages can potentially have
a dramatic impact on the outcome of the acute inflammatory response, prompting
the restoration of the healthy state in an otherwise chronic scenario. Furthermore,
as shown in Table 4.5 the effectiveness of the manipulation of the recruitment of
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neutrophils (through parameter αncr) appears to be slightly more beneficial in terms
of healing time, compared to the tuning of parameter αmr. Conversely, the impact
of manipulation of parameter αngr, while still effective, is considerably delayed com-
pared to other parameters. Similarly, our results suggest that strategies acting on
limiting the initial damage, both in size and severity, can prove determinant in pre-
venting inflammation from becoming chronic. This, while not providing an immediate
therapeutic target in terms of pharmacological action, points at the importance of
controlling the initial tissue damage, which, in case of sterile inflammations such as
in the scope of our models, has a direct impact on surgical techniques and strategies
to reduce the inevitable tissue injury upon surgery as much as possible.
The manipulation of the parameters key to the resolution of inflammation, as
detailed in Table 4.4, results in simulations where the initial damage is effectively
tackled, limited in spread and eventually resolved, as represented in Figure 4.9 where
healing is prompted via regulation of neutrophils’ recruitment, effectively fixing either
αncr “ 0.1 or αngr “ 0.0015. Simulations of the remaining healing scenarios reported
in Table 4.4, namely the ones obtained by decreasing the damage size (r) and sever-
ity (c0) and the ones achieved by improving the macrophage recruitment (αmr) and
neutrophil recruitment via g (αngr), provide visually similar results in terms of final
outcome to the one showed in Figure 4.9 referring to the manipulation of parameter
αncr. They vary though in the overall healing times, with the average total num-
ber of ticks required for the inflammation to be cleared and resolved differing from
one scenario to the other, as already discussed and reported in Table 4.5. Interest-
ingly, we also observe variations in the number of cells recruited and concentrations
of mediators involved. These differences are illustrated in Figure 4.10, where results
from each set of simulations are averaged and compared. The results shown in Fig-
ure 4.10 provide a temporal analysis of the concentrations of both groups of cells and
chemicals and, while neglecting the spatial distribution of agents, offer nonetheless a
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(a) Active neutrophils. (b) Apoptotic neutrophils.
(c) Macrophages. (d) Pro-inflammatory mediators.
(e) Anti-inflammatory mediators.
Figure 4.10: Plots for the ABM corresponding to the average results of batches of
100 simulations, with resolution obtained by increasing αncr from 0.05 to 0.1 (blue),
decreasing αngr from 0.015 to 0.0015 (red) and decreasing αmr from 0.25 to 0.05
(yellow), r from 10 to 5 (purple) and c0 from 1 to 0.5 (green); all other parameters
as in the second column of Table 4.4.
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valuable assessment of the progression and final outcome of the acute inflammatory
response by highlighting the tight interactions between leukocytes and mediators.
Firstly, we observe that the overall healing profiles, achieved via manipulation of
αncr, αngr, αmr, r and c0 respectively, share specific patterns in terms of dynamics.
In particular, we observe how the number of active neutrophils (Figure 4.10a) at
each tick is closely followed by that of apoptotic neutrophils (Figure 4.10b), as ex-
pected, since all active neutrophils eventually undergo apoptosis. The macrophagic
activity (Figure 4.10c) on the other hand is expressed in response to the presence
of both apoptotic neutrophils and pro-inflammatory mediators. This explains why
peaks of macrophage presence within the inflamed tissue are delayed compared to
active neutrophils. Conversely, the pro-inflammatory mediator concentration is en-
hanced in correspondence to those apoptotic neutrophils that become necrotic before
being effectively phagocytosed by macrophages, thus releasing their toxic content and
further promoting the inflammatory activity. This is well reflected in Figure 4.10d
in which the surge in concentration of pro-inflammatory mediators follows the same
timescale pattern of the increase in apoptotic neutrophils. Finally, the production
and release of anti-inflammatory mediator is actively promoted by the phagocytosis
of apoptotic neutrophils by macrophages. Thus, Figure 4.10e should be read as the
result of the joint interaction of these two agents that eventually leads towards the
resolution of inflammation, with all the variables plotted in Figure 4.10 exhibiting
zero concentrations by the end of the simulation at t “ 5000 accordingly.
Additionally, interesting differences emerge with respect to each healing strategy
employed. In particular, Figure 4.10 shows how decreasing the size of the initial
damage r is the most effective target, as represented by the plots in yellow, with the
number of active neutrophils and macrophages involved being minimised and the anti-
inflammatory response being in turn of a considerably lower scale. Adjustments to
neutrophils’ recruitment (αncr, plotted in blue) and the decrease in the initial damage
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severity (c0, plotted in purple) provide instead similar benefits in terms of healing
times and levels of cells and mediators involved, but are sensibly larger than the results
achieved via manipulation of r. Finally, while still effective in resolving inflammation,
changing the value accounting for the recruitment of macrophages through parameter
αmr, provides an inflammatory response of a considerably larger scale, with respect
to both healing times and concentrations of leukocytes and mediators featured, as
shown in the plots in red.
4.4.4 Comparison with the PDE model of Chapter 3
Given that the modelling approach proposed by the ABM paradigm is substantially
different to the one offered by PDEs, it is interesting to compare the results provided
by both sets of models. To this end, Figures 4.11–4.12 present a combination of results
from the inflammation model described in Chapter 3 and the ABM introduced in this
chapter. Both models depend on sets of parameters representing the main cellular and
chemical interactions; the accurate tuning of some sensitive and biologically significant
ones provides different outcomes in terms of the resolution of inflammation, as shown
throughout Chapters 3–4. We note, here, that the model of Chapter 3 and the ABM
constructed in this chapter operate on very different spatial scales: the model of
Chapter 3 is applied on a square domain of width 10 cm, while the ABM of this
chapter uses a smaller domain of width 2mm (as discussed in Section 4.3). For this
reason, the numbers of cells reported for the PDE model of Chapter 3 are typically
at least one order of magnitude higher than those of the ABM in Figures 4.11–4.12.
Figure 4.11 combines results from Figures 3.9 (by appropriately rearranging the
data and plotting at each time step the total number of cells and the maximum con-
centration of mediators) and 4.10, from the PDE and ABM simulations respectively.
While the plots for each cellular and chemical group do not overlap exactly, the over-
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all behaviour is similar in presenting a surge in each variable upon injury and their
eventual dampening, with the restoration of a healthy state. Similarly, Figure 4.12
compares simulations from Figures 3.11 and 4.8. The immediate visual comparison
between the two sets of plots is straightforward in highlighting the persistent high
levels of both white blood cells and inflammatory mediators, typical of chronic in-
flammation. More importantly, regardless of the modelling approach, the outcome of
these simulations is directed and controlled by a careful manipulation of the models’
parameters. As such, the PDE model’s outcome (left panel) is obtained by tuning the
parameters accounting for the rate at which active neutrophils undergo apoptosis (ν).
Simulations of the ABM yield the chronic outcome by changing either of the parame-
ters that act as switch between resolved and chronic outcomes, namely the threshold
of pro-inflammatory mediators upon which new neutrophils and macrophages are re-
cruited (αncr, αngr and αmr), and the damage size and severity (r and c0 respectively).
In particular, it is crucial to observe that in both the PDE and the ABMs, the inflam-
mation outcome changes from a healthy state to a chronic one by manipulating the
neutrophil activity, which in turns affects the release of pro-inflammatory mediators
and the level of disruption within the tissue. The mechanisms are specific to the
modelling approach, with the PDE model highlighting the role of apoptosis through
manipulation of parameter ν and the agent based model with respect to parameters
αncr and αngr, controlling the recruitment of neutrophils instead.
Analogously, both the PDE and the ABM are susceptible to the regulation of
macrophage activity, as addressed in Chapter 3 with respect to the phagocytosing
rate φ and in Section 4.4.2 of the current chapter via parameter αmr controlling the
macrophage recruitment, respectively. Therefore, qualitatively comparable results be-
tween the two models are similarly achieved by tuning the macrophagic activity, which
directly controls (by either delaying or impairing) the anti-inflammatory mediators
action. This aspect highlights the importance of neutrophil’s controlled recruitment
4.5. PARAMETER SENSITIVITY ANALYSIS 172
and apoptosis on one hand and of macrophages on the other hand in terms of possible
therapeutic targets, in addition to the sensible beneficial effects achieved by minimis-
ing the initial damage size and severity. This suggests that the manipulation of both
the action of leukocytes and the containment of tissue injury could be key to restoring
a healthy state and preventing the chronic state of inflammation.
4.5 Parameter sensitivity analysis
In order to provide an exhaustive assessment of the model capabilities and analyse
its dependence on individual parameters, we perform a parameter sensitivity analy-
sis. The aim of such study is to individuate parameters that have a key impact on
the model’s outcome, while also highlighting the marginal role of those remaining
parameters whose variation does not significantly affect the system’s behaviour.
4.5.1 Set up
We consider the standard chronic outcome outlined in Section 4.4.1 as our reference
simulation and investigate, through a systematic set of simulations where individual
parameters are changed one at time, differences arising in the final outcome of the in-
flammatory response. We outline a set of parameter values to be tested with the aim
to assess the model’s response to significant increases and decreases of each parame-
ter with respect to the reference set of parameter values listed in the second column
of Table 4.4. For each parameter individually, increases and decreases of 50% of the
reference value are considered. The resulting set of values tested is listed in Table 4.6,
with the second column reporting the reference chronic values for convenience and
the third and fourth columns exhibiting decreased and increased values respectively.
The outline in Table 4.6 provides a guide to the simulations performed for the sen-
sitivity analysis, where the model is systematically set up with all combinations of
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Figure 4.11: Left panels: solution of (3.7–3.11, 3.29), with parameters as in Table 3.2.
At each time step, we plot the global cell counts and the maximum concentration of
mediators. Right panels: plots for the ABM corresponding to the average results of
batches of 100 simulations, with parameters as in the third (green), fourth (purple),
fifth (blue), sixth (red) and seventh (yellow) columns of Table 4.4.
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Figure 4.12: Left panel: solution of (3.7–3.11, 3.29). At each time step, we plot
the global cell counts and the maximum concentration of mediators. The rate of
neutrophil apoptosis is updated to ν “ 0.075, all other parameters are as in Table 3.2.
Right panels: plots for the ABM corresponding to the average results of the batch of
100 simulations, with parameters as in the second column of Table 4.4.
4.5. PARAMETER SENSITIVITY ANALYSIS 175
parameters resulting from the reference column and each of the updated parameter
values one at time. It is important to observe that parameter δac, accounting for
the increment of pro-inflammatory mediators in response to apoptotic neutrophils’
necrosis, is excluded from the parameter sensitivity analysis. This is due to δac being
the parameter with respect to which all other parameters are scaled, as detailed in
Section 4.3. Additionally, as is visible in Table 4.6, parameter pma, representing the
probability of macrophages to phagocytose apoptotic neutrophils, is only tested in
terms of a decrease from its reference value, since the baseline chronic value of pma “ 1
is already maximal. The total global concentration of mediators and the number of
neutrophils are monitored over 5000 ticks, collected and saved as output in order
to be compared against the reference data. In particular, we record the percentage
change in these two measures in comparison to the reference data.
4.5.2 Analysis
In order to take into account the randomness within the ABM framework, both the
reference simulation and each set of test simulations are analysed over a batch of
100 runs. Upon selection of a timepoint of interest tp, each set of data is averaged.
Variations over single batches of simulations are computed with respect to the per-
centage change compared to the reference simulation. Figure 4.13 shows the results
corresponding to each combination of parameter values from Table 4.6. Simulations
corresponding to parameter decreases are marked by red downward-pointing triangles.
Conversely, simulations for parameter increases are marked by green upward-pointing
triangles. Here, all results are reported at the final tick, so tp “ 5000 throughout.
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Parameter
Reference values Decreased values Increased values
(Chronic outcome) (´50% of reference value) (`50% of reference value)
c0 1 0.5 1.5
r 10 5 15
Dc 1.5 0.75 2.25
Dg 1.5 0.75 2.25
γc 0.002 0.001 0.003
γg 0.002 0.001 0.003
δnc 0.001 0.0005 0.0015
δmg 0.001 0.0005 0.0015
pnr 0.02 0.01 0.03
pnc 0.5 0.25 0.75
pmr 0.04 0.02 0.06
pmg 0.8 0.4 1
pml 0.8 0.4 1
pma 1 0.5 n/a
αncr 0.05 0.025 0.075
αngr 0.015 0.0075 0.0225
αmr 0.25 0.125 0.375
αml 0.02 0.01 0.03
Table 4.6: Parameter values for the reference chronic outcome (second column) and
for sensitivity study with values to be tested representing decrease in half of reference
value (third column) and increase in half of reference value (fourth column).
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Figure 4.13: Parameter sensitivity analysis results showing the percentage change in
(a) the number of active neutrophils and (b) the concentration of pro-inflammatory
mediators, both with respect to the reference chronic simulation at final tick t “
5000, for variations of individual parameters. Green and red triangles represent 50%
increases and decreases respectively. Bars indicate change in minimum and maximum
changes in percentage over 100 simulations for each parameter. Note that a change
in response of ´100% corresponds to a switch from a chronic to a healthy outcome.
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4.5.3 Discussion
The data collected in the simulations run for the parameter sensitivity study are rich
and of complex interpretation, as is evident from the results in Figure 4.13. In par-
ticular, the total concentrations of pro-inflammatory mediators and the total number
of active neutrophils inform differently upon the acute inflammation outcome. Since
the data resulting from each batch of simulations is plotted in terms of percentage
changes with respect to the chronic reference, we are interested in the markers’ diver-
gence from the chronic baseline at zero. Thus, upward deflections from such baseline
correspond to worsening inflammatory conditions, since they represent higher con-
centrations of mediators and higher numbers of cells involved. Conversely, downward
deflections represent improvements in the inflamed tissue, with the presence of lower
amounts of mediators and cells compared to the reference data. In this sense, the
analysis of Figure 4.13a provides a neat interpretation of the tissue’s health state at
the end of the simulations at tick t “ 5000. Markers aligned at zero indicate the
absence of any discrepancy with the reference data, meaning that the tested param-
eter did not change the model’s final outcome toward neither healing nor worsening
conditions. More importantly, overlapped upward and downward triangle markers
highlight how increases and decreases of a specific parameter are irrelevant to the
model’s overall behaviour. Conversely, markers aligned at ´100 indicate a decrease
of 100% in the final amount of active neutrophils at tick t “ 5000 with respect to the
reference chronic data, pointing at the resolution of inflammation.
Observing Figure 4.13a, the key parameters affecting the system’s outcome and
providing a drastic switch from chronic inflammation to its resolution are immediately
individuated as c0, r and αncr. In particular, a decrease in half from the reference
value for either of the parameters controlling the initial damage (i.e. its severity c0
and its radius r), results in the complete resolution of inflammation. Similarly, health
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is restored upon an increase in half of the nominal value of parameter αncr controlling
the recruitment of active neutrophils. These results are in complete agreement with
the corresponding analysis presented in Section 4.4.2. A notable discrepancy emerges
with respect to the system’s sensitivity to parameter αmr, controlling the recruitment
of macrophages, which does not appear to be determinant in the model’s outcome
when decreased by half of its reference value αmr “ 0.25, but is proved to provide a
switch from chronicity to health when set at a considerably lower value of αmr “ 0.05,
as presented in 4.4.2. The apparent incongruity on the role of parameter αmr arises
from forcibly pushing the system toward resolution through a decrease of 80% from
the reference chronic value of αmr, while a decrease in 50% of its nominal value does
not provide any sensitive anti-inflammatory impact.
Similarly, the role of parameter αngr as a possible switch between chronic and
resolved outcomes is not entirely caught by the parameter sensitivity analysis. As
exposed in Section 4.4.2, a significant decrease in the threshold value controlling the
recruitment of neutrophils upon levels of anti-inflammatory mediators is necessary in
order to push the system toward resolution. Such variation is in order of 90% from
the chronic reference of 0.015 to the updated 0.0015 and does thus not feature in the
sensitivity analysis results, where variations of ˘50% are only considered.
As already highlighted in Section 4.4.3, within this model, parameters αncr, αngr
and αmr are individuated as possible therapeutic points of control, suggesting that
their manipulation via targeted drugs could be beneficial to the resolution of inflam-
mation. From the additional parameter sensitivity analysis we further infer that such
drugs would have a stronger impact when aimed at the recruitment of neutrophils
and, conversely, an enhanced action on the recruitment of macrophages is required
for the resolution of inflammation.
More interesting points of discussion emerge from observing Figure 4.13a, fo-
cusing on the system’s behaviour when increasing the diffusion of pro-inflammatory
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mediators Dc and upon decreasing the probability of recruiting neutrophils pnr, the
probability of neutrophils to release pro-inflammatory mediators pnc or the increment
in pro-inflammatory mediators by neutrophils δnc. In particular, the markers for these
specific tested parameters are very closely aligned to the reference data, indicating
the persistence of the chronic outcome, but exhibiting significant variations that sig-
nal the occasional resolution of inflammation in a fraction of the batch simulations.
This is significant in highlighting once more the non-deterministic nature of the ABM
framework, which thus results better suited to describe complex biological processes
whose nuanced interactions are not always captured in full by the deterministic ap-
proaches provided by ODEs and PDEs.
The parameter sensitivity analysis on pro-inflammatory mediators (4.13b) presents
a more complex result. In particular, the main considerations about the decreases in
key parameters c0, r and increase in αncr are retained, with the respective markers
aligned at ´100, thus indicating a switch from the chronic reference outcome to full
recovery. Conversely, the level of inflammation severity with respect to the chronic
baseline is of more difficult interpretation, with most markers presenting a significant
divergence from the reference data. The high variations provide an understanding for
such behaviour, explaining the strong variability in the concentration levels of pro-
inflammatory mediators at every stage of inflammation, depending in first instance
by the presence of active neutrophils which provide a continuous background release
(as explained in Section 4.2.4) and more importantly to the surges of c upon necrosis
of apoptotic neutrophils (as described in Section 4.2.5). Thus, overall, levels of global
concentrations of pro-inflammatory mediators appear to be more informative in terms
of the severity of inflammation, rather than being an indicator for its resolution.
Another important observation arising from the parameter sensitivity analysis is
with respect to probabilities. In particular, as evident from the results in Figure 4.13,
the model is largely insensitive to choices of most probabilities, thus overcoming the
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biological uncertainty in identifying suitable values for such parameters.
4.6 Conclusions
In this chapter we introduced a new modelling framework, defining the ABM paradigm
and presenting related applications of biological relevance. We then proceeded to
model acute inflammation taking into account the response of white blood cells, dif-
ferentiating between neutrophils and macrophages and their action, as well as that of
both pro- and anti-inflammatory mediators. Both groups of leukocytes of the ABM
implement chemotaxis and direct their motion within the domain accordingly. The
system’s behaviour, including that of each group of agents, is controlled through pa-
rameters that can be tuned to simulate both healthy and unresolved outcomes of
the inflammatory event. Key parameters around which such behaviour is modulated
find a direct correspondent both biologically and with respect to the PDE model of
Chapter 3, to which a comparative analysis in terms of results was also carried out.
A key result from this novel model is that of accounting for cells individually while
also retaining the diffusive and chemotactic behaviours introduced in the previous
chapter. This better reflects the heterogeneous response of cells that exhibit varied
responses according to their location and particular environment, rather than acting
as a homogeneous group as implied in the definition of the PDE model.
The main focus of our analysis has been on highlighting how parameters of high
biological significance, namely the size and severity of damage and the efficiency
of leukocyte recruitment, can have a determining impact on the inflammatory out-
come, acting as a switch between healthy and chronic scenarios. We also investigated
the effects of phagocytosis on the healing process, assessing recovery times in corre-
spondence of the tuning of the parameter controlling the likelihood of macrophages
effectively clearing apoptotic neutrophils. This detailed analysis allowed us to individ-
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uate these biological interactions as key targets for possible therapeutic interventions,
suggesting tailored strategies for drugs either enhancing macrophage recruitment or
controlling neutrophil recruitment and surgical procedures at aiming in minimising
size and severity of the tissue damage. Additionally, our analysis shows that all these
strategies would be sensibly affected in terms of recovery times upon macrophages
impaired phagocytosing action. Finally, a parameter sensitivity analysis was per-
formed, to gain further insight into the role of individual parameters in controlling
the system’s behaviour. In response to systematic increases and decreases of param-
eter values from their reference chronic set, the model results are robust to variations
of the probabilities regulating leukocytes’ behaviour and to inflammatory mediators’
increments, diffusivity and decay rates. Conversely, manipulation of parameters con-
trolling the initial damage and cells’ recruitment have a regulatory action on the
system’s outcome in terms of resolution of inflammation. This is also in accordance
with the results presented in earlier Sections 4.4.2–4.4.3 and further suggests the ben-
efits of targeting tissue damage and neutrophil recruitment as key mechanisms of the
inflammation’s outcome. In this regard, an important observation emerges from the
impact of cell’s recruitment, with the parameter sensitivity analysis exposing the sys-
tem’s stronger response to recruitment of neutrophils than macrophages. Evaluating
this result in terms of therapeutic targets, drugs aiming at controlling macrophage’s
recruitment would need an enhanced action to tackle effectively inflammation and
promote its resolution.
We note that, in this model, there is a degree of choice over the exact manner
in which a tick of the model is defined. For convenience, we have assumed that all
cellular decisions are implemented every tick, with the exception of the recruitment
of neutrophils and macrophages, which we recruit every two and five ticks respec-
tively in order to account for delays in cell recruitment in vivo. We note that the
definition of a tick in the agent-based component of our model does not impact upon
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the numerical solution of the PDEs describing mediator concentrations, since the nu-
merical timestep used to solve these PDEs is implemented separately, with multiple
numerical timesteps occurring per tick. It is well-known that neutrophils are recruited
more rapidly than macrophages in vivo, which motivates our choices of recruitment
frequencies used here; however, it is intuitive to expect that variations in these re-
cruitment frequencies could have an impact upon the results obtained. Näıvely, we
may expect more frequent neutrophil recruitment to move the model toward chronic
outcomes, while more frequent macrophage recruitment may promote restoration of
health. However, since the pro- and anti-inflammatory effects of these cells are del-
icately connected, the effects of varying these parameters may be somewhat more
complex. We briefly revisit the question of how the scheduling of cell recruitment
impacts upon model observations in the following chapter.
Going forward in our analysis we aim to capture with greater detail the chemo-
tactic mechanisms that drive the motion of leukocytes, in order to help elucidate its
role within the physiologic inflammatory response and individuate points of control
to prevent impairment and defects in cells’ collective motility.
Chapter 5
An enhanced model of directed
neutrophil motility
In this chapter our objectives focus on modelling chemotaxis with greater detail, by
calibrating our model against available experimental data and to evaluate the impact
of the improved leukocytes motion within the inflammatory ABM. We further aim
to investigate the inflammatory pathology Chronic Obstructive Pulmonary Disease
(COPD) as a case study for model validation.
Numerous inflammatory conditions are associated with aberrant migration of neu-
trophils, in particular, while detrimental changes in neutrophil migration have also
been observed in ageing, with neutrophils generally exhibiting reduced chemotaxis
(Wagner & Roth, 1999; Sapey et al., 2014b; Jasper et al., 2019). The in-vitro
study of Sapey et al. (2011) used time-lapse photography to record trajectories of
healthy and COPD-affected neutrophils migrating up gradients of interleukin-8 (IL-
8), demonstrating that healthy neutrophils chemotax more efficiently, while impaired
neutrophils can have weaker sensitivity to the local chemoattractant gradient, which
we associate with an impaired ability to resolve tissue damage. We use the quanti-
tative measurements of directed neutrophil motility given by Sapey et al. (2011) to
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calibrate our description of leukocyte chemotaxis in the model presented below.
To include a novel calibrated description of chemotaxis, we will firstly introduce bi-
ological aspects of cells’ directed motion, particularly focusing on leukocyte migration
under physiological conditions. After a brief review of the relevant literature in terms
of both experimental and mathematical models of cell motility, an agent-based model
of neutrophil migration under a chemoattractant source is presented and thoroughly
analysed, with the aim to simulate and replicate experimental data obtained from
the available literature, with key parameters providing a switch between healthy and
pathogenic scenarios. In particular, our main focus is comparing cell walks exhibited
by our model to appropriate experimental data. We further characterise the model
of neutrophils’ directed motion in terms of balance between chemical attraction to a
source of mediators and cells’ persistence of motion. The aim for such characterisa-
tion directly arises from the observed features of leukocyte migration, as laid out in
the work of Foxman et al. (1999). More in detail, we model cells’ directed motion
in terms of biased persistent random walk, to best describe the in vivo leukocyte mi-
gration described in Taylor et al. (2013). Finally, we investigate the implications of
impaired chemotaxis on inflammatory mechanisms.
5.1 The biology of cell motility
Cell migration is an essential feature of living organisms, characterising embryoge-
nesis and directly affecting and regulating morphogenesis and inflammation. The
organised collective motion cells exhibit persists also in adult organisms and consti-
tutes a key aspect of a variety of physiological processes, including tissue homeostasis
and immune responses, amongst others, as well as being essential to many biotech-
nology applications such as tissue-engineered scaffolds and cellular transplantation.
Crucially, cell migration plays a fundamental role also in pathology, acting as a driv-
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ing factor for different diseases such as cancer spread, chronicisation of inflammation,
mental disorders, arthritis and atherosclerosis (Ridley et al., 2003). Given the dual
nature of this phenomenon, with single cells responding to molecular and physical
stimuli but also acting in group towards a global directed movement, biologically the
motion of cells can be described and analysed with respect to both single-cell and
collective cell migration.
Mechanically, a cell moves through a cyclic set of actions characterised by po-
larisation (in response to extracellular signalling), membrane extension, adhesion of
protrusions, contraction, traction and adhesion detachment (Horwitz & Webb, 2003;
Lauffenburger & Horwitz, 1996). The velocity and distinctiveness of these stages de-
pend on the cell type, with leukocytes in particular exhibiting a smooth and quick
drift over the substratum of migration. The source of polarisation triggering cellu-
lar directed motion can vary in nature, with local gradients associated with either
chemokinetic (upon variations of the receptor-ligand interface), haptotactic (with
concentrations of chemical attractants expressed by the substrate) or chemotactic
stimuli (Horwitz & Webb, 2003). The transduction of the relevant signalling inter-
nally to the cell results in the physical modifications at the membrane that allow for
the movement, with the development of protruding structures known as lamellipodia
(broad and flat) and filopodia (thin and cylindrical) that mediate the adherence and
detachment of substratum adhesion (Lauffenburger & Horwitz, 1996; Lodish et al.,
2008). The attachment site provides a firm focal adhesion between the cell’s mem-
brane protrusions and the substrate, leading the way to the cell body translocation
through consecutive contraction and traction forces between cell and substratum ad-
hesion points. The practical movement is thus achieved as a result of the mechanical
forces exerted by the cellular structures and the resisting forces of the cell-substrate
adhesions that, in turn, are rapidly detached at the cell’s rear upon movement (Lodish
et al., 2008). On the other hand, the understanding of the signalling and coordinated
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activity involved in the cell’s mechanics remains still unclear, particularly at the bio-
chemical level but also in terms of temporal and spatial behaviour (Lauffenburger &
Horwitz, 1996). Such processes are also studied at a larger scale, by considering the
temporal and spatial characterisation of collective cell migration. The prominence and
centrality of collective cell migration in a number of physiological and pathological
events, namely morphogenesis, wound healing and cancer, with the latter two directly
relating to inflammation, further explains the importance of a clear understanding of
this phenomenon. When analysed in its whole, the global directed motion of cells fol-
lows a similar pattern to the one of single cells, by polarising with respect to a source
of attraction, protruding towards it and eventually moving by balancing contractive
and adhesive forces with the surrounding matrix (Trepat et al., 2012). Furthermore, a
collective behaviour in terms of cohesiveness, permeability and mechanical cell-to-cell
signalling is also exhibited.
Overall, though, it is important to highlight how, in adult organisms, only stem
cells, fibroblasts and leukocytes preserve the ability to migrate, along with tumour
cells whose spread and metastatisation constitutes a crucial aspect of the disease
progression and ultimate lethality (Entschladen & Zanker, 2010). Similarly, as al-
ready pointed out in Section 1.2, the effective and prompt migration of leukocytes
to sources of inflammation also proves to be essential in the restoration of a healthy
state and particularly in tackling chronic inflammation, further motivating our focus
on neutrophil motility in this chapter.
5.1.1 Leukocyte motility in health and disease
The role of neutrophils in human physiology is key in a number of issues, includ-
ing in mediating the innate immune response and most prominently in leading the
inflammatory process. In particular, neutrophils constitute the front line response
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to tackling tissue injuries or pathogenic intrusions and their prompt and efficient re-
cruitment at the insulted site is central to the restoration of a healthy state. The
migrating mechanisms that regulate leukocyte motility follow the pattern described
in 5.1 but are specific in the cells’ intrinsic polarisation as well as the integrated pro-
cess of adhesion and release between front and rear cell, resulting in a characteristic
gliding motion (Entschladen & Zanker, 2010). Unlike most other cells, neutrophils
along with metastatic tumour cells, naturally exhibit the ability to move within varied
tissues. Their directed drift towards specific targets, namely sites of inflammation,
results from a number of overlapping conflicting but highly coordinated signals. The
nature and unfolding of such signals that regulate leukocyte motion is particularly
complex and still partially unclear. The network of interactions tightly controlling
neutrophils’ responsiveness is mediated by both chemicals (including growth factors,
hydrogen peroxide and cytokines) and the extracellular matrix. The latter, in partic-
ular, functions as an inhibitor of cell migration, directly acting on cells’ polarisation,
protrusion, adhesion and detachment, effectively regulating their speed. A key coun-
teraction to the promoters of leukocyte motility is provided by pro-inflammatory
mediators that, in addition to their role as the main chemoattractant, also act as
inhibitors to cell migration, once at the injured site, thus blocking neutrophils within
the inflamed tissue and ensuring high optimal concentrations of white blood cells to
efficiently neutralise sources of damage (Entschladen & Zanker, 2010).
Given the crucial role of neutrophils in the initiation, promotion and progression of
inflammation, impairments of neutrophil motility can have disruptive consequences on
the normal physiology, leading to and a number of pathologies. In particular, specific
immunodeficiency disorders arise from defects in neutrophil recruitment, typically
due to transmutations at genetic level of key receptors, as in the case of diseases such
as leukocyte adhesion deficiency, Wiskott-Aldrich syndrome and Whim syndrome,
amongst others, with patients affected by either disorder prone to frequent infections
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(Entschladen & Zanker, 2010). Chronic inflammatory diseases, including both hered-
itary and developed disorders such as Crohn’s disease, gout, arthritis, just to name
a few, while still little understood in terms of pathogenesis, are characterised by a
clear overconcentration of neutrophils within the damaged sites. As highlighted in
Chapter 1, these leukocytes further promote the pro-inflammatory activity and the
their faulty or uncontrolled up-regulation from physiological levels eventually leads
to chronic inflammation. While the broader causes that result in impaired leukocyte
motility and related diseases have been individuated, it is still challenging to gain an
exhaustive comprehension of the defective mechanisms that lead to such abnormali-
ties.
5.2 Models of collective cell movement
The relevance of cell migration in both health and disease has long motivated the
great interest of researchers in clarifying intrinsic cellular mechanisms and external
signalling activity that prompt and regulate this phenomenon. While the under-
standing of cell locomotion at the molecular level plays a key role in explaining the
chemical and mechanical response underlying cellular motion, it is the complex coor-
dination and regulation of these processes that results in the cells’ polarised motion
experimentally observed. This highlights the challenges posed by this problem, with
mathematical models providing an effective tool to help tackle this multidisciplinary
task. More specifically, cells’ persistence in motion is analysed in terms of direction
(Taylor et al., 2013). Furthermore, there is a clear understanding that in vivo and
in vitro cell migration function differently, particularly in response to chemotactic
gradients (Entschladen & Zanker, 2010), with research in this area still failing to
provide an exhaustive explanation of the signalling and mechanics that regulate cells’
collective motion (Horwitz & Webb, 2003). The mathematical modelling of such phe-
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nomena aims therefore to narrow the existing gaps in the understanding, and inform
over possible therapeutic targets to tackle impaired cell migration.
5.2.1 Previous models of cell migration
Given the centrality of cell migration in many fundamental biological processes, from
embryogenesis to the regulation of the immune system, there is great interest in
modelling this phenomenon, with research in this field focusing on capturing different
aspects of the collective motion of cells. As such, a number of valuable mathematical
models of cell motility have been proposed, providing a valuable resource in terms
modelling approaches and new insights into collective cell motion.
In their review, Camley & Rappel (2017) introduce the basics of collective cell
modelling, with distinct models capturing only a subset of these aspects, according to
each model purpose and specificity. In particular, single cells’ velocity and persistence
of motion are described in terms of stochastic differential equations, in function of
the cell’s polarity distribution, i.e. the asymmetry in the positioning of signalling
components on the cell’s surface. Similarly, a number of mathematical representations
of cells’ shape and mechanics are provided for implementation for models that aim to
capture these aspects. Among these, phase field models are introduced, with each cell
assigned a region, or phase field, and their motion described as a transition between
an inner or outer location of the field. In Camley & Rappel (2017) such transition
functions are modelled with respect to both single cells and cell-to-cell energies, while
also being straightforwardly extended to account for additional parameters such as
the phase field surface’s width and cell’s membrane bending energies. However, these
models are admittedly costly in terms of computation and are more suitable for
simulations of small numbers of cells, thus best serving models that aim to investigate
biochemical interactions and cells mechanics.
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Because of its intrinsic nature, the problem of modelling collective cell motion
is commonly tackled by accounting for individual cells as basic units. While ABMs
provide a straightforward answer in representing in an accurate and relevant way such
scenario, other approaches have also been investigated. In this regard, Palsson (2001)
proposed a 3D model of cells implementing motion in terms of change in shape and
conservation of volume. Cell types are then defined according to a set of parameters
accounting for sitffness, adhesion and locomotive force generation, adding to the flex-
ibility of the model and its suitability to describe different multicellular systems. A
cell’s orientation is configured with respect to both chemotactic gradient and their
previous location, upon a threshold value serving as tool in selecting the direction of
movement. The cell-to-cell forces exerted upon motion are also accounted for, with
adhesive and viscous forces prescribing the cell’s deformation and ultimate movement.
Simulations from the model are compared to available experimental data, successfully
replicating cells sorting and chemotactic collective motion in typical physiologic sce-
narios but lacking any extension to possible impairments and neglecting more specific
interactions at play in wound healing and embryogenetic processes. A more detailed
study of cell migration by Palsson & Othmer (2000) focusing on slime mould mo-
tion proposes an ABM investigating the cell-to-cell forces at play in collective motion
mechanisms. The model is firstly assessed with respect to adhesive forces and cellu-
lar mass surface tension in the absence of chemotaxis, subsequently analysing cells’
aggregation in response to varying configurations of chemoattractant presence and
studying the overall effect of adhesion in cells assembling and collective movement.
In particular, validating their model against experimental results, Palsson & Othmer
(2000) investigate closer aspects of cell-to-cell interactions, elucidating the cellular
deformation mechanisms that can explain cellular aggregation by individuating in
cells’ increased speed the main drive to collective rotational movements.
Schumacher et al. (2016) review modelling approaches that specifically focus on
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embryogenesis-driven cell migration, in particular with respect to neural crest cells, a
fundamental embryonic structure giving rise to different specialised cells of the periph-
eral nervous system and heart amongst others. Similarly, Maini & Baker (2014) also
assess models of collective cell motion, ranging from a classical PDE-based represen-
tation for tumour cell invasion, an agent based system for cells motility in epithelial
sheets and a hybrid model for neural crest migration. Starting from energetic con-
siderations in tumour cells metabolism, a mathematical analysis of their competitive
behaviour revealed how the invasion of cancerous cells is best described by travelling
waves, with the corresponding PDE model accounting for densities of both healthy
tissue and pathological cells, as well as concentrations of critical agents promoting
tumour invasion. Parameters were estimated from the relevant literature when avail-
able, with remaining ones tuned to capture the observed biological behaviour and
simulations predicting effective treatment strategies for reducing tissue the metas-
tatisation driven by tumour cells invasion. A model for epithelial cell migration is
also presented, with cells represented as polygons sharing edges and grouped through
common vertices. The model accounts for the assembling and positioning of such
structures, which is crucial in the later stages of embryonic development. Finally, an-
other embryogenic process is modelled in order to study the impact domain’s growth
on cells’ migration. This is achieved by coupling a PDE based model describing
concentrations of Vascular Endothelial Growth Factor (VEGF) which diffuses within
tissue and, being consumed by cells, practically acts as a chemoattractant agent; cells
are instead implemented as single agents, within a ABM framework. The model is
then tested upon different scenarios, in order to clarify cellular migratory mecha-
nisms, with the emerging result suggesting that cells at the back are responsive to
correspondent cells at the front, rather than to the chemoattractant VEGF. Fur-
ther experimental investigations confirmed this phenomenon revealing a difference in
genetic expression at the base of such behaviour.
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Neilson et al. (2011) propose a framework for modelling cell migration subject to
chemotaxis in the form of reaction-diffusion equations over evolving domains. This
approach takes into consideration the cell’s shape, with the corresponding PDE’s
solution driving the cell’s motion and morphology. The model is studied with respect
to local stimuli and the cell’s pseudopods’ response to them, with a leading pseudopod
emerging from a group of multiple competing ones. The model is further tested by
simulating a single cell movement and its repositioning upon the introduction of the
chemoattractant. The model compares well to experimental observations but does
not include any pathological scenario; furthermore the mechanical forces regulating
the cell’s crawling do not take into account adhesive interactions, with the authors
suggesting such implementation as a natural extension of their model.
Gavagnin & Yates (2018) highlight the duality between the continuum, deter-
ministic PDE-based approach and the discrete stochastic ABM one. By exposing
strengths and weaknesses of both, they review a number of relevant past models,
including those extending the analysis of collective cell movement to cell prolifera-
tion and chemotaxis. In particular, on the latter, they underline the centrality of
persistence and diffusiveness in describing these phenomena at population-level. Fur-
thermore, methodologies towards the convergence of the deterministic and stochastic
approaches are presented, by framing the diffusive behaviour typically implemented
by PDEs within the ABM paradigm.
5.2.2 Modelling motility in terms of cell walks
Computational approaches in the understanding of cell motility are widely used and
offer a straightforward tool for the analysis of experimental data and, more crucially,
for the assessment of hypotheses that would otherwise remain unexplored with the
support of in vivo measurements only. In particular, from the mathematical analysis,
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computational processing and final elaboration of such data a number of cellular walk
models have emerged and are now considered as an established part of the basic under-
standing of cell movement (Read et al., 2016). Providing a mathematical description
of directed motility is crucial in a wide range of fields, from biology to ecology; tradi-
tionally, models of motion derive from extensions of random walk processes that are
in turn based on the principles of Brownian motion, named after the botanist Brown
and his work on plants’ pollen movement (Brown, 1828). In its simplest form, a model
of movement is based on an uncorrelated and unbiased random walk, highlighting the
independence between current and past directions and the lack of a preferred direc-
tion, respectively, basically reproducing the behaviour resulting from purely diffusive
equations (Codling et al., 2008). Accordingly, persistent or correlated random walks
refer to the local directional bias of the moving object and a degree of persistence in
maintaining a direction of motion. The strength and influence of such persistence can
vary, typically modelled as decreasing in time and eventually uniformly distributed
in directions. The straightforward biological interpretation of this model of motion
is the tendency to keep moving forward, that is when memory of previous moves is
relevant in determining the following moves. Further studies by Nava-Sedeno et al.
(2017) expose the non-trivial role of persistence in affecting the cell’s motion, studying
the impact of reorientation and highlighting the dynamic non-linear effect of mem-
ory. In contrast, a biased random walk is characterised by a global directional bias,
usually implemented in terms of probabilities to move to certain preferred directions.
An obvious biological correspondent is thus motility subject to chemical gradients,
with biased random walks describing a generic chemotactic movement. The two key
features of persistence and bias can also be combined, resulting in a biased persis-
tent random walk that describes optimal neutrophil motility (Taylor et al., 2013).
The coupled effects of persistence and memory in cells’ collective motility are further
analysed by Foxman et al. (1999). In particular, they expose the role of competitive
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chemoattractant sources in guiding and diverting the cells’ motion, with the overall
direction resulting from the vectorial sum of the target orientations. In addition, a
cells’ persistent walk is also tested in contexts of biased motion, to investigate the
role of memory and its relevance upon chemotaxis. Interestingly, it is found that,
when subject to complex (multi-sourced) chemotactic fields, cells navigate through
chemoattractants sequentially, with such dynamical regulation provided by memory
(Foxman et al., 1999).
The lack of inflammatory models based on measured cell trajectories, as exposed
in the above literature review, motivates our aim in refining the ABM of Chapter 4
to calibrate the leukocytes motion upon experimental in vitro data. In particular,
we model cells moves as a regulated combination of persistence in their walk and
sensitivity to the chemotactic attractant, calibrated against the experimental data of
Sapey et al. (2011), for both healthy subjects and patients affected by COPD.
5.3 Model construction
As already outlined in the beginning of this chapter, we aim to closer investigate
leukocyte directed motility upon chemotactic gradient. Thus, we firstly start with a
preliminary model that includes one type of cell and a fixed chemoattractant gradi-
ent. The structuring details of this preliminary model are defined and analysed in
this section and later assessed with appropriate simulations. The preliminary model
for leukocyte chemotactic motion will be then plugged into the inflammatory ABM
framework presented in Chapter 4 in order to analyse the resulting enhanced model of
inflammation, with the manipulation of chemotactic-specific parameters controlling
physiologic and impaired motion of cells.
With respect to the physiological stages of inflammation, the effective migration
of leukocytes to the injured site is a key aspect of the inflammatory process, with
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faulty neutrophil recruitment or impaired chemotaxis posing a serious threat to the
restoration of the healthy state, possibly prolonging recovery time, evolving into long
term chronic inflammation or even giving rise to major pathologies (as described in
Section 1.1). Furthermore, while there is an overall understanding of the mechanisms
that regulate neutrophil motility in terms of both free movement and migration to-
wards a chemoattractant source, the cell’s response to competent signals and its
resulting directed motion still remain unclear and need further investigation (Nuzzi
et al., 2007). To this end, we build a model comprising of neutrophils subjected to a
chemoattractant source in order to provide greater detail into the fundamental mecha-
nisms of leukocytes directed motion described in the previous models of inflammation
presented in Chapters 3 and 4.
Similarly to the ABM inflammatory model in Chapter 4, we here describe the
initial assembly of an agent based framework to characterise the basic chemotactic
interactions between a group of cells and a chemical acting as attractant. A such, two
main variables are individuated: neutrophils, described in class Cell and chemical
mediators acting as a chemoattractant source and characterised in class Environment,
purposely recalling the class of the same name of the inflammatory model of the
previous chapter. The preliminary model has a minimal setup, with the main focus
being on providing an accurate characterisation of cells’ chemotactic motion.
5.3.1 Domain and initial conditions
As is evident by comparing Figure 4.3, which illustrates the structure of the ABM-
based inflammation model of Chapter 4, to Figure 5.1 it is evident how the system
we aim to model here focuses on a subsection of the interactions described in previ-
ous chapters, particularly characterising with greater detail the motion of neutrophils
upon a variety of different stimuli, in order to simulate both physiological and im-
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Figure 5.1: Flow chart representing the preliminary ABM of chemotaxis and illus-
trating the cyclic chain of actions with respect to the tick count. Green triangles
represent thresholds, diamonds represent decision points.
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paired motility of these cells. We retain the framework from the previous ABM, with
the model’s agents referred through both a grid with relative coordinates and neigh-
bourhood considerations and a continuous space for visualisation purposes. Further-
more, our agents’ actions (i.e. the system’s variables), namely Cell and Environment
will be defined according to their state at each tick t.
The formal setting of the chemotactic preliminary model follows the same struc-
ture of the ABM inflammatory model of Chapter 4 in terms of domain. In particular,
we study the chemotactic motion of agents over a squared domain subject to periodic
boundary conditions, initialising the system with a fixed number of cells ncells and a
constant gradient of mediators. Mediators’ distribution is uniformly localised at the
top border of the squared domain with concentration Achem, with a linear decreasing
gradient toward the bottom of the domain.
5.3.2 Modelling chemotaxis
In order to take into account the main considerations about neutrophil motility, as
outlined in Section 5.1, we model the motion of leukocytes as a combination of random
walks: a biased walk, towards a chemoattractant source, and a persistent walk, with
cells exhibiting memory properties that preserve past directions (Albrecht & Petty,
1998). By combining these different behaviours, we aim to model a biased persistent
random walk, as experimentally shown by Taylor et al. (2013). To this end, we
structure a joint probability pchem describing a cell’s likelihood to move from its
current position to a neighbouring one as a combination of both the surrounding
mediator concentrations (pgrad, taking into account the biased component of the walk)
and the agent’s previous position (pmem, modelling the persistence in walk), with
pchem “ pgrad ¨ pmem being the resulting probability.
The specifics of each cell’s behaviour are defined at each tick, upon which the
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agent’s move is modelled in terms of either a chemotactic motion or a random one.
Firstly, the source global concentration in the cell’s neighbourhood is sensed and
compared against a parameter βrand identifying a threshold for the directed motion
to happen. For concentrations smaller than the threshold βrand, the cells will simply
move randomly to a neighbouring position. Upon concentrations equal to or exceed-
ing βrand, the cell will instead proceed to move chemotactically. The agent is thus
set to move to a direction according to a combined probability of the surrounding
concentration gradient and the cell’s previous move. To provide greater flexibility in
tuning the balance between the effects of chemoattractant gradient and cell mem-
ory, for cell i with neighbourhood Ni, we apply a weighting function wpcjq to the
chemoattractant concentrations at all positions j P Ni. For each position j P Ni, the










Here, we consider the exponential weighting function:
wpckq “ ekgradck , (5.2)
with scaling parameter kgrad. The weighting function is thus assessed against each of
the eight neighbouring positions of cell i, as illustrated in Figure 5.2.
In terms of a cell’s memory, agents of the system are embedded with the record
of their previous move, serving as record for the direction from which a cell is com-
ing. This information thus identifies one of the eight possible previous points of
origin, as illustrated in Figure 5.3. The probability associated with the cell’s memory
(pmem) follows a gaussian distribution, with the strongest likelihood associated with
the preservation of direction. The likelihood of other directions are directly controlled
through the parameter σmem, referring to the standard deviation of the probability
distribution associated to the eight possible points the cell can move to and with mean
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Figure 5.2: Graphic representation of chemoattractant concentration at each cell’s
neighbouring position. The mediator’s concentration ci at the cell’s location i and
the neighbouring concentrations cj , j “ 1, . . . , 8 are the arguments of the weighting
function w, as defined in (5.2).
Figure 5.3: Graphic representation of cell’s embedded record of its previous move with
respect to its Moore’s neighbourhood. The likelihood of the cell’s next move depend
on its previous position, with the two neighbouring positions from the origin being
the least likely (in red), followed by the side positions with an increased likelihood
(in orange) and the furthest ones with maximum likelihood (in green).
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equal to the angle θprev, representing the information enclosed in the agent’s track
record of its previous position. Thus, the probability of cell i with neighbourhood
Ni to move with direction prescribed by the angle θj , j “ 1, . . . , 8 given its previous














where K is a normalising constant that ensures probabilities sum to one. Finally, we











determines the cell’s new position.
Here, we consider that cells do not die, with the initial (and fixed) number of
cells determined through parameter ncell instead. This, though, is coherent with
the purposes of this new chemotactic model in which the interactions of interest are
studied on a shorter timescale, with particular focus on the nature of cells’ movement
rather than the mechanisms analysed in the previous chapter. Furthermore, another
parameter nrun is introduced, regulating the number of times per tick the agents
update their state. This parameter is modulated from the Sapey et al. (2011) paper,
in which neutrophil motions upon different healthy and non-healthy scenarios are
studied. In particular, the experimental work presented by the authors highlights how
in specific pathological circumstances, affected neutrophils present a more disordered,
yet quicker, motion. This data shows that, when compared to healthy scenarios,
while there is an increase in the overall non-directed speed of cells, the velocity in
approaching the chemotactic target is significantly reduced. Thus, the parameter nrun
allows to control the switch between a physiological and non-healthy scenario.
The modelling of chemical mediators acting as the chemoattractant source for
leukocytes, while having an analogous setup to the corresponding class of the model
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Parameter Definition Class Standard value
ncell number of neutrophils ChemotaxisBuilder 10
Achem maximum concentration of chemoattractant ChemotaxisBuilder 1
nrun number of moves per tick Cell 1
βrand threshold minimum concentration of chemoattractant
for chemotactic motion
Cell 0.001
σmem standard deviation of likelihood of positions within the
cell’s Moore’s neighbourhood with gaussian distribution
Cell
kgrad scaling parameter appearing in the weighting function
of (5.2)
Cell
Table 5.1: Parameters of the ABM chemotaxis model.
in Chapter 4, presents significant differences in terms of features. In particular, in
this case we do not differentiate between pro- and anti-inflammatory mediators, since
the main focus in this model is the cells’ chemotactic behaviour, rather than the
nature of the chemoattractant source. Similarly, the mediators’ intrinsic ability to
diffuse and decay is here neglected, in favour of a linear gradient of concentration
proportional to a fixed parameter Achem, as outlined in Section 5.3.1. Similarly, kgrad,
βrand and σmem are identified in order to qualitatively reproduce the physiological
motion of neutrophils described in Albrecht & Petty (1998) and Taylor et al. (2013).
In particular, the specific choice of values for parameters σmem and kgrad is crucial
in defining the chemotactic movement of leukocytes as a biased persistent random
walked, as observed experimentally (Taylor et al., 2013; Jones et al., 2015). Table 5.1
summarises the model’s parameters, providing standard values for all parameters
except kgrad and σmem, which we discuss below.
Figure 5.4 illustrates the role of parameter σmem in calibrating the cells’ motion.
The value σmem “ 1.75, for example, (as detailed in Figure 5.4b) ensures that pro-
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gressing in the broader direction set by θprev, that is allowing a maximum shift of ˘π4
radians from the cell’s previous position, is 54.51% likely, while shifts of π
2
radians are
25.94% likely and backwards motion (shifts greater than 3
4
π radians) has a likelihood
of only 19.55%. The study of the combined effect of both persistence and bias in
the cells’ movement is presented in Figure 5.5, which shows different motion profiles
obtained by varying both σmem and kgrad. Value ranges are chosen as to illustrate
extreme and intermediate behaviours, with σmem “ 0.1 implying that the direction
consistent with the cell’s θprev property is picked with probability p
mem “ 1, effectively
forcing the cell to never change direction, regardless of the concentration gradient, or,
on the other hand, σmem “ 10 cancelling the effects of persistence on cells’ motion,
with all directions prescribed by pmem being equally likely, thus selecting the point
to move to with respect to the gradient only. Conversely, by varying kgrad between
kgrad “ 1 and kgrad “ 80, we gradually strengthen the response to the attractant. We
describe the manner in which we can select appropriate choices of kgrad and σmem,
given suitable experimental data, in the following section.
5.4 Comparison with experimental data
Defects in neutrophil recruitment result in a delayed progression of inflammation, po-
tentially preventing the restoration of a healthy state and leading the way to diseases
(as described in 5.1.1). Understanding the conditions that prevent the correct mi-
gration of leukocytes to the sources of damage upon an inflammatory event is key to
developing effective therapeutic tools, in order to contain and eventually tackle such
disorders. The model developed in Section 5.3 is purposefully articulated with respect
to different parameters in order to take into account a wide spectre of leukocyte be-
haviour, ranging from a healthy physiological chemotactic motion to different impair-
ments in motility due to specific disorders. One of such pathological conditions that
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(a) σmem “ 0.1
















(b) σmem “ 1.75
















(c) σmem “ 10
Figure 5.4: Probability distribution of (5.3) for different values of the standard devi-
ation σmem.








































































(i) σmem “ 10, kgrad “ 80
Figure 5.5: Tracking of cell motion from t “ 0 to t “ 1000 (initial and final positions
marked with black circles and black crosses respectively) for varying choices of σmem
and kgrad. The number of cells per simulation is fixed at ncell “ 1, with all other
parameters as in Table 5.1.
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we aim here to replicate, in order to provide both an in silico correspondent to existing
experimental observations and eventually a tool to capture intrinsic aspects that are
missed in in vivo studies is COPD. COPD is a complex inflammatory disease charac-
terised by both airflow limitations and extrapulmonary systemic manifestations. It is
currently individuated as the third global cause of death worldwide (WHO, 2018) and
is usually associated with a number of comorbidities that further complicate its treat-
ment and management, while also constituting an important burden in terms of both
cost and resources to healthcare services globally (Barnes & Celli, 2009; Mannino &
Buist, 2007). COPD develops from systemic persistent low level inflammation, with
increased concentrations of leukocytes and pro-inflammatory mediators playing a key
role in preserving and pathologically prolonging the inflammatory state (Agusti et al.,
2012). The initiating causes that can trigger such an inflammatory state are varied
and sometimes unclear, although mainly environmental (smoking, occupational and
air pollution, ageing) and, to a minor degree, genetic factors are all distinctive fea-
tures that are known to pose great risk in the development of this condition (Mannino
& Buist, 2007). The relevance and great impact of COPD on morbidities worldwide
motivates the interest of researchers in investigating this condition with a particu-
lar focus on the wide spectrum of comorbidities and phenotypes that characterise it
as well as the underlying biological mechanisms at tissue level that express typical
inflammatory patterns. Concentrating on this latter aspect, Sapey et al. (2011) de-
termine and highlight the impairments in neutrophil migration suffered from subjects
affected by COPD, by investigating through experimental observations and analyses
the cells’ chemotactic motion with respect to selected case studies, namely healthy
non-smoking subjects, healthy smokers, subjects genetically prone to develop COPD
and finally subjects already affected by COPD. The results provided by this research
allow us to effectively introduce defects and impairments of the cells’ chemotaxis to
our ABM preliminary model, by carefully calibrating the parameters of Table 5.1 in
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order to capture the relevant changes in neutrophil motility exposed by Sapey et al.
(2011). In their study, Sapey et al. (2011) monitor neutrophils of both COPD af-
fected subjects and control groups through videomicroscopy, tracking ten randomly
chosen cells over time upon a fixed concentration of chemoattractant. As part of the
migration assessment different measures are recorded, including speed cell of move-
ment (indicating the movement in any given direction), cell velocity (in the direction
of the chemoattractant) and a chemotactic index, which measures the cells’ mean
orientation with respect to the chemical gradient. Interestingly, results from this ex-
perimental work showed that neutrophils in COPD-affected subjects exhibit greater
overall speed compared to healthy subjects, while the cells’ directed chemotactically-
driven velocity is also considerably reduced, with a significantly smaller chemotactic
index as well.
5.4.1 Nondimensionalisation
The implications stemming from defective neutrophil chemotaxis in connection to
inflammatory diseases and more specifically to COPD, as exposed in Sapey et al.
(2011), motivate our aim in linking up the preliminary ABM chemotactic model to
experimental in vitro data. This allows for a more in depth investigation of the role
of leukocyte directed motion in the acute inflammatory response in terms of the cells’
spatial localisation, which will be explored in the following sections with the analysis
of a new joint ABM of inflammation and chemotaxis.
In order to compare results from Sapey et al. (2011) and our ABM chemotaxis
framework, we introduce a nondimensionalisation of the model presented in Sec-
tion 5.3, tailored upon the authors’ experimental setup. In particular, by choosing
to set each grid space to correspond to 1µm and given that the in vitro chemotactic
chamber in which neutrophils are tracked measures 240µm ˆ 180µm, we consider
5.4. COMPARISON WITH EXPERIMENTAL DATA 208
a 240 ˆ 180 rectangular grid as our domain. The recorded speeds of neutrophils in
both healthy and COPD affected subjects are available from Sapey et al. (2011), with
the former group registering an average motion of 3.77µm min´1 and the latter pre-
senting neutrophils moving significantly faster at 5.12µm min´1 but, crucially, with
a decreased sensitivity to the chemotactic target. We derive a timescale fitting the
experimental data in which each tick corresponds to 20 s, and allow cells to move a
suitable number of times per tick in a healthy physiological scenario, as prescribed
by parameter nrun, whose value is calibrated to the available cell velocity data as il-
lustrated in the following section. In the following sections we calculate the expected
distance travelled.
5.4.2 Calibration against experimental data
We incorporate the analysis provided in the previous sections into our model by
analytically computing the expected number of moves and chemotactic index for any
given combination of chemotactic strength kgrad and walk persistence σmem.
The evaluation of the parameter values, based on the nondimensionalisation of
Section 5.4.1, is structured upon a mathematical fitting of our preliminary model
setup to the experimental data. In particular, Sapey et al. (2011) analyse their re-
sults with respect to cell speed s (measuring movement in any direction), cell velocity
v (speed towards the chemoattractant) and chemotactic index Ichem (measuring cells’
accuracy in chemotaxis as the cosine of the angle between the cell’s direction and the
chemotactic gradient’s orientation). We consider these indicators of the chemotactic
efficacy into our calculations to compare it to the experimental observations reported
in Sapey et al. (2011). The resulting set of pairs of pσmem, kgradq that satisfy the
constraint given by the cell velocity v is then narrowed by allowing only those com-
binations that provide a suitable value of the chemotactic index Ichem, also reported
5.4. COMPARISON WITH EXPERIMENTAL DATA 209
in Sapey et al. (2011). Finally, we prescribe a value for parameter nrun by fitting the
experimental data about the total distance travelled by cells recorded over a span of
t “ 20 minutes in terms of the number of moves per tick.
Let us consider a cell’s walk in terms of its global motion over a given span of time,
its recorded cell velocity and the corresponding chemotactic index. By decomposing
such a trajectory into single moves of an agent over gridspaces, let us define mk as
the kth move of a cell. We are thus interested in the probability of the cell to pick
move mk, from the eight possible moves of Figure 5.3, given its previous move mk´1.
We define a transition matrix, P, such that, at move k, pi,j represents the probability
that the kth move is move j given that the pk ´ 1qth move was move i; i.e.
pi,j “ P pmk “ j |mk´1 “ iq , i, j “ 1, . . . , 8 . (5.5)


















As described in Section 5.3.2, agents are initialised with a randomly assigned direc-
tion of origin, while at subsequent iterations the dependence of the selection of the
future move given the previous one is according to probability (5.4). Thus, the initial





















At each stage, represented by movemk, with k “ 1, . . . , n, the statistical description of
a cell’s motion is described by the Markov chain defined by the transition probability
P and the initial data Π0. Given this initial data, the probability that the kth move
is move i is given by
P pmk “ iq “ pΠ0 ¨ Pkqi , i “ 1, . . . , 8 . (5.8)
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Let us now define a new matrtix Q such that
qi,k “ P pmk “ iq , (5.9)
with the right-hand side of (5.9) being computed according to (5.8). Given this
















Given a target cell velocity, we can infer an expected distance of travel from the
experimental data, and by comparing this with (5.10), we prescribe the total number
of moves to be carried out within a given simulation. This effectively prescribes the
parameter nrun in our model, holding fixed the required number of ticks.
Similarly, for each possible move i, let us construct a vector α such that αi is the































Integrating the data available from Sapey et al. (2011), which is summarised in
Table 5.2, we are able to tune the parameters kgrad and σmem to values that fit the
measured cells’ velocity v and chemotactic index Ichem. Furthermore, our computation
yields the total number of moves required to match the recorded v and Ichem for each
suitable pair of pkgrad, σmemq identified.
Figure 5.6 illustrates values of the predicted mean chemotactic index resulting
from a range of combinations of possible parameter values kgrad and σmem. While
initially investigated on a larger scale, the range is here narrowed to sensible choices
of these two key parameters, in accordance to the results derived in Section 5.3.2,
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Measure Physiological chemotaxis COPD-affected chemotaxis
s rµmmin´1s 3.77 5.12
v rµmmin´1s 2.14 0.09
Ichem 0.39 0.04
Table 5.2: Measured data during studies of neutrophils’ migration upon chemotactic
gradient, as reported in Sapey et al. (2011).

















Figure 5.6: Map of values of the predicted mean chemotactic index Ichem correspond-
ing to combined values of parameters kgrad and σmem. The black curve highlights the
subset of parametric combinations that correspond to the physiologic chemotactic
index Ichem “ 0.39, as reported in Sapey et al. (2011).
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with kgrad P r50, 100s and σmem P r0.1, 2s. To fit the available data to our model, the
parameters kgrad and σmem are calibrated to the corresponding physiological chemo-
tactic index, that is Ichem “ 0.39, which is also highlighted in black in Figure 5.6.
Thus, any pair of values pkgrad, σmemq sitting on that curve, satisfy the chemotactic
index and cell velocity requirements. We choose kgrad “ 80 and σmem “ 1 to illustrate
the behaviour. Since such combination fits a number of total moves of n “ 160 and
given that each tick corresponds to 20 s, as per the nondimensionalisation presented
in the previous Section 5.4.1, we prescribe for each agent a number of moves per tick
of nrun “ 3.
With an analogous approach, the chemotactic parameters kgrad and σmem are
also fitted against the data arising from COPD-affected neutrophils. In particular,
as reported in the second column of Table 5.2, the chemotactic strength kgrad and
the cells’ persistence regulated by σmem are set in accordance to an increase in the
overall undirected speed of motion s and a sharp decrease in the chemotactic index
Ichem. The resulting map of parameter combinations fitting the measured data is
shown in Figure 5.7 from which kgrad “ 8 and σmem “ 1.2 emerge as suitable choices.
Furthermore, as already pointed out in Section 5.4.1, in line with the results of Sapey
et al. (2011), we allow COPD-affected cells to move twice as fast as the healthy cells,
thus setting updating the value of parameter nrun controlling the number of moves
per tick to nrun “ 6. The set of parameter values characterising both physiological
and pathological chemotaxis is outlined in Table 5.3.
By initialiasing our chemotactic model with the parameter values informed by
the calibration to the data available in Sapey et al. (2011), we are able to fully
assess its efficacy and reliability in describing both healthy and pathological chemo-
taxis. Figure 5.8 shows tracks of neutrophil chemotactic motion from both in vitro
and in silico results. The experimental study conducted by Sapey et al. (2011) fo-
cused on analysing neutrophil chemotaxis from varied groups of individuals, partic-
5.4. COMPARISON WITH EXPERIMENTAL DATA 213

















Figure 5.7: Map of values of the expected mean chemotactic index Ichem corresponding
to combined values of parameters kgrad and σmem. The black curve highlights the
subset of parametric combinations that correspond to the physiologic chemotactic
index Ichem “ 0.04, as reported in Sapey et al. (2011).
Parameter Definition Standard physiologic value Updated value
nrun number of iterations at each tick t 3 6
σmem standard deviation of likelihood of positions within the
cell’s Moore’s neighbourhood with gaussian distribution
1 1.2
kgrad rate parameter of likelihood of positions within the cell’s
Moore’s neighbourhood with exponential distribution
80 8
Table 5.3: Updated values for parameters of the ABM chemotactically impaired
model. All other parameters retain the values listed in Table 5.1.
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ularly healthy, never-smoking subjects and COPD-affected patients amongst others,
by recording through videomicroscopy 10 randomly chosen cells for a duration of
20 minutes. Neutrophils were subject to a chemotactic source directed top to bot-
tom, with paths and directions indicated by white arrows (Figures 5.8a and 5.8c).
Similarly, our simulations monitor 10 cells at time, for a duration of t “ 60 ticks
(Figures 5.8b and 5.8d). As emerging from both experimental results and model sim-
ulations, in healthy scenarios, neutrophils are able to quickly orientate towards the
chemoattractant and move smoothly towards it (Figures 5.8a and 5.8b). Conversely,
COPD-lead defective neutrophil motion results in significant impairments delaying
the cells’ ability to promptly direct themselves according to the chemotactic signal.
The faulty responsiveness of COPD-affected neutrophils to the chemoattractant dis-
rupts the correct recruitment of leukocytes, enhancing the inflammatory mechanisms
towards uncontrolled, eventually pathological, levels. In addition to the qualitative
validation of the ABM against the experimental results of Sapey et al. (2011) detailed
in Figure 5.8, with comparable cell trajectories in both healthy and diseased cases, our
agent-based model matches the in vitro data also in terms of the quantitative differ-
ences arising from the analysis of control and COPD-affected subjects. In particular,
in correspondence to the increase in undirected speed, sharp decrease in oriented mo-
tion and chemotactic inefficiency quantified by Sapey et al. (2011) in COPD-affected
neutrophils, our model exhibits also a significant decrease in the value of parameter
kgrad, responsible for the cells orientation. It is also interesting to observe how pa-
rameter σmem, reflecting the persistence of cells’ walk, plays a key role in controlling
healthy chemotaxis, while, as highlighted in Figure 5.7, the COPD case is largely
insensitive to σmem. The agent-based model’s ability to retain the typical features
in terms of behaviour of migrating cells in varying scenarios and its tuning through
parameters experimentally measurable and of biological significance is a key point in
the validation and effectiveness of this model and leads towards further investigations
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in the role of chemotaxis as a point of control and regulation of inflammatory events
through this novel approach.
5.4.3 Discussion
Physiological neutrophil motility
The effectiveness of the modelled neutrophil motility, implemented as described in
Section 5.3.2, is evaluated with respect to the qualitative behaviour of cells exhibit-
ing a biased persistent walk, as first described in Section 5.2.2. These results in
particular show how such characteristic cellular walk is implemented for each cell,
by balancing the effects of both parameters kgrad and σmem, controlling bias and
persistence respectively, effectively modelling the chemotactic migration described in
Figure 5.5f, calibrated to the data inferred from Sapey et al. (2011).
In conclusion, through the parameter kgrad we are able to control the chemotactic
behaviour of cells in our ABM. The effectiveness of this parameter directly depends on
the maximum concentration of mediators Achem (located at the top of the domain and
linearly decreasing to the bottom), while also being bound to the parameter account-
ing for the persistence in cells’ random walk, ie σmem. With this regard, we provide
values for kgrad and σmem such that the combined probability pchem “ pgrad ¨ pmemory
reflects balanced weights for contributions of both bias and persistence of cells’ mo-
tion. Such tuning of parameters effectively models an ideal healthy scenario, inferred
from experimental observations investigated by a number of researchers, in particular
by Foxman et al. (1999) and Taylor et al. (2013) showing the dual conflicting nature
between memory and gradient in leukocyte chemotactic motion, and by Sarris et al.
(2012) with respect to chemical gradients actually limiting leukocyte motility once
the cells reach the chemoattractant source. While this setting successfully replicates
the healthy behaviour exhibited by leukocytes as analysed by Khandoga et al. (2009),
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(a) Healthy in vitro neutrophils





(b) Healthy in silico neutrophils
(c) COPD in vitro neutrophils





(d) COPD in silico neutrophils
Figure 5.8: Comparison between experimental results from Sapey et al. (2011) (left
column) and simulations from the ABM, with final tick at t “ 60 (right column).
Neutrophils are tracked both in a healthy scenario (first row, ABM parameters as
in third column of Table 5.3) and a pathological (COPD) one (second row, ABM
parameters updated as in fourth column of Table 5.3).
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Sapey et al. (2011) and Jones et al. (2015), overall confirming the in vivo results pre-
sented by these researchers, we will now focus on impaired neutrophil motility, at
the base of many pathologic conditions, as described in 5.1.1, analysing the results
provided by an accurate manipulation of the model’s parameters.
Impaired neutrophil motility
With respect to our preliminary model, in order to accurately take into account the
qualitative and quantitative changes in leukocyte migration of COPD-affected sub-
jects compared to healthy ones, we focus on three main parameters that provide a
switch from a physiological scenario of efficient neutrophil chemotaxis to a patholog-
ical one: namely kgrad, σmem and nrun. Manipulation of parameter nrun serves to
reflect the increased undirected speed of impaired neutrophils as reported in Sapey
et al. (2011), to preserve consistency with simulations in Section 5.4.2, with changes
in the value of nrun not affecting the system’s behaviour. The parameter kgrad is
considerably decreased to model the loss of accuracy in the cells’ chemotactic motion,
thus serving as a correspondent to the chemotactic index computed in Sapey et al.
(2011) study. In particular, the choice for kgrad in this setting directly takes into
account the tuning provided in Section 5.4.2, by purposefully choosing kgrad “ 8 to
correspond to the behaviour described in Figure 5.8d. Here, the chemotactic direc-
tioning is less accurate compared to the nominal healthy scenario of Figure 5.8b when
kgrad “ 80, as employed instead in calibration of Section 5.4.2. Finally σmem is also
updated in order to effectively model the cells’ impairment in sensing the chemotactic
signal typical of pathological conditions and exhibiting a stronger persistence in their
directed walk as a result. Thus, the correction introduced in σmem deregulates the
cells’ chemotactic behaviour.
Upon pathological impairments, while cells preserve the overall tendency to move
chemotactically, their migration is defective and highly inefficient. In particular a
5.5. AN ENHANCED INFLAMMATORY MODEL 218
fraction of cells do not eventually reach the chemotactic target, while the neutrophils
that successfully reach and stay within higher concentrations of mediators do so
through a much less smoother path, compared to cells migrating in physiological
conditions (Figure 5.8d).
The biological consequences of such inefficiencies in cells’ motility are multiple
and severely disruptive of the inflammatory process, which in itself opens the way
to further complications, as exposed in Section 1.1. The switch from physiological
to pathological chemotaxis provided by this model by simply adjusting few key pa-
rameters highlights the high sensitivity of cells’ behaviour to their microenvironment.
Furthermore, the sets of results this model yields also suggest that neutrophils retain
their chemotaxis ability in terms of persistent biased random walk even in patho-
logical conditions such as the ones typically prescribed by COPD, with the overall
impairment in their migration being subject to greater randomness in direction, at
the expenses of bias towards mediators.
5.5 An enhanced inflammatory model
In order to investigate inflammatory mechanisms more thoroughly and to assess the
full impact that chemotaxis has on the resolution of inflammation, we integrate the
chemotactic model developed in the previous sections into the model of Chapter 4. In
particular, our aim is to assess the inflammatory outcomes arising from refined mod-
elling of the chemotactic motion of populations of neutrophils and macrophages with
respect to the analysis presented in Section 4.4, where only an elementary version of
the cells’ chemotaxis was implemented. The resulting new ABM retains the structure
and all functionalities of the model of Chapter 4. Additionally, with the inclusion
of the improved chemotaxis of cells toward pro-inflammatory mediators, the working
scheme of the model is updated to Figure 5.9, where the new chemotactic parameters
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are also highlighted.
Figures 4.3–4.6 remain accurate in the description of the new chemotactically en-
hanced ABM of inflammation. Initialisation and parametrisation of the new model are
also inherited from the ABM of Chapter 4. We therefore prescribe an initial damage
modelled through a circular concentration of pro-inflammatory mediators centred in
a square domain. Parameters retain their scaling with respect to the unitary amount
δac of pro-inflammatory mediators released by apoptotic neutrophils upon their necro-
sis, with all the considerations highlighted in Section 4.3 remaining valid. Finally, by
describing the leukocytes’ motion with higher accuracy, we introduce the two subsets
of parameters modelling the neutrophil and macrophage chemotaxis respectively, as
detailed in Table 5.4. In particular, when subject to standard physiological chemo-
taxis and in line with the parametrisation in Chapter 4, we consider neutrophils
moving twice per tick, compared to macrophages moving only once per tick, with
each tick being equivalent to one minute. Conversely, as inferred by the calibration of
Section 5.4.2, in specific pathological conditions such as COPD, neutrophils’ chemo-
taxis is affected and exhibits a greater undirected speed of motion. To reflect this,
we prescribe a set of chemotactic parameter values controlling neutrophils’ motion in
disease accordingly.
With the new inflammation model outlined as above, we investigate the impact
of chemotaxis on the mechanisms controlling the resolution of inflammation. In par-
ticular, we study a set of scenarios of biological interest by integrating an effectively
regulated chemotaxis of neutrophils and macrophages toward pro-inflammatory me-
diators. In particular, we will assess expected chronic outcomes, as outlined by the
model in Chapter 4, against both healthy and impaired chemotaxis. We will further
analyse the efficacy of leukocytes’ chemotaxis upon expected healthy outcomes, thus
exposing the essential contribution of cells’ directed motility in resolving inflamma-
tion.
5.5. AN ENHANCED INFLAMMATORY MODEL 220
Figure 5.9: Schematic diagram representing the ABM of inflammation with im-
proved chemotaxis and illustrating the constituent interactions between populations
of healthy neutrophils, apoptotic neutrophils and macrophages, modelled as agents,
in response to pro- and anti-inflammatory mediators, modelled through PDEs. In-
teractions are shown by arrows and can be in turn regulated by parameters. Param-
eters are differentiated by colour and refer to probabilities in red, increments in blue,
thresholds in green, with PDE parameters in black. Newly introduced chemotactic
parameters are in purple.
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Parameter Definition Standard physiological value Pathological value
nrun number of neutrophil iterations at each tick t 2 4
σmemn standard deviation of likelihood of positions within the neutrophil’s
Moore’s neighbourhood with gaussian distribution
1 1.2
kgradn rate parameter of likelihood of positions within the neutrophil’s
Moore’s neighbourhood with exponential distribution
80 8
mrun number of macrophage iterations at each tick t 1 1
σmemm standard deviation of likelihood of positions within the
macrophage’s Moore’s neighbourhood with gaussian distribution
1 1
kgradm rate parameter of likelihood of positions within the macrophage’s
Moore’s neighbourhood with exponential distribution
80 80
Table 5.4: Values for chemotactic parameters, with neutrophils’ chemotaxis being
affected in disease as inferred from Sapey et al. (2011) and reported in the fourth
column.
5.5.1 Impaired chemotaxis
We firstly analyse the effects that more refined modelling of chemotaxis have on pre-
viously chronic outcomes. By doing so, we initialise our model of inflammation with
the set of parameter values given by the second column of Table 4.4, combining these
with compromised chemotactic motion of neutrophils, as set out in the fourth column
of Table 5.4. The results of this simulation are shown in Figure 5.10, which confirms
that the previously chronic outcome of Figure 4.8 remains chronic given pathological
choices of chemotaxis parameters here. This is an intuitive result, since taking the
limit of small kgrad in the model of Section 5.3 qualitatively recovers the chemotaxis
model of Chapter 4, provided that σmem is of Op1q or larger. Given the calibration
exercise of Section 5.4, we could regard the chemotaxis model of Chapter 4 as an
accurate model of chemotactically impaired neutrophils in the context of an inflam-
matory condition (such as COPD); however, there is potential scope for the model
of Chapter 4 to omit some healthy outcomes in which resolution is heavily reliant on
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efficient chemotaxis of leukocytes. We examine this further below. This result is of
particular interest in highlighting the versatility of the original inflammatory system
of Chapter 4, which in its current extended version reaches the scope of successfully
modelling prominent inflammatory pathologies affecting neutrophils, such as COPD.
5.5.2 Healthy chemotaxis
Healthy inflammatory outcomes
With the aim of investigating the role of chemotaxis in the effectiveness of inflamma-
tory models, we analyse possible changes in the outcome of the acute inflammatory
response upon chemotactically enhanced motion of leukocytes. In particular, we con-
figure our enhanced model with inflammatory parameters that, in the absence of
refined chemotactic mechanisms, would lead to chronic inflammation, while keep-
ing the chemotactic parameters that prescribe physiological cell motility, as in the
third column of Table 5.4. Interestingly, as shown in Figure 5.11, integrating an
enhanced description of cellular chemotaxis into the model significantly changes the
inflammatory outcome, prompting the restoration of the healthy state. This rein-
forces the key role of chemotaxis in inflammatory mechanisms and exhibits it as an
additional therapeutic target that could not be otherwise captured by the previous
model of Chapter 4. As a comparison with the inflammatory model of Chapter 4,
its equivalents parameteric configuration, represented in Figure 4.7, where only basic
chemotactic mechanisms are modelled, results in a perpetual state of inflammation.
Furthermore, it is of interest to observe the spatial configuration of cells at different
stages of the inflammatory response. While the central localisation of the initial dam-
age immediately attracts both macrophages and neutrophils at the site of injury, the
former group of cells remains chemotactically anchored to higher concentrations of
pro-inflammatory mediators and, upon phagocytosing nearby apoptotic neutrophils,
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(a) Active neutrophils. (b) Apoptotic neutrophils.
(c) Macrophages. (d) Pro-inflammatory mediators.
(e) Anti-inflammatory mediators.
Figure 5.10: Plots for the ABM corresponding to the average results of the batch of
100 simulations, with inflammatory parameters as in the second column of Table 4.4
and chemotactic parameters as in the fourth column of Table 5.4. Shades around the
plots represent standard deviations.
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starts releasing anti-inflammatory mediators. This in turn inhibits the local recruit-
ment of new neutrophils, with existing neutrophils moving chemotactically towards
diffusing concentrations of pro-inflammatory mediators. After such initial patterning
of different cells, homogeneous levels of pro-inflammatory mediators across the tissue
prompt the redistribution of leukocytes, with apoptotic neutrophils eventually cleared
and macrophages leaving upon the resolution of inflammation.
To further highlight the effects of taking into account more refined chemotactic
mechanisms in the modelling of the inflammatory response, Figure 5.12 shows the
overlapped timecourses corresponding to Figures 5.10 and 4.7. In particular, it is
evident how defects in the cells’ ability to sense the chemoattractant and move to-
wards it accordingly is a crucial aspect in the effectiveness of the immune response.
With respect to our model, this mechanism is controlled by parameter kgrad, through
manipulation of which we can effectively model both physiological inflammatory re-
sponses (solid coloured lines) or pathological inflammatory conditions, such as COPD
(grey dashed lines).
It is also of interest to assess the new enhanced model of inflammation in sce-
narios where the more basic model of Chapter 4 was already delivering a healthy
outcome. To this end, we consider the sets of parameter values provided in Ta-
ble 4.4 highlighting the inflammatory mechanisms that shift the system’s outcome
from chronic to healthy. The key parameters individuated in Chapter 4 providing a
switch from chronic to healthy outcomes, namely c0 and r controlling the initial dam-
age and αncr, αngr and αmr regulating the leukocytes’ recruitment, are now evaluated
in the context of the improved implementation of healthy chemotaxis. Figure 5.13
shows the results of these simulations, overlaid with the corresponding results from
Figure 4.10. In particular, the plots illustrated in Figure 5.13 focus on the global
count of cells, throughout a timespan of 5000 ticks. As already discussed in Sec-
tion 4.4.2, manipulation of the key inflammatory parameters provides a switch from
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Figure 5.11: Simulation of the ABM running from t “ 0 (upper left corner) to
t “ 5000 (bottom right corner), with inflammatory parameters as in the second
column of Table 4.4 and chemotactic parameters as in the third column of Table 5.4.
Macrophages are represented with blue circles, active neutrophils with green triangles
and apoptotic neutrophils with orange triangles.
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(a) Active neutrophils. (b) Apoptotic neutrophils.
(c) Macrophages. (d) Pro-inflammatory mediators.
(e) Anti-inflammatory mediators.
Figure 5.12: Plots for the ABM corresponding to the average results of the batch
of 100 simulations, with healthy outcomes in solid coloured lines (chemotactic pa-
rameters as in the third column of Table 5.4) and pathological ones in dashed grey
lines (chemotactic parameters as in the fourth column of Table 5.4). All other pa-
rameters are as in the second column of Table 4.4. Threshold values on pro- and
anti-inflammatory mediators controlling the recruitment of cells are plotted as dot-
ted (αngr and αncr) and dotted (αmr) lines, respectively. Shades around the plots
represent standard deviations.
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(a) c0 “ 0.5.














(b) r “ 5.














(c) αncr “ 0.1.














(d) αngr “ 0.0015.














(e) αmr “ 0.05.
Figure 5.13: Plots for the ABMs with basic (dashed lines) and enhanced (solid
lines) models of chemotaxis, with inflammatory parameters as in the third to seventh
columns of Table 4.4 (for plots (a) to (e), respectively) and chemotactic parameters
as in the third column of Table 5.4.
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previously chronic outcomes to healthy ones. This crucial result is retained also in
our enhanced model, where, as expected, simulations exhibit the final resolution of in-
flammation. An important point to observe is that there is not a significant difference
in either healing times or severity between the inflammatory model of Chapter 4 and
the chemotactically more advanced one of the current chapter. These results indicate
that these switches from chronic damage to full resolution are not heavily reliant upon
efficient chemotaxis; moreover, it is the delicate balance between neutrophil recruit-
ment due to pro-inflammatory mediators and the competing anti-inflammatory role
of macrophages that determines the ultimate outcome for these choices of parameters.
Chronic inflammatory outcomes
It is important to highlight that, even in the presence of physiological (healthy) chemo-
taxis in this enhanced model, the model still supports both healthy and chronic long-
term outcomes. The strength of the chemotactic behaviour is not sufficiently large to
out-weigh the other behaviours in the model. We illustrate this briefly in Figure 5.14,
in which we increase the parameter regulating the recruitment of macrophages from
αmr “ 0.25 to αmr “ 0.4. Figure 5.14 illustrates that a disruption of the healing
process caused by more significant initial damage and/or detrimental changes to cell
recruitment parameters can yield a chronic response, in spite of optimal chemotac-
tic motion of leukocytes. The model hence retains the fundamental bistability of all
of the models studied within this thesis, in the presence of our enhanced model of
physiological chemotaxis. A qualitatively similar result is obtained upon increasing
the parameter accounting for neutrophil recruitment via anti-inflammatory mediators
from αngr “ 0.015 to αngr “ 0.02, with figures omitted for brevity.
5.5. AN ENHANCED INFLAMMATORY MODEL 229
(a) Active neutrophils. (b) Apoptotic neutrophils.
(c) Macrophages. (d) Pro-inflammatory mediators.
(e) Anti-inflammatory mediators.
Figure 5.14: Plots for the ABM corresponding to the average results of the batch
of 100 simulations, with αmr “ 0.4 and all other inflammatory parameters as in the
second column of Table 4.4 and chemotactic parameters as in the third column of
Table 5.4. Shades around the plots represent standard deviations.
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5.5.3 Parameter sensitivity
In Figure 5.15, we examine the extent to which the inflammatory outcome depends
upon our choices of model parameters. Holding chemotactic parameters fixed at the
healthy choices calibrated in Section 5.4.2 (kgrad “ 80, σmem “ 1), we perform simula-
tions with each parameter in Table 5.5 increased by 50% (denoted by upward pointing
green triangles in the figure) and decreased by 50% (denoted by downward pointing
red triangles in the figure) and record the mean percentage change in the maximal
level of pro-inflammatory mediator c and active neutrophils n at t “ 5000. (We
omit the parameter δac from this analysis, as this parameter is directly implicated in
the non-dimensionalisation of the inflammatory model described in Section 4.3. For
parameters representing probabilities for which an increase of 50% would result in a
choice greater than one, we instead perform simulations with unit probability.) As
usual, all results are averaged across batches of 100 simulations. Since the baseline
parameter set of Table 5.5 yields a chronic outcome (Figure 5.14), we are particu-
larly interested in whether changes in parameter values can result in a switch to full
resolution (i.e. a percentage change of ´100% in Figure 5.15).
Intuitively, a reduction in the severity of the initial damage (via either c0 or r)
can result in the inflammation being fully resolved. Interestingly, the model is highly
sensitive to variations in the rate of pro-inflammatory mediator diffusion, Dc, in that
both high and low choices can drive resolution, by weakening the model’s positive
feedback or strengthening its negative feedback respectively. ForDc large, the damage
rapidly spreads spatially, attaining low levels across the domain. This results in a
much weaker neutrophil response, which is ultimately overcome by macrophages.
Conversely, for Dc small, the initial damage remains more localised, with greater
levels of pro-inflammatory mediator at the site of initial damage. This triggers more
rapid recruitment of macrophages, which in turn generate increased release of anti-
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Parameter
Reference values Decreased values Increased values
(Chronic outcome) (´50% of reference value) (`50% of reference value)
c0 1 0.5 1.5
r 10 5 15
Dc 1.5 0.75 2.25
Dg 1.5 0.75 2.25
γc 0.002 0.001 0.003
γg 0.002 0.001 0.003
δnc 0.001 0.0005 0.0015
δmg 0.001 0.0005 0.0015
pnr 0.02 0.01 0.03
pnc 0.5 0.25 0.75
pmr 0.04 0.02 0.06
pmg 0.8 0.4 1
pml 0.8 0.4 1
pma 1 0.5 n/a
αncr 0.05 0.025 0.075
αngr 0.015 0.0075 0.0225
αmr 0.4 0.2 0.6
αml 0.02 0.01 0.03
Table 5.5: Parameter values for the reference chronic outcome (second column) and
for sensitivity study with values to be tested representing decrease in half of reference
value (third column) and increase in half of reference value (fourth column).
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Figure 5.15: Parameter sensitivity analysis results showing the percentage change in
(a) the number of active neutrophils and (b) the concentration of pro-inflammatory
mediators, both with respect to the reference chronic simulation with parameter val-
ues given in Table 5.5 at final tick t “ 5000, for variations of individual parameters.
Green and red triangles represent 50% increases and decreases respectively. Bars in-
dicate change in minimum and maximum changes in percentage over 100 simulations
for each parameter. Note that a change in response of ´100% corresponds to a switch
from a chronic to a healthy outcome.
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inflammatory mediators, which once again trigger full resolution. Similarly the model
exhibits some dependence upon the pro-inflammatory mediator decay parameter, γc.
For the parameters studied in Figure 5.15, a reduction of γc is sufficient to stimulate
a greater macrophage response, yielding a long-term reduction in the severity of the
damage. The model is much less sensitive to the PDE-parameters associated with
anti-inflammatory mediators, Dg and γg, for the parameters investigated here.
Reducing the recruitment of neutrophils by increasing αncr (or decreasing pnr) or
stimulating the recruitment of macrophages by reducing αmr can switch the model
to a healthy outcome. The model is less sensitive to choices of the neutrophil re-
cruitment parameter αngr; however, more significant reductions in this parameter can
also drive resolution, as illustrated in Figure 5.12. The model exhibits a bidirectional
sensitivity to the strength of the pro-inflammatory neutrophil feedback (δnc, pnc) in
the same manner as is described for the diffusion parameter Dc above. The model
is largely insensitive to variations in the remaining parameters (for the combinations
examined here); in particular, while variations in probabilistic parameters related to
macrophages may affect the timescales associated with macrophage recruitment and
the anti-inflammatory response, these do not affect the long-term inflammatory out-
come here. The parameter αml does not affect the resolution of damage; only the rate
at which macrophages vacate the tissue after damage is resolved.
In comparison with the parameter sensitivity analysis of Chapter 4 (Figure 4.13),
we observe how the models’ responses to variations of parameters controlling the lev-
els of pro-inflammatory mediators c are driven by chemotaxis strength. In particular,
the effects of parameter Dc are less strong in the inflammatory model of Chapter 4,
due to the cells’ reduced sensitivity to the chemotactic signal. Similarly, the discrep-
ancy in the sensitivity analysis for parameters γc, pnc and δnc between Figures 5.15
and 4.13 is explained by the stronger effect that the spatial distribution of c has in
the chemotactically enhanced model.
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Finally, in Figures 5.16 and 5.17, we briefly assess the models sensitivity to our
implementation behaviours per ticks of the ABM algorithm. We note that varying
the definition of a tick does not affect the numerical solution of the PDE portions of
the model, since a separate numerical timestep is also implemented. Since all other
cellular behaviours are scheduled every tick in our model, we focus, in particular, upon
how varying the frequencies of cell recruitment affects the outcome of the model. In
all previous simulations we recruit neutrophils every two ticks and macrophages every
five ticks to account for the more rapid recruitment of neutrophils in vivo. Here (and
in Figure 5.16 and 5.17), we label the recruitment frequencies of neutrophils and
macrophages as nfreq and mfreq respectively.
In Figure 5.16, we show how variations in nfreq and mfreq affect the otherwise
healthy outcome obtained for αmr “ 0.05 (shown in Figure 5.13e). For the choices of
nfreq and mfreq shown, the outcome is still one of full resolution; the scheduling of cell
recruitment has negligible effect on the results, and only gives rise to small variations
in the time taken to resolve the damage. In Figure 5.17, we perform a similar analysis
for the baseline set of parameter values listed in the second column of Table 5.4, for
which we usually obtain a chronic outcome. For small variations in the cell recruit-
ment frequencies (e.g. nfreq “ 3 or mfreq “ 2, shown in blue and red respectively) we
obtain a similar chronic result to that previously obtained in Figure 5.14 (shown in
black here). However, for significantly slower neutrophil recruitment (e.g. nfreq “ 5;
magenta) or significantly more rapid macrophage recruitment (e.g. mfreq “ 2; green),
we may observe a switch from chronicity to restoration of health. Thus, the model
does exhibit some sensitivity to the manner in which behaviours (cell recruitment,
in particular) are scheduled; however, in most cases the model parameters listed in
Table 5.4 seem to have much greater influence upon model outcomes. We reflect on
this further in the discussion below.
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(a) Active neutrophils. (b) Apoptotic neutrophils.
(c) Macrophages. (d) Pro-inflammatory mediators.
(e) Anti-inflammatory mediators.
Figure 5.16: Results obtained on varying the frequencies of neutrophil and
macrophage recruitment (nfreq and mfreq respectively) for αmr “ 0.05,with inflam-
matory parameters as in the seventh column of Table 4.4 and chemotactic parameters
as in the third column of Table 5.4. The healthy outcome obtained for our standard
choice of nfreq “ 2 and mfreq “ 5 is shown in black. The remaining curves repre-
sent the following: nfreq “ 1 and mfreq “ 5 (blue); nfreq “ 5 and mfreq “ 5 (red);
nfreq “ 10 and mfreq “ 5 (green); nfreq “ 2 and mfreq “ 2 (magenta); nfreq “ 2
and mfreq “ 10 (cyan). While the time taken to full resolution varies slightly, these
parameters have no significant impact on the final outcome.
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(a) Active neutrophils. (b) Apoptotic neutrophils.
(c) Macrophages. (d) Pro-inflammatory mediators.
(e) Anti-inflammatory mediators.
Figure 5.17: Results obtained on varying the frequencies of neutrophil and
macrophage recruitment (nfreq and mfreq respectively) for the baseline inflammatory
parameters given in the second column of Table 4.4. The chronic outcome obtained
for our standard choice of nfreq “ 2 and mfreq “ 5 is shown in black. The remain-
ing curves represent the following: nfreq “ 3 and mfreq “ 5 (blue); nfreq “ 2 and
mfreq “ 2 (red); nfreq “ 2 and mfreq “ 1 (green); nfreq “ 5 and mfreq “ 5 (magenta).
Small variations in these parameters have negligible impact on the outcome; however,
very slow neutrophil recruitment or very rapid macrophage recruitment can switch
the outcome from chronicity to health.
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5.6 Conclusions
In this chapter we developed a model of leukocyte chemotaxis to better detail the
chemotactic mechanisms initially implemented in the previous model of Chapter 4.
In particular, the limitations introduced by the simplifications of the previous model
were tackled in this chapter by analysing specific features of cells’ directed motion.
This was done by constructing a more advanced model of chemotaxis that incorporates
cells’ persistence in motion to better replicate experimental observations.
Firstly, the biological mechanisms regulating cell migration were presented, with a
particular focus on leukocyte motility in both physiological and pathological contexts.
The relevant scientific literature was reviewed and typical modelling approaches in
terms of random walks were also presented. We proceeded by defining an ABM
accounting for neutrophils moving to a chemotactic target upon tuning of a set of
parameters that reflect significant biological features, namely bias (attraction to the
chemoattractant) and persistence (memory of past moves) in the cells’ random walk,
and are in accordance to the experimental setting of the study conducted by Sapey
et al. (2011). The model was carefully calibrated against the experimental data pub-
lished by Sapey et al. (2011) for healthy patients and COPD patients, thus allowing us
to define sets of chemotactic parameters defining both physiological and pathological
(COPD-affected) cellular motility. Variations in the values of such key parameters
can shift the model’s behaviour from a healthy scenario to a pathological one, with
particular reference to COPD. This is a proof of principle demonstrating how our
model can be to tuned to accurately describe leukocyte chemotaxis under a specific
inflammatory condition. The model retains the distinctive features of neutrophil
motility, implemented in the form of a biased persistent random walk. Simulations
resulting from both physiological and pathological scenarios are directly comparable
to experimental data. The model’s assessment is followed by an analysis of the result-
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ing simulations, calibrated against the data of Sapey et al. (2011), highlighting strong
agreement between in vitro and in silico results, confirming the model’s validity and
opening up the way to further investigations in this direction and the use of the model
as a predictive tool in both health and disease.
Finally, we incorporated our enhanced chemotaxis model into the model of Chap-
ter 4. In fact, while the model of Chapter 4 describes the inflammatory response
well in the context of an inflammatory condition with impaired chemotaxis, it omits
the observations that some seemingly chronic outcomes can actually be resolved by
efficient chemotaxis in healthy patients. This novel ABM, on the other hand, offers
an important improvement in the landscape of inflammatory models, by providing
an enhanced description of directed cell motility and successfully capturing the in-
flammatory mechanisms at play upon defective chemotaxis. In particular, we firstly
investigated the effects of impaired chemotaxis on the inflammatory outcome. Our
simulations show (in Figure 5.10) that in an impaired chemotactic regime, in which
cells are equipped with a weaker sensitivity to the chemotactic target (i.e. reduced
kgrad) and a greater persistence in their direction of motion (i.e. increased σmem),
an otherwise healthy response can be pushed to a self-perpetuating inflamed state.
We then extended the analysis of physiological cellular motility during the acute
inflammatory response by determining the different scenarios that determine the res-
olution of inflammation and, by contrast, its ongoing chronic state. Additionally, we
exposed how not all resolution is dependant on chemotaxis. In particular, the long-
term inflammatory outcome is determined by a balance between the pro-inflammatory
(positive) feedbacks of neutrophils and the anti-inflammatory (negative) feedbacks of
macrophages; conditions which enhance the neutrophil response (via e.g. δac, δnc
large or αncr small in our model) are more likely to yield a self-perpetuating inflam-
matory condition, while treatments that enhance the macrophage response (via e.g.
δmg large or αmr small) are more likely to stimulate resolution in the long-term. (See
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Figures 5.13 and 5.14.) To this end, mediated cell recruitment remains an important
therapeutic target, regardless of chemotactic strength. We concluded our investi-
gation of the model by performing a parameter sensitivity analysis, to evaluate the
model’s dependence on its parameters, exhibiting how initial conditions, cells’ recruit-
ment and regulation of pro-inflammatory mediators c can have a driving effect on the
resolution of inflammation.
Overall, the hybrid model presented here has facilitated inclusion of a greater array
of cell-specific behaviours than is afforded by many previous (mostly ODE- or PDE-
based) models. For example, the model includes a description of cells’ chemotaxis
toward pro-inflammatory mediators that is calibrated against experimental data, and
also specifically incorporates the preferential motion of macrophages toward nearby
apoptotic neutrophils. Furthermore, the model includes an explicit (while simplistic)
description of the activation of the anti-inflammatory macrophage response that can
be applied on a cell by cell basis as each macrophage undergoes its first phagocytosis
of an apoptotic neutrophil. The precise cellular and sub-cellular mechanisms that
initiate production of anti-inflammatory mediators is complex (Dunster & Drans-
field, 2016); however, the link between the phagocytosis of apoptotic cells and the
phenotypic switch of macrophages from the classically activated M1 phenotype to
the alternatively activated, anti-inflammatory M2 phenotype is well documented in
existing literature (Schnyder & Baggiolini, 1978; Korns et al., 2011; Hiemstra, 2013).
This notwithstanding, it is well-known that the M1/M2 classification of macrophages
presents a degree of over-simplification in itself, with the broad range of macrophage
phenotypes actually spanning a continuous spectrum Dunster & Dransfield (2016).
There is a great degree of scope to extend our model to include more detailed descrip-
tions of macrophage phenotypes and corresponding inflammation-related behaviours
going forward. In the model presented here, we include only the anti-inflammatory
effects of the M2 macrophage; however, macrophages of the M1 phenotype can also
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provide pro-inflammatory stimuli, which are here omitted as we focus on the dom-
inant pro-inflammatory effects of neutrophils. Our model also omits the scope for
bidirectional switching between macrophage phenotypes. More refined modelling of
the relevant cell signalling cascades that govern phenotypic switching of macrophages
remains a target for future study.
Our model exhibits significant scope to be calibrated to model specific inflam-
matory conditions in specific tissues. An open question, in this context, is that of
how to infer some parameter values directly from experiments. While the PDE pa-
rameters (Dc, Dg, γc, γg) can be inferred from existing literature to some extent,
and chemotactic parameters (kgrad, σmem) can be inferred from cell tracking experi-
ments as described here, there remains a degree of uncertainty regarding the various
threshold parameters controlling cell recruitment (αncr, αngr, αmr) and the strengths
of the corresponding inflammatory feedbacks (δnc, δac, δmg). These parameters are
likely to vary across both inflammatory conditions and affected tissues. We have the
least confidence in the precise values of the probabilistic parameters in the model;
however, we have also shown that in most cases the model’s outputs are robust to
variations in these values (Figure 5.15). Furthermore it is to be expected that our
model exhibits some sensitivity to the choice of how cellular responses are scheduled
‘per tick’, or equivalently how a tick itself is defined. We note that tick definition
affects only the agent-based components of our model, since numerical solution of the
PDEs is implemented independently. In our implementation, most behaviours are
scheduled to occur at every tick. We anticipate that alternative implementations of
most behaviours simply correspond to alternative choices of the related probabilities
or feedback parameters, and thus would not impact upon the qualitative observa-
tions presented here. The only behaviour that is not scheduled every tick here is
cell recruitment, which we schedule every two ticks for neutrophils and every five
ticks for macrophages to account for more rapid recruitment of neutrophils in vivo.
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Simulations that experiment with alternative choices of these recruitment frequencies
(Figures 5.16 and 5.17) reveal that the model is relatively robust to variations of
these values. For parameter choices that yield a healthy outcome here (Figure 5.13),
alternative choices of cell recruitment frequencies generally still result in a healthy
outcome, but with some small variation in the time taken to achieve full resolution
of damage ( 5.16). For a parameter-set corresponding to a typical chronic simulation
(e.g. that of Figure 5.14), small variations in recruitment frequencies make minimal
difference to model results; however, significantly slower neutrophil recruitment or
significantly more rapid macrophage recruitment can yield a switch from chronicity
to restoration of health in some cases (5.16). Experimental studies that quantify




In this work, we have studied a number of mathematical approaches to effectively
model a spatio-temporal description at tissue level of the acute inflammatory response.
The prominence of inflammation in several pathologies has long been established,
with the presence of low persistent levels of inflammation being a key precursor in
critical conditions such as neurodegenerative disorders (Alzheimer’s, Huntington’s,
Parkinson’s) and cancer, as well as aggravating existing comorbidities such as type-2
diabetes and Chronic Obstructive Pulmonary Disease (COPD), among others. The
clear understanding of inflammation and in particular the mechanisms controlling
its resolution remains a highly challenging objective for the scientific community,
tackled through very multidisciplinary approaches. Overall, our models address the
question of how localised damage can invade neighbouring healthy tissue, which is
not thoroughly investigated in literature. The clear understanding of such features is
a key point in preventing chronic undesired outcomes and, throughout this work, we
aimed at identifying the leading mechanisms in resolving damage.
In Chapter 2, we firstly extended an existing ODE model as a starting point
for our work. We proceeded by studying the basic underlying interactions between
pro-inflammatory mediators and cells, where the damage triggering the acute inflam-
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matory response is driven by a function of time f . We assessed the stabilities of
the steady states and investigated potential scope for pattern formation. Our thor-
ough analysis of this first simplified PDE model of inflammation revealed the key
role of a subset of biologically significant parameters, namely φ, the rate at which
macrophages phagocytose apoptotic neutrophils, and βa, a constant representing the
saturation level upon which the release of pro-inflammatory mediators depends. The
bifurcation analysis along with manipulation of sensitive parameters in simulations
and an accurate analysis of Turing instabilities excluded the model’s capability of
exhibiting spatially inhomogeneous outcomes, which prompted further investigations
into addressing this first model’s shortcomings.
In Chapter 3, we extended the PDE model of Chapter 2 by including a second
group of chemicals acting as anti-inflammatory mediators and adding a direct in-
teraction between active neutrophils and the enhanced presence of pro-inflammatory
mediators. Furthermore, we modelled cellular motion as chemotactically driven to-
ward higher concentrations of pro-inflammatory mediators. By investigating the sta-
bility of the steady states associated to the correspondent ODE system, we found
a pattern-forming regime driven by Hopf bifurcations. In particular, we found that
careful manipulation of key parameters φ, accounting for the phagocytosing rate,
and ν, representing the rate at which neutrophils become apoptotic, yield a range
of biologically meaningful outcomes, namely homogeneous resolution and restoration
of the healthy state, homogeneous damage and persistent inflammation and, most
interestingly, spatially inhomogeneous outcomes, either stationary or oscillatory, rep-
resenting chronic recurring inflammation. These chronic inhomogeneous solutions
lie in an area of parameter space for which the corresponding ODE model predicts
full resolution of damage. Having identified the areas of pφ, νq–space that exhibit
spatially inhomogeneous solutions, we examined the extent to which the balance be-
tween the pro-inflammatory feedback from active neutrophils and the counteracting
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anti-inflammatory feedback from macrophages can bias the system toward globally
inflamed or spatially inhomogeneous solutions. For strong pro-inflammatory feedback
or weak anti-inflammatory feedback, spatial patterns are eliminated and the results
of the corresponding homogeneous model are recovered. The anti-inflammatory me-
diator thus plays a key role in mediating the spatial spread of damage. While the
PDE model of Chapter 3 presents a reasonably thorough catalogue of biological in-
teractions, these are not exhaustive. The PDE modelling framework used here is
somewhat prohibitive as regards incorporating further interactions, thus motivating
a switch to the alternative strategy of agent based modelling.
In Chapter 4 we developed a novel hybrid PDE–ABM framework where cells are
accounted for as individual agents, retaining the PDE implementation for inflamma-
tory mediators. In particular, while providing a new modelling framework for mod-
elling the acute inflammatory response, we improved upon the previous PDE-based
model by including macrophages’ ability to preferentially exhibit chemotaxis toward
apoptotic neutrophils and differentiating their role with respect to their contribution
of actively releasing anti-inflammatory mediators. The key results that this alterna-
tive modelling approach provided included the individuation of a set of parameters
of biological significance that acted as switches between undesired chronic outcomes
and the resolution of inflammation. In particular, the parameters of interest control
the initial damage in terms of both severity (c0) and size (r) and the recruitment of
neutrophils and macrophages (αncr, αngr and αmr, respectively). This allowed us to
determine such biological features as key targets for therapeutic strategies, suggest-
ing minimising the sterile damage in surgical procedures on one hand and developing
tailored drug treatments for enhancing macrophage recruitment and inhibiting neu-
trophil recruitment on the other hand. The phagocytosing ability of macrophages
was also assessed, with manipulation of the phagocytosing rate decreasing the heal-
ing time. Finally, a parameter sensitivity analysis was also performed, confirming the
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robustness of the model with respect to its parameters.
In Chapter 5 we investigated the role of chemotaxis in inflammatory mechanisms.
We developed an initial ABM of chemotaxis, calibrating it against the experimental
data reported by Sapey et al. (2011). This demonstrated how our model could be
tailored to specific conditions. In particular, we modelled leukocytes’ chemotaxis in
terms of a random biased persistent walk, where cells’ motion is regulated by pa-
rameters controlling the preference to move toward their chemotactic target and the
memory of the direction the are coming from. We then included the improved descrip-
tion of chemotaxis into our ABM inflammatory model. This new chemotactically en-
hanced model of inflammation improves on the previous model of Chapter 4 by effec-
tively capturing critical inflammatory processes that are eventually resolved because
of cells’ efficient chemotaxis. A parameter sensitivity analysis further highlighted the
stronger response of the model to the spatial distribution of pro-inflammatory medi-
ators c, driven by the enhanced chemotactic mechanisms. Finally, we completed our
investigation of the chemotactically improved inflammatory ABM by evaluating the
impact of alternative choices of cell recruitment frequencies. In particular, manipu-
lating the frequencies at which neutrophils and macrophages are recruited was shown
to have minimal effects on the systems outcome when acting on a set of parameter
values that yield a healthy response, with only small variations in the healing times.
Conversely, for parameter choices that yield chronic outcomes, only large variations
of cell recruitment frequencies can yield the restoration of the healthy state in some
cases, via either a significantly increased macrophage recruitment frequency or sig-
nificantly slowed neutrophil recruitment. The model presented in Chapter 5 is the
most robust of the four models presented in this thesis, given that it includes a full
repertoire of inflammatory interactions and a description of cell chemotaxis that can
be easily calibrated against experimental data (as we have demonstrated here with
respect to COPD). The model exhibits significant scope to be tuned to model spe-
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cific tissues, ailments or clinical interventions in the future, given the availability of
suitable experimental data. The hybrid approach used is advantageous as it is read-
ily accessible to non-theoreticians, and includes stochastic rules that can be easily
adjusted to incorporate new biological insights as they arise.
In summary, in this work, we developed spatial models of the acute inflamma-
tory response, investigating the biological interactions occurring at tissue level be-
tween leukocytes and inflammatory mediators. To this end, we extended the model
of Dunster et al. (2014) into a PDE system comprising of cell populations (active
neutrophils, apoptotic neutrophils and macrophages) and two groups of chemicals
(pro- and anti-inflammatory mediators), including the description of both diffusion
and cellular chemotaxis. We observed that the addition of the anti-inflammatory re-
sponse and cellular feedback into the release of pro-inflammatory mediators are key for
the system to permit sustained inhomogeneous oscillations, corresponding to chronic
non-resolving outcomes. We further developed a novel ABM inflammatory model,
improving on the previous model by including a differentiated phagocytosing mech-
anism for macrophages and prescribing their preferential chemotactic motion toward
apoptotic neutrophils. We identified possible therapeutic strategies for the resolu-
tion of inflammation in the targeting of the initial damage size and severity and in
cells’ recruitment mechanisms. We then proceeded to develop a ABM of leukocyte’s
chemotaxis, modelling cells’ motion in terms of bias toward a prescribed chemical
and memory of past moves, calibrating the novel model against experimental data
from Sapey et al. (2011), thus providing a proof of principle for modelling specific
pathologies arising from poor chemotaxis. We finally included our improved descrip-
tion of chemotaxis into the ABM inflammatory model, investigating the impact of
physiologic chemotaxis into resolving critical inflammatory states.
The highly interdisciplinary nature of this work and the prominence of inflamma-
tion in research topics provides interesting results that can be further extended and
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investigated in future works. In particular, parametrisation remains a highly challeng-
ing issue for our modelling. To better tackle this, we suggest to identify parameters
of interest (including those regulating diffusion and chemotaxis) through experiments
tailored on specific conditions. In this regard, some parameters remain difficult to
capture with traditional laboratory techniques, increasing the need to consider a fit-
ted experimental design. Overall, to effectively investigate this, we suggest to focus
on those parameters that models are sensitive to. Another key point of interest that
prompts further studies is the more accurate modelling of the macrophage response
and the relevant cell signalling it involves. In particular, macrophage action does not
depend on a binary active/inactive state of the cells, rather operating on a spectrum
of behaviours. This feature is only partially covered in the implementation of our
ABM inflammatory model and can be further extended to better reflect the complex
behaviour of macrophages. Moreover, an important step into further integrating this
research with biology will be to consider software development aimed at providing
simulations in the biological domain. This is particularly suited for models imple-
mented through the ABM framework, for which the system’s simulation settings can
be easily designed, controlled and manipulated through a tailored Graphical User
Interface (GUI), a feature where ABMs emerge as preferable to PDE ones. In the
most recent literature, other researchers’ work investigating mathematical models of
inflammation have been mainly focused on targeting specific inflammatory conditions
(such as psoriasis (Ringham et al., 2019) and atherosclerosis (Thon et al., 2019)) or
pathologies closely linked to it, with the vast and growing research on in the field
mathematical oncology on one hand (Karolak et al., 2018) and agent-based mod-
elling applied to biology on the other hand (Vodovotz & An, 2019). As such, this
work can be conveniently extended and adapted to better describe and investigate
specific inflammatory mechanisms and diseases that arising from the inflammation’s
spread and persistence. We note that, while our models pay close attention to leuko-
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cyte movement within the tissue of interest, the description of how leukocytes arrive
from the vasculature was kept deliberately simple throughout the inflammatory mod-
els of Chapters 2–5. In reality, cell transmigration from blood vessels depends on a
complex set of events that reduce the velocity of cells flowing in blood and enable cell
adhesion to the endothelial lining, resulting in the endothelial lining itself activating
to allow cells to migrate through the vessel wall into the tissue (Nourshargh & Alon,
2014). While including all of these events would be unnecessarily complex in a model
of generic inflammatory damage, the models presented here could easily be adapted
to include feedbacks from mediators that enhance or restrict transmigration. We
note that doing so within our ABM framework may involve replacing existing rules
governing maximum global cell numbers with more localised analogues that account
for spatial variations in endothelial lining activation. Such modifications constitute
a valuable target for future work, but would be best addressed when suitable exper-
imental data are available to focus the application of the models toward answering
questions related to specific tissues or inflammatory conditions.
Furthermore, there is currently significant and growing interest in multimorbidity,
i.e. the concurrent presence of two or more chronic conditions such as COPD and
cardiovascular disease, which is more common with increasing age and is thought to
be associated with inflammation and cellular dysfunction (Hughes et al., 2020). Un-
derstanding how the inflammatory process is modified by disease, healthy ageing and
drugs, both alone and in combination, is difficult but necessary if therapeutic targets
are to be identified and their effects fully understood. The models presented in the
previous chapters are generic but can act as a framework within which future modifi-
cations in line with specific tissue and/or disease can be easily incorporated. An ex-
ample would be modelling the effects of Rheumatoid arthritis on the synovium where
macrophage numbers have been shown to correlate with disease activity and their de-
pletion has a therapeutic effect (Udalova et al., 2016; Ouboussad et al., 2019). Such
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adaptation would require, among others, changes to our description of macrophage
heterogeneity but could allow clinical investigations into the effects of drugs that tar-
get circulating monocytes and thereby reduce macrophage transmigration into tissue
(Udalova et al., 2016). In particular, with respect to the models of Chapters 4–5, the
advantage of hybrid models, which integrate constituent underlying processes across
multiple scales, is that they are easily comparable to experimental data (such as his-
tological studies) and offer easily interpreted tools that could be used in progressing
our understanding of such complex, multifaceted inflammatory scenarios. Finally,
among other key open issues that this work prompts for further investigation, there
is scope for better addressing the emerging links between ageing and inflammation
and, more in detail, the impact of ageing neutrophils on inflammatory diseases (Lord
et al., 2001).
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Reaction-diffusion systems are generally a quite mathematically convenient form of
describing many biological processes and present possible patterned behaviours in
terms of spatial instability. It is thus of great interest to precisely determine how,
even from homogeneous equilibrium states, a system can develop specific patterns and
structures (Turing, 1952). In this regard, there are different mechanisms that lead to
spatial pattern formation that are relevant and recurring in a variety of developmental
or morphogenic processes. The main focus here is on systems presenting steady state
spatially heterogeneous patterns (Murray, 2003), with the main aim of this section
being to define the conditions under which such an instability is found.
In order to derive these conditions, let us consider a generic PDE system in two
variables u, v:
ut “ fpu, vq ` Du∇2u, (A.1)
vt “ gpu, vq ` Dv∇2v, (A.2)
with equations (A.1) to (A.2) being already presented in their dimensionless form,
f and g representing the nonlinear reaction kinetics and Du and Dv the respective
diffusion constants.
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Turing’s theory explicits the constraints that allow a system in the form of (A.1)-
(A.2), given a stable steady state in the absence of diffusive terms, to develop spatial
inhomogeneity due to diffusion (in contrast with the traditional approach of regarding
diffusion as a stabilising process). To this purpose, to properly pose the mathematical
problem, given initial conditions are considered and boundary conditions are fixed.
For convenience, to be consistent with the modelling tasks that will be developed in
the following chapters, let us consider periodic boundary conditions, that is:
u, v : Ω Ă Rn Ñ R






upx1, . . . , xi´1, ai, xi`1, . . . , xnq “ upx1, . . . , xi´1, bi, xi`1, . . . , xnq
vpx1, . . . , xi´1, ai, xi`1, . . . , xnq “ vpx1, . . . , xi´1, bi, xi`1, . . . , xnq
@px1, . . . , xnq P Ω, i “ 1, . . . , n,
and let pu0, v0q be the solution associated to the steady state, satisfying
fpu0, v0q “ 0, (A.3)
gpu0, v0q “ 0. (A.4)
Since the instability of interest is spatially dependent only, the system is analysed in
function of its state variables, by determining the conditions for the linear stability of
the associated homogeneous steady state, firstly when diffusion terms are switched off
and subsequently by imposing instability of the extended system inclusive of diffusive
behaviour.
A.1 Stability of the homogeneous steady state
In the absence of diffusion, system (A.1)–(A.2) can be rewritten as
ut “ fpu, vq, (A.5)
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vt “ gpu, vq. (A.6)
In order to determine stability conditions for (A.5)-(A.6), the linearisation around
the steady state pu0, v0q is considered by defining w “ pu ´ u0, v ´ v0qJ which, given






























wt “ Aw, (A.8)
with A being the stability matrix, that is the Jacobian evaluated at pu0, v0q and its
elements conveniently renamed as fu0 , fv0 , gu0 , gv0 .
The stability constraint is then met when the steady state w “ 0 has ℜpλq ă 0, for
every eigenvalue λ. Eigenvalues can easily be determined as solutions to the equation
|A ´ λI| “ 0, with I being the identity matrix, to provide
λ1,2 “
fu0 ` gv0 ˘
a
pfu0 ` gv0q2 ´ 4pfu0gv0 ´ fv0gu0q
2
(A.9)






By exploiting well known algebraic properties relating eigenvalues to their associated
matrix, namely trpAq “ ři λi and detpAq “
ś
i λi, conditions for stability (that is
ℜpλq ă 0) can be conveniently reformulated as
trpAq “ λ1 ` λ2 ă 0 (A.11)
detpAq “ λ1 λ2 ą 0 (A.12)
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that, applied to matrix A yield respectively to
fu0 ` gv0 ă 0 (A.13)
fu0gv0 ´ fv0gu0 ą 0. (A.14)
The expressions in (A.13)-(A.14) specify the stability conditions with no spatial vari-
ations, holding for (A.5)-(A.6).
A.2 Adding diffusion

















































wt “ Aw ` D∇2w. (A.16)
A particular solution of (A.16) is in the form of










with λ representing the growth rate in time and k the wave number. Substitut-
ing (A.17) in the general expression (A.16) and considering the steady state wt “ 0
yields to
Arwpeλteikxs ` D∇2rwpeλteikxs “ 0
Awpe
λteikx ` Dwpeλtp´k2qeikx “ 0
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Awp “ k2Dwp
A ´ k2D “ 0,

















fu0 ´ k2Du fv0
gu0 gv0 ´ k2Dv
˛
‚ (A.19)
and, analogously to the stability analysis in Section A.1, the characteristic polynomial







fu0 ´ k2Du ´ λ fv0








which straightforwardly leads to







The corresponding characteristic polynomial is then
pkpλq “ λ2 ` λrk2pDu ` Dvq ´ pfu0 ` gv0qs ` hpk2q (A.20)
having defined the function hpk2q as
hpk2q “ k4DuDv ´ k2pfu0Dv ` gv0Duq ` |A|. (A.21)
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When k2 “ 0, the analysis falls within the previous case with stability guaranteed
under conditions (A.13)-(A.14). At this point, though, for instability of a spatially
inhomogeneous solution of (A.16) it is required that at least one eigenvalue λ of pkpλq
presents ℜpλq ą 0, thus at least one of the conditions given by either
k2pDu ` Dvq ´ pfu0 ` gv0q ă 0 (A.22)
or
hpk2q ă 0 (A.23)
is expected to hold.
By firstly analysing expression in (A.22), it is straightforward to notice that,
from (A.13) we have fu0 ` gv0 ă 0, thus both group of terms ´pfu0 ` gv0q and
k2pDu ` Dvq are actually always positive, therefore k2pDu ` Dvq ´ pfu0 ` gv0q ą 0
@ k ‰ 0. Hence conditions to have spatial instability have to be imposed on hpk2q
only.
Given the conditions in (A.14), for hpk2q to be negative it is necessary, but not
sufficient, that fu0Dv ` gv0Du ą 0. Furthermore, from (A.13) it is known that fu0 `
gv0 ă 0, thus for fu0 ` gv0 to be positive we require that Du ‰ Dv.
In order to meet the assumption in (A.23), a negative value for hpk2q can be
explicitly found at its minimum:
hpk2q ă 0 ñ D hmin | hminpk2q ă 0
that is easily computed by differentiating hpk2q with respect to k2 as
h1pk2q “ 2k2DuDv ´ pfu0Dv ` gv0Duq “ 0,
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´ pfu0Dv ` gv0Duq
2
2DuDv
` |A| “ (A.25)
“ ´pfu0Dv ` gv0Duq
2
4DuDv
` fu0gv0 ´ fv0gu0.
The imposition hminpk2q ă 0 thus implies that
pfu0Dv ` gv0Duq2 ´ 4DuDvpfu0gv0 ´ fv0gu0q ą 0.
The conditions for instability due to space can hence be summarised as
fu0Dv ` gv0Du ą 0 (A.26)
pfu0Dv ` gv0Duq2 ´ 4DuDvpfu0gv0 ´ fv0gu0q ą 0, (A.27)
particularly with (A.26) implying Du ‰ Dv.
A.3 Critical points
A change in stability in the system behaviour occurs when at least one of the roots
of the characteristic polynomial (A.20) is equal to zero. Thus, by conveniently refor-
mulating it as
pkpλq “ λ2 ` bλ ` hpk2q, (A.28)






which straightforwardly leads to
hpk2q “ 0 (A.30)
In this regard, for critical values of k2 such that hminpk2q “ 0, a bifurcation from
stability to spatially driven instability can be observed. To fully characterise the
stability in terms of wavenumber k let us consider hminpk2q “ 0, that is, from (A.25):
fu0Dv ` gv0Du “ 2
a
DuDvpfu0gv0 ´ fv0gu0q “
a
2DuDv|A|. (A.31)
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By computing the roots of hpk2q, as defined in (A.21), the interval rk1, k2s of spatial
instability can be found:
hpk2q : k4DuDv ´ k2pfu0Dv ` gv0Duq ` |A| “ 0
k2
1,2 “
fu0Dv ` gv0Du ˘
a
pfu0Dv ` gv0Duq2 ´ 4DuDv|A|
2DuDv
.
Accordingly, the interval of spatial instability can be expressed in function of the
wavenumber k, or analogously of its squared value k2 such that:
hpk2q ă 0 for k2
1
ă k2 ă k2
2
, k2c P rk21, k22s | hpk2c q “ 0.
Appendix B
Routh-Hurwitz criterion
The Routh-Hurwitz criterion, originally independently proposed by both mathemati-
cians E. J. Routh and A. Hurwitz ((Routh, 1877), (Hurwitz, 1895)) providing neces-
sary and sufficient condition for the roots of a polynomial to present, respectively, all
positive and all negative real parts, determines the number of positive and negative
real part roots of a given polynomial by its coefficients ((Allen, 2006)). This result
derives from the more general Routh-Hurwitz theorem ((Meinsma, 1995), (Murray,
2001)).
Theorem 1. A polynomial ppxq “ anxn ` an´1xn´1 ` ¨ ¨ ¨ ` a0, with ai P R, i “
0, 1, . . . , n and a0 ‰ 0, is stable if and only if all elements of the first column of the
associated Routh matrix Rppq are nonzero and have the same sign.
Given the polynomial
ppxq “ anxn ` an´1xn´1 ` ¨ ¨ ¨ ` a0 “ 0 (B.1)
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where elements bi, ci and followings directly depend on the polynomial coefficients
and are computed as determinants of the minor matrix taking elements of column I
and the column to the right of the current position and the two rows above, divided



















The matrix construction ends as soon the computing procedure leads to a single
null determinant matrix, while, where not present, all other matrix elements are to
be considered zero. The sign permutations of the elements of the first column of
the Routh matrix Rppq determine the stability of the associated polynomial, with
each sign variation corresponding to a positive real part root and conversely each
permanence to a negative real part root.
The information on the sign of the real part of polynomial roots provided by this
criterion, straightforwardly leads to important implications in systems control and
stability, particularly by studying the corresponding eigenvalues real part signs by





Chapters 2, 3, 4, 5
γc rate of mediator decay
γg rate of anti-inflammatory mediators’ decay
Dc pro-inflammatory mediator diffusion constant
Dg anti-inflammatory mediators diffusion constant
Chapters 2, 3
χn maximal rate of neutrophil’s influx
ν neutrophil’s apoptosis rate
γa rate of necrosis of apoptotic neutrophils
φ rate of apoptotic neutrophil’s removal by macrophages (secondary
necrosis)
χm maximal rate of macrophages’ influx
α mediator’s production rate
Continued on next page
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Table C.1 – continued from previous page
Parameter Definition
βa apoptotic neutrophils’ saturation constant (concentration of apop-
totic neutrophils required for half maximal release of cptq)
γm rate at which macrophages leave the tissue
βn active neutrophils’ saturation constant (concentration of active neu-
trophils required for half maximal release of cptq)
βgc inflammatory mediators’ saturation constant (concentration scale
over which neutrophils influx rate decreases)
βg anti-inflammatory mediators’ saturation constant (concentration of
anti-inflammatory mediators over which apoptosis rate increases)
βc pro-inflammatory mediators’ saturation constant (concentration of
pro-inflammatory mediators over which apoptosis rate decreases)
γg rate of anti-inflammatory mediators’ decay
θn active neutrophils’ chemotaxis constant
θm active macrophages’ chemotaxis constant
Dn active neutrophil’s diffusion constant
Dm macrophage’s diffusion constant
ka mediator’s concentration produced by apoptotic neutrophils
kg anti-inflammatory mediators’ production from macrophages (concen-
tration of gptq produced in response macrophages presence)
kn pro-inflammatory mediators’ production from active neutrophils
(rate of cptq concentration produced in response active neutrophils
presence)
Continued on next page
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Table C.1 – continued from previous page
Parameter Definition
Chapters 4, 5
c0 initial pro-inflammatory mediators’ concentration (damage severity)
r initial damage’s radius (damage size)
δac increment of pro-inflammatory mediators upon apoptotic neutrophils
undergoing necrosis
δnc increment of pro-inflammatory mediators upon active neutrophils ac-
tivity
δmg increment of anti-inflammatory mediators upon macrophagic activity
pnr probability of recruitment of new neutrophils
pnc probability conditioning release of pro-inflammatory mediators upon
neutrophils activity
pmr probability of recruitment of new macrophages
pmg probability upon which macrophages initiate the anti-inflammatory
response
pml probability at which macrophages leave the tissue
pma probability at which macrophages phagocytose apoptotic neutrophils
αncr threshold of pro-inflammatory mediators above which new neu-
trophils are recruited
αngr threshold of anti-inflammatory mediators below which new neu-
trophils are recruited
αmr threshold of pro-inflammatory mediators above which new
macrophages are recruited
Continued on next page
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Table C.1 – continued from previous page
Parameter Definition
αml threshold of pro-inflammatory mediators below which macrophages
leave the tissue
ncell number of neutrophils
Achem maximum concentration of chemoattractant
nrun number of moves per tick
βrand threshold minimum concentration of chemoattractant for chemotac-
tic motion
σmem standard deviation associated with the likelihood of cells changing
their direction of motion
kgrad scaling parameter appearing in the weighting function of (5.2)
Table C.1: Parameters appearing in the models of Chapters 2–5.
